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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Bacteria which belong to the family Mollicutes and genus Mycoplasma, referred to as 
mycoplasmas, are commonly found in nature. The term mollicutes will be used to refer to all 
members of the family, including the nonpathogenic Acholeplasma species. While many 
mycoplasma can be considered part of the normal commensal flora in vertebrates, others are 
well established pathogens of man and animals (219). The diseases resulting from 
mycoplasmal infections are usually chronic in nature with the host inunune system playing 
an important role in development of pathological lesions. Areas of colonization are usually 
limited to the lungs, genital tract and joints. Diseases are often high in morbidity, but 
mortality is rare. 
Although initially classified together because of their conmion lack of a cell wall, these 
prokaryotes have many other features in conunon. They are among the smallest and simplest 
bacteria known. Genetically, they contain small genomes, have one to two copies of rRNA 
genes, and have a limited number of tRNAs. Biochemically, they lack most metabolic 
pathways, exhibited by the inability to produce amino acids, fatty acids, cholesterol, and 
nucleotides. Hence, it is not surprising to find them in a parasitic relationship. Razin has 
written the following: 
Living in the relatively constant enviroimient of their host, mycoplasmas could do 
without the protection of a rigid cell wall. In this way the considerable number of 
genes involved in synthesis of the bacterial wall polymers were eliminated. On 
becoming parasites, mycoplasmas could do without many biosynthetic and 
degradative pathways and thus do without a considerable number of genes. In fact, 
mycoplasmas depend on their host for essentially the complete spectrum of amino 
acids, fatty acids, cholesterol and vitamins (169). 
This gene absence includes the tricarboxylic acid pathway in all mycoplasmas and the 
glycolytic pathway for a select few (169). The recent completion of the sequencing of the 
entire genome of Mycoplasma genitalium verifies the lack of metabolic capabilities in the 
mycoplasmas (62). 
In any parasitic relationship, the boundary between the parasite and the host is a 
battlefield. The parasite must acquire nutrients and the host must engage in defense. In 
mycoplasmal infections, the battlefield location is the membrane interface between the 
mycoplasma and the epithelial cell of the mucosal surface. Mycoplasmas maintain a tight 
adherence to this epithelial layer in spite of an active immune response by the host. 
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Consequently, the study of adherence has been a primary thrust of mycoplasma research. In 
spite of this activity, an understanding of actual adherence mechanisms from any 
mycoplasma species has remained elusive. Likewise, an understanding of the host defense 
strategy is lacking. It is well known that the host defense is ineffective at clearing the 
organism, and often the continued assault by the host defense system leads to a much more 
serious destruction of host tissues. 
Adherence factors are the most well known and characterized proteins of the mycoplasma 
membrane. However, other activities must be present at the surface to acquire the necessary 
nutrients mycoplasmas need to survive and to evade itself from the immune system. Along 
with the adhesins, the membrane components shown in Table 1.1 have been identified. In no 
case have these functions been proven. 
Table 1.1. Membrane activities of mycoplasmas 
Activity Putative Function 
Mitogens nonspecific stimulation of the immune system leading to a 
nonproductive host defense (146) 
Variable lipoproteins evasion of the immune system (231) 
Capsules antiphagocytic (217) 
Fc, Fab binding proteins alter antibody function (217) 
Hemolysins acquisition of cholesterol and phospholipids (83) 
Phospholipases acquisition of phospholipids (217) 
Nucleases acquisition of nucleotides (139) 
This dissertation focuses on the membrane-associated nucleases of mycoplasmas. 
Mycoplasmas must acquire nucleotides from their surrounding environment, and it is 
hypothesized that the nucleases are involved in this acquisition process. Although 
mycoplasmas must have intemal nucleases for DNA repair systems, and in a few species 
restriction-modification systems have been discovered (50,195), membrane-associated 
nucleases had only been discovered in Mycoplasma pulmonis (139). This research has mainly 
study those nuclease activities associated with the membrane of the genus Mycoplasma. The 
following hypothesis has been examined: 
Since purines and pyrimidines are essential mycoplasma nutrients and must be 
obtained from the host environment, nuclease activities are an important part of 
mycoplasma membranes. Consequently, it is proposed that mycoplsismas produce 
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multiple membrane-associated nucleolytic proteins as products of different structural 
genes. This redundancy would serve to reduce the likelihood of lethal mutations 
arising at high frequency in a single essential gene and thus prolong survival of the 
organism. 
The specific aims of the project are as follows: 
• To establish nuclease detection assays 
• To examine the prevalence of membrane nucleases in various mycoplasma species 
• To characterize the membrane nucleases of M. pulmonis biochemically 
• To clone at least one membrane nuclease gene of M. pulmonis and characterize the 
sequence 
• To search for similar sequences in other mycoplasmal species 
Dissertation Organization 
This dissertation has been prepared in an alternative thesis format, and contains five 
chapters. Chapter 1 is an general introduction and contains the literature review. Chapters 2 
through 4 are manuscripts complete in themselves, with an abstract, introduction, materials 
and methods, results, discussion, and acknowledgments. The second chapter has been 
published and discusses the prevalence of nucleases among many different species, and 
characterizes the amount of activity present and the nucleolytic protein pattems by sodium 
dodecyl sulfate-polyaciylamide gel electrophoresis. The third chapter details the discovery of 
at least two nuclease genes from a genomic library and characterizes one gene with regard to 
its sequence and amino acid profile analysis. Finally, the fourth chapter describes the 
presence of the nucleotide exclusion repair system in mycoplasmas. A general discussion of 
this research is presented in Chapter 5. The references cited in the text are located after 
Appendix C. Appendix A and Appendix B report the biochemical analysis of the nucleases 
from Acholeplasma oculi and M pulmonis. Appendix C is a listing of all plasmids 
constructed during this project 
Literature Review 
An ideal parasite may be described as an organism which is able to survive and replicate 
itself in a dependent relationship with the host for an extended period of time with little or no 
apparent recognition by the host's inmiune defenses. These organisms must also be able to 
spread to other sites. In most aspects, mycoplasmas are ideal parasites. These organisms 
acquire most of their macromolecules from the host and live in a saprophitic relationship for 
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months or even years without elimination. Clinical symptoms resulting from most 
mycoplasmal infections often go unnoticed or result in only subtle physical changes. 
The purpose of this section is to review the current knowledge of the mycoplasma 
infectious processes. Specifically, it is of interest to know why mycoplasmas exist in a 
parasitic relationship rather than being able to survive as true free living organisms. It is also 
of interest to study aspects of the host inmiune response against these organisms and the 
resultant tissue destruction associated with the disease. In many mycoplasmal species, 
described membrane activities are postulated to aid in maintaining and furthering continued 
survival in the host. The last section of the literature review will discuss the characteristics of 
several nonspecific bacterial nucleases which have been described and the nuclease activities 
found in mycoplasmas. 
Mycoplasmas 
General characteristics 
Mycoplasmas contain essentially the minimal mmiber of organizational units which are 
apparently necessaiy for cell growth and replication: a plasma membrane to separate itself 
from the exterior environment; ribosomes and a minimal number of tRNAs used to assemble 
proteins; and a circular double-stranded DNA molecule to provide the necessary genetic 
information (166,169). Their genome sizes range firom 580 kilobase pairs (kbp) for M. 
genitalium to 1350 kbp for Mycoplasma mycoides subspecies mycoides (20,62). It has been 
held that only DNA polymerase m is used by mycoplasmas to replicate the chromosome 
(169) but in the DNA sequence of both M. genitalium and Mycoplasma capricolum, a DNA 
polymerase I homolog was found (19,62). Most chromosomes contain one or two rRNA 
operons. In comparison, Escherichia coli contains seven rRNA operons (20). Only 29 of the 
potential 61 tRNA types have been found in M. capricolum (20), and 33 tRNAs, 
corresponding to 32 different anticodons, were recently identified in Mycoplasma 
pneumoniae (201). One of these tRNAs deserves attention. Mycoplasmas produce a 
tryptophan charged tRNA with the anticodon TCA (80,233). In the universal genetic code, 
the UGA codon is a stop codon, has no corresponding tRNA, and is recognized by release 
factor 2 to bring about translation termination. 
The gene organization of mycoplasmas and mechanisms of transcription and translation 
are similar to other eubacteria (20). Both monocistronic and polycistronic transcriptional 
units have been characterized, but repressor proteins have not been identified (20). Assuming 
that 20-30% of the genome consists of intergenic spacer regions, transcriptional signals, etc.. 
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the estimated coding capacity of mycoplasmias is between 400-500 proteins (143). The 
genome of M. genitalium encoded for 482 genes, comprising 88% of the genome, and it is 
thought to reveal the near-minimal set of genes required for independent life (73). This 
number of proteins is insufficient to supply all of the anabolic pathways. 
Mycoplasmas contain a truncated respiratory system. They lack quinones and 
cytochromes, components of the electron transport system. In fermentative mycoplasmas, all 
ATP is generated through glycolysis. Nonfermentative mycoplasmas lack the glycolytic 
cycle and produce ATP by a 3-enzyme arginine pathway (91,165). 
There is also well documented evidence that mycoplasmas lack the ability to synthesize 
their nucleotides, phospholipids and cholesterol and many of the amino acids and vitamins 
(reviewed in (131)). All mycoplasmas lack the orotic acid pathway for pyrimidine synthesis 
and the enzymatic pathways needed for de novo synthesis of purine bases (165). Pyrimidine 
and purine phosphorylases are present to convert nucleotide phosphates to the corresponding 
free base (166). Mycoplasmas are also either partially or totally incapable of synthesizing 
long chain fatty acids (204). Some mycoplasmas, like Mycoplasma gallisepticum, even 
require preformed phospholipids for growth (176). In most prokaryotes, the plasma 
membrane fluidity is mauitained by the preferential fatty acid synthesis and incorporation. 
However, membrane fluidity in mycoplasmas is influenced by the phospholipids they obtain 
from the environment and is regulated by the incorporation of cholesterol. 
The deletion of the majority of metabolic and biosynthetic pathways is advantageous 
from an energy standpoint, but adapting to a parasitic mode of life has its disadvantages. An 
increased dependence on transport and acquisition processes is obviously required. In 
addition, mycoplasmas appear to establish a tight interaction with the host cell surface to 
possibly facilitate the acquisition of macromolecules. 
Genome sequencing 
Because of the relatively small genome size of mycoplasmas and their association with 
human disease, the genome of mycoplasmas are actively being sequenced in three different 
genome projects. The genome of M. genitalium has now been completely sequenced and the 
sequence deposited in the Genome Sequence Data Base (GSDB) (accession number L43967) 
Additional sequence similarity data and coordinates of the predicted coding regions are 
available at URL http://www.tigr.org (62). Information for the M. capricolum sequencing 
project, although not complete, has been deposited in the EMBL database with accession 
numbers from Z33005 to Z33376 (19). The genome of M. pneumoniae is also being 
sequenced and some sequence information has been deposited in GrenBank. M. genitalium 
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and M. pneumoniae were selected for genome sequencing because of their association with 
human disease. M. genitalium appears to have the smallest genome among the mycoplasmas 
and would represent the minimal number of genes required by mycoplasmas to survive. By 
comparison M. capricolum has one of the larger genomes among the mycoplasmas and does 
not have many of the growth requirements of other mycoplasma species. Sequencing of this 
species would indicate the wide range of proteins that can be found in mycoplasmas, and the 
maximum information mycoplasmas may contain while still being classified as a 
mycoplasma. 
The genomic sequencing of these species verifies many of the biochemical aspects of 
mycoplasmas known for years, such as truncated respiratory systems, and lack of amino acid, 
lipid and nucleotide metabolic pathways. The sequence data has also filled in informational 
gaps. For instance, DNA repair has not been studied in mycoplasmas, and the sequence 
information sheds light on the types of repair systems mycoplasmas use. It is tempting to 
assume that since the homologs for many E. coli ox Bacillus subtilus proteins are present, 
these proteins must fimction in the same maimer as they do in other bacterial species. The 
wisest course of action, however, is to use the information to guide research endeavors. 
Goffeau in a commentary writes the following; 
How rapidly will the new information be exploited at the biochemical level? Two 
facts might hinder such progress, which in principle could result in a definition of the 
minimal biochemical mechanisms and pathways required for life. One limiting factor 
might be the relatively small size of the scientific community actively working on 
molecular aspects of this bacteria (probably a few dozen compared to the thousands 
of molecular biologists studying yeast or Escherichia coli). Another difficulty is that 
the tools of classical or molecular genetics cannot be applied; no auxotrophic or other 
mutants are presently available for this parasite, which cannot grow on synthetic 
media. For further studies to take place, each of the M. genitalium genes should be 
over expressed in a heterologous host - a procedure that remains cumbersome (73). 
Mycoplasma pathogenesis 
Adherence factors 
The prerequisite for mycoplasma parasitism and infection is attachment of the organism 
to the host cell surface (172). Invasion into the submucosal areas is a rare event. Adherence 
of mycoplasmas has been actively studied since their discovery, and the genetic and 
biological basis of adherence are the best studied areas in mycoplasmology. Most adherence 
studies have been performed with the human pathogens M. pneumoniae and M. genitalium. 
These two species are closely related, and many of the adherence factors found in one have 
been later discovered in the other. Because M. pneumoniae and M. genitalium are both flask 
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shaped organisms and produce a specialized attachment tip, their adherence mechanisms are 
distinctly different than those of other mycoplasma species which have no similar structure. 
The best characterized adhesin is the 170 kDa PI protein of M. pneumoniae (reviewed in 
(10,172)). This protein is densely clustered in the attachment tip with small amounts of the 
protein randomly distributed in the remainder of the cell membrane. The proline-rich C-
terminus is believed to assist in the topological organization of the adhesin in the membrane 
(172). Mutants lacking PI are unable to attach to epithelial surfaces and monoclonal 
antibodies directed towards PI also block adherence (10). The sequence and genetic 
organization of PI have also been well characterized. PI is part of a three gene operon. 
Hybridization of PI sequences with the genome indicated that as much as two-thirds of the 
structural gene for PI could be found in multiples copies (211). Within these multiple copies 
are several different repetitive elements, and it has been proposed that rearrangements may 
occur by placing different copies of a repetitive element within the coding region of a 
structural gene (186). These repetitive elements appear to have a core element which is 
surrounded by other larger variable repetitive mosaics (58). Su et al postulated that sequence 
diversity generated by genetic recombination within the structural gene for PI and PI-related 
sequences may affect not only immunogenicity of PI but, more importantly, the 
cytadherence of Af. pneumoniae and thus ultimately tissue tropism and pathobiology (211). 
Clearly, the importance of PI to an infection by M. pneumoniae cannot be underestimated. 
The finding of PI positive nonadhering mutants of M. pneumoniae suggested that PI 
alone was insufficient to mediate attachment. Using these mutants, various proteins have 
been shown to either be involved directly in adherence or involved in organizing PI in the 
attachment tip. Cytadherence mutants have been classified into the following groups. Class I 
mutants fail to produce five high molecular mass proteins designated HMWl to HMW5 (10). 
They also fail to cluster the cytadhesin PI at the tip of the attachment organelle. These 
proteins have been shown to be part of a cytoskeleton-like scaffolding network in the 
mycoplasma cell (207,208), and several of them are phosphorylated (44). Like PI, these 
proteins also are rich in proline (44,152). Mutants of this class arise spontaneously and a 
potential regulatory locus important in their expression has recently been identified (75). 
Class n mutants lack the 30 kDa adhesin, which is also clustered in the attachment tip and 
has a proline rich C-terminus (10). Class HI mutants lack proteins designated A, B and C (72, 
85 and 37 kDa, respectively) (10). These proteins appear to be encoded in the same operon as 
PI and are located near PI in the tip structure (61,106-108). Class IV mutants are 
represented by a single mutant which lacks PI and proteins A, B, and C (10). This mutant has 
not been studied further. Research continues to define the gene products required for 
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attachment and construction of the specialized attachment tip. Recently, a proline rich 65 
kDa protein was also identified as a component of the scaffolding in the attachment tip (161). 
The primary receptors for M. pneumoniae are the sialoglycoconjugates on the host cell 
surfaces (reviewed in (95,168)). However, neuraminidase treatment of these receptors does 
not completely abolish adherence, indicating that other types of receptors are also used by 
this pathogen. Other receptors implicated in M. pneumoniae adherence are sulfated 
glycolipids on metabolically active cells (97) and a sialic acid-fiee glycoprotein (68). 
Together, all of these receptors account for 90% of the attachment of M. pneumoniae to cell 
surfaces (61). Sialoglycoconjugates have also been demonstrated to be receptors for Af. 
genitalium, M. gallisepticum, and Af. synoviae. 
Adhesins in other mycoplasma species have also been identified. In Af. genitalium, a PI 
like protein termed MgPa has been described and sequenced. It is similar both biochemically 
and genetically to the PI protein. It has a proline rich C-terminus, is localized to the 
attachment tip and the chromosome has multiple copies of the gene sequence (39). The 
hydrophobicity plots of the C-termini of the two proteins are almost superimposable (40), 
and antibodies to one protein are capable of blocking adherence of the other (10). In addition, 
to the complete operon, nine repetitive elements that share sequence homology with the 
MgPa region are found in the genome, equaling 4.7% of the chromosome (62). Recent 
sequence data from different isolates suggests that recombination between these repetitive 
regions and the MgPa operon occurs. This recombination may result in antigenic variation 
within the MgPa protein and potential evasion of the host immune response (158). 
Homologues of the P30 and HMW3 have been discovered in Af. genitalium (175), and Pl-
like adhesin genes have been described for Mycoplasma pirum (215), Af. gallisepticum (45), 
and Mycoplasma synoviae (142). 
Several potential adhesin factors in Af. gallisepticum have been described; a 155 kDa 
protein was found which reacted to antiserum against PI (172), an open reading frame 
encoding a 193 kDa protein was identified by PCR using PI-specific sequences (45), a 64 
kDa lipoprotein appears to function in hemagglutination (60), and a 67 kDa surface protein 
termed pMGA (124) also seems to be involved in hemagglutination. There is the possibility 
that the 64 kDa protein, the 67 kDa protein and a 69 kDa protein isolated by lectin affinity 
chromatography (23) are identical and that the differences may be attributable to differences 
in experimental conditions (124). The pMGA appears to be a lipoprotein (126), and multiple 
copies of the pMGA gene are found in the Af. gallisepticum chromosome (125). When four 
of these genes were analyzed, it was determined that mRNA was produced from all four 
genes with the mRNA coding for the predominant antigen on the cell being produced at 
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levels 20 to 40 times the amount of the others. Thus, it appears likely that there is some 
mechanism for transcriptional control in the selection of the pMGA gene expressed (72). 
In contrast to the sialoglycoconjugates being the primary receptors for many of the above 
described adhesins, other mycoplasma species predominantly ^pear to use sulfated residues 
(113). Mycoplasma hyopneumoniae has been shown to bind to several diverse sulfated 
carbohydrate sequences in glycolipids, suggesting that there are several different receptors on 
the host cell surface (241). Further study of M hyopneumoniae has implicated a 97 kDa 
protein (242) in adherence. Mycoplasma hominis has also been shown to bind primarily to 
sulfated glycolipids (153) and several potential cytadhesins have been identified (76). M. 
pulmonis has been shown to bind to sulfated glycolipids (112) and adherence to red blood 
cells is blocked by sulfated residues (83). 
Adherence of Mycoplasma penetrans appears to occur through flbronectin binding (71). 
This species has been associated with acquired immunodeficiency syndrome (AIDS) and is 
one of three mycoplasmas believed to reside intracellularly in the host (74). The binding to 
fibronectin appears to induce a cytoskeleton reorganization in the cell, potentially leading to 
host mediated internalization of the organism (71). 
There are a few overriding themes presented by the study of the adherence factors of 
mycoplasmas. First, these organisms use more that one adhesin type to attach to the host cell 
surface thus extending their tissue and cell specificity. Second, a significant percentage of 
genomic information is used for the adhesins. The genes are repeated, at least partially, in all 
species examined at the genomic level. It is estimated that the PI sequences comprise up to 
6% of the chromosome in M. pneumoniae (172). It is assumed that further research will 
continue to find additional adhesins and cellular receptors. 
Host immune response 
Disease causing mycoplasmas have been found in virtually every mammal. Table 1.2 lists 
many of the major pathogens by host species and site of infection. Most mycoplasmas 
isolated from animals are not known to cause disease, and of those that do cause disease, the 
incident of disease may be sporadic (197). There is also a high degree of variability in 
pathogenesis among mycoplasma strains of the same species. Avirulent strains occur 
naturally, and there can be carriers with no apparent disease until the host is stressed. 
Simecka et al. has stated the following regarding pathogenesis: 
The pathogenesis of mycoplasma disease is a complex process influenced by the 
genetic background of both the host and the organism, enviroiunental factors, and the 
presence of other infectious agents. Although many virulence factors have been 
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Table 1.2. Diseases caused by mycoplasmas* 
Host Organism Type of Disease 
Human 
Cattle 
Sheep, goats 
Swine 
Poultry 
Horses 
Rodents 
M. pneumoniae 
M. hominis 
M. genitalium 
M fermentans 
M.fermentans subsp. 
incognitus 
M. penetrans 
M. pirum 
M. mycoides subsp. 
mycoides SC 
M. bovis 
M. bovoculi 
M. dispar 
M. bovigenitalium 
M. bovirhinis 
M. califomicum 
M. alkalescens 
M. canadense 
M. agalactiae 
M. capricolum 
F38 mycoplasma 
M. capri 
M. mycoides subsp. 
mycoides LC 
M. ovipneumoniae 
M. conjunctivae 
M. hyopneumoniae 
M. hyorhinis 
M. hyosynoviae 
M. gallisepticum 
M. meleagridis 
M. synoviae 
M. iowae 
M. equigenitalium 
M. equirhinis 
M. felis 
M. arthritidis 
M. pulmonis 
Respiratory 
Urogenital 
Urogenital, Respiratory 
Urogenit^ 
Intracellular, associated 
with AIDS 
Intracellular, associated 
with AIDS 
associated with AIDS 
Respiratory, arthritis 
Respiratory, mastitis 
arthritis 
Ocular 
Respiratory, mastitis 
Mastitis, Urogenital 
Mastitis, Respiratory 
Mastitis 
Arthritis, Respiratory 
Mastitis 
Arthritis, mastitis, systemic 
Respiratory, arthritis, 
systemic 
Respiratory 
Respiratory 
Respiratory, ar^tis, 
systemic 
Respiratory 
Conjunctiva 
Respiratory 
Ai^tis 
Arthritis 
Respiratory, Sinuses, eggs, 
urogenital 
Airsacs 
Airsacs, arthritis, eggs 
Airsacs, joints 
Urogenital 
Throat, tonsils 
Respiratory 
Arthritis 
Respiratory, Urogenital, 
Artiiritis 
* taken from (95,183,197) 
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suggested for various mycoplasmas, there is no clear case of cause and effect between 
these factors and pathogenicity (197). 
Also contributing to the pathology of mycoplasma infections is the host immune response. A 
lymphocytic infiltration is an integral part of lesion development (197). There is a balance 
reached between the host and the mycoplasmas which leads to a persistent long term 
infection in most situations. 
Humoral immune response 
The interaction of B cells with mycoplasmas can be divided into two categories, a 
specific response designed to bring about protection to the host, and a nonspecific response 
caused by the mitogenic properties of mycoplasma membranes. Humoral antibody responses 
cannot protect against mycoplasmal disease but they seem to prevent dissemination of 
infections to other tissues. Immune responses may also contribute to the development or 
exacerbation of disease (199). Although it was initially felt that antibodies were of primary 
importance in the clearance of the organisms, it has now been conclusively shown that 
development of an antibody response is usually insufficient to rid the host of mycoplasmas. 
In some situations, resistance to infection can be transferred passively with antibodies, as in 
protection of mice from M. pulmonis. However, even with the same species, passive transfer 
of antibodies does not work in other situations, as shown in the lack of protection to M. 
pulmonis in rats (78). 
Antibodies of the IgM, IgG and IgA classes are produced during mycoplasma infections, 
but their production often occurs after the infection has established itself. In some cases, 
detectable levels of antibodies are not produced for weeks or even months after infection. 
IgM are detected initially, and the presence of IgM antibodies usually indicates an active 
disease rather than a prior infection or carrier state (199). The antibody class that appears 
second in the infection is dependent upon the host, the species, and route of infection. There 
may be some preferences for the production of particular subclasses of IgG, and the 
regulation and development of those subclasses may be important in defense mechanisms 
(197). The antibody at the local site may be much more important than a systemic immune 
response. The initial events in the development of immunity most likely occur either at the 
site of infection or within nearby lymphoid tissue (199). The most important functions for 
antibodies are in the activation of complement and in opsonization, both of which are 
actively used against the organism. 
The extent of the humoral immune response may also play a role in the severity of the 
disease. With M. pulmonis, severity of disease appeared to correlate with antibody response. 
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Simecka et al. found that in LEW rats, which have more severe disease when infected with 
M. pulmonis, the antibody responses were greater than those found in the relatively resistant 
F344 rats (196,198). Antibody responses may also contribute to disease through the 
formation of immune complexes, as has been suggested for mycoplasma-induced arthritis 
(225). 
Cellular immune response 
The lymphocytic infiltrate seen in the lesions of a mycoplasma infections can contain 
neutrophils, macrophages, natural killer (NK) cells, and T and B lymphocytes. Phagocytosis 
of mycoplasmas has been the subject of a recent review by Marshall et al. (127). Several 
factors appear to determine the capacity of the host to eradicate mycoplasmas. First, 
phagocyte activation, either induced directly or through cytokine production, is important in 
determining mycoplasmacidal activity. Second, the efficiency of phagocytosis varies with 
both the strain of mycoplasma and the individual host. Third, the nature and origin of a 
phagocyte influences its capacity to engulf and destroy mycoplasmas, probably as a result of 
differences in receptors or killing mechanisms. Finally, environmental factors may help 
modulate the host immune system (127). Mycoplasma antigen is probably sufficient to attract 
phagocytes to the site of infection, but even after recruitment of the cells, the antigen persists 
at the location. There is no evidence for phagocytosis of mycoplasmas by neutrophils or 
macrophages in the absence of antibody, although this point is subject to debate (127). 
Usually, after opsonization, phagocytosis occurs rapidly and the mycoplasmas are killed 
intracellularly (127). 
The adherence of mycoplasmas to the membrane of the phagocytic cells appears to 
influence phagocytosis. This adherence may both stimulate the phagocyte and actually inhibit 
the uptake of other bacteria (reviewed by (197)). These observations may explain why 
mycoplasma infections activate macrophage function while also increasing susceptibility to 
other infectious agents. There is also evidence that macrophages are also able to kill surface-
associated mycoplasmas through the release of hydrolytic enzymes and activated 
complement components (214). 
Several components from mycoplasma membranes have been shown to induce the 
release of TNF-a, INF-y, IL-1 and/or IL-6 from monocytes. Presumably, this stimulation also 
occurs in vivo with monocytes and macrophages. Faulkner et al. (53) undertook a study to 
examine the gene expression and production of various cytokines as they may be associated 
with pathogenesis in M. pulmonis infection in mice. IL-1 a and TNF-a were detected as early 
as 1 hour after infection. EL-ip and IL-6 were seen at four to six hours after infection. INF-y 
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was not evident until 24 hours post infection. It was suggested that these cytokines were 
produced by alveolar macrophages. Those studies implicated TNF-a production in the 
pathogenesis caused by M. pulmonis. TNF-a plays a role in the stimulation of inflammatory 
cytokine production, but it is not solely responsible for the acute inflammatory lesions. IL-1 
may mediate, along with TNF-a, neutrophil recruitment. The role of IL-6 was unclear, but it 
was suggested that this cytokine may modulate the inflammatory response and may have 
both local and systemic effects during the disease progression. In a similar study, IFN-y and 
TNF-a were detected 24 hours after infection and the results supported the idea that 
cytokines released from the lung tissue may be responsible for disease progression by 
influencing vascular permeability and accumulation of inflammatory cells (149). 
The release of INF-ymay account for the enhanced NK activity in mycoplasma infections 
(197). Alternatively, the mycoplasma mitogens may upregulate NK activity, as has been 
shown with the M. arthritidis mitogen (37). It has been suggested that NK cells may function 
in limiting the spread of certain mycoplasmas, rather than actual clearance from the site of 
infection (197). In studies using BALB/c mice or mice with severe combined 
immunodeficiency infected with M. pulmonis, clearance of mycoplasmas was inhibited 
significantly by antibodies directed to IFN-y or NK cells (103,104). This indicated that the 
NK cells may be the principle cell responsible for mycoplasmacidal activity in the respiratory 
tract of mice (41). 
T cells appear to have conflicting roles in some mycoplasma diseases, and T cell subsets 
may have different effects on the pathogenesis of mycoplasma disease (197). Rats and mice 
deficient in T cells develop less severe respiratory disease than do normal animals after 
infection with M. pulmonis (43,234). The role of T cells in a mycoplasma infection has not 
been extensively studied. 
Cell components which affect the host immune response 
The membranes of mycoplasmas contain many different components which not only give 
rise to antibodies in the host, but also influence immune cells. Many of the mycoplasma 
species have been shown to have mitogenic activity associated with their membranes 
(reviewed by (128,146)). A partial list includes M. pulmonis. Mycoplasma neurolyticum, M. 
hyorhinis, M. synoviae, M. gallisepticum. Mycoplasma arginini. Mycoplasma orale, M. 
hominis, M. pneumoniae, M. fermentans, M. fermentans subsp. incognitus, and M. penetrans 
(54,128). Mycoplasma arthritidis has been shown to secrete a mitogen belonging to the 
superantigen family (8), but it is the only mycoplasma identified with this characteristic. 
Mitogenic activity has been associated with lipoglycans, glycoproteins and an unidentified 
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lipid in M. neurolyticum (86) while proteins and carbohydrates are involved in Af. pulmonis 
(147,199). Using mitogenesis inhibiting monoclonal antibodies, Lapidot et al. determined 
that Af. pulmonis mitogens are unique membrane complexes of variable molecular weights 
which are highly susceptible to heat and partially sensitive to reducing agents (lOS). Thus, it 
appears that different mycoplasmas exert their mitogenic activities via different cell 
components, and the organisms may express more than one type of mitogenic constituent. 
The membranes of Af. pulmonis have been shown to be both mitogenic and to possess 
chemoattractant qualities for B cells but not T cells (18S, 199). Af. hyorhinis and M arginini 
membranes are mitogenic for B-cells (162), whereas the superantigen firom Af. arthritidis is 
strictly a T-cell mitogen. The immune cell stimulated and the degree of stimulation may 
differ with each species of mycoplasma and the host involved. 
Components of the mycoplasma membrane have also been shown to induce the release of 
cytokines (reviewed in (128)). These include interferon (INF)-Y, tumor necrosis factor 
(TNF)-a, interleukin (IL)-lp and IL-6 (128). Species identified which stimulate release of 
TNF-a are Af. orale (65), Af. capricolum (190), M.fermentans (48,72), Af. arginini (77), Af. 
hyorhinis (93), Af. mycoides subsp. mycoides (178), and Af. gallisepticum (128). Many of 
these species also induce either IL-1, IL-6 or nitric oxide. The membrane constiments have 
been characterized as membrane lipoproteins (77) or as low-molecular weight carbohydrate 
(235) in Af. arginini In M.fermentans, cytokine inducing activity is associated with a 48 kDa 
membrane protein (92) and a lipid structure (143,144). Both a protein molecule and a glycan 
moiety from Af. hyorhinis are responsible for inducing cytokine release (93). As was 
described for the mitogenic activities in mycoplasmas, different membrane components also 
appear to be responsible for stimulation of cytokine release from macrophages and 
monocytes, and each species of mycoplasmas may produce more than one type of activating 
substance. Although mycoplasmas do not contain lipopolysaccharide (LPS), the finding that 
many of the cytokine inducing factors contain lipid and lipoglycans may indicate that the 
membrane has LPS-like biological features. LPS is a potent virulence factor and a known 
inducer of cytokines (12,28). Recent evidence indicates that stimulation by mycoplasma 
membranes uses some, but not all, of the pathways that LPS uses to stimulate cytokine 
release. Mycoplasmas and LPS appear to trigger the cells through different membrane 
receptors (164). It is probably a general phenomenon of mycoplasma membranes to be both 
mitogenic and induce cytokine release. 
Another mechanism to circumvent the immune response is the production of Fc or Fab 
receptors. An Fc receptor has been discovered on Af. arginini, a common tissue culture cell 
contaminant (109). This receptor did not appear to have antibody specificity and functions as 
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a lectin to bind the carbohydrate moiety of the antibody (109). A similar protein was found in 
Mycoplasma salivarium, with specificity towards IgG molecules (189). M. arginini and M. 
hominis have also been shown to express a protein which react with the Fab fragments of IgG 
molecules (2). Research in this area is lacking, and the role of these activities in virulence or 
inmiune system evasion has not been addressed (217). 
Pathology associated with the infection 
The pathogenic potential of mycoplasmas stems from the membrane-membrane 
interactions with host epithelial cells. Ciliostasis is seen in most infections. The mechanisms 
involved in cell injury are not well understood. It is clear that several mycoplasmas have the 
capability to directly cause cell injury. It is also possible that immune or inflammatory 
responses to the infection may directly contribute to cell injury through "innocent bystander" 
damage (197). Microscopic lesions generally contain phagocytic cells, show hyperplasia of 
the epitheliimi and a lymphoid response in the submucosa. There is a correlation between 
ciliostasis and tissue injury seen after infection with many mycoplasma species (197). 
Mycoplasma species can differ in the degree of ciliostasis induced, severity of tissue injury 
and type of tissue injury (6). Lymphoid hyperplasia and chronic inflammation in the region 
of the infection are characteristic of disease. In M. pulmonis, it is apparent that host responses 
are probably not the major cause of the initial epithelial damage (205). After initial damage, 
the evidence leans towards the host cellular immune responses affecting lesion development 
(90,226). INF-a and IL-1 were found to contribute to the development of pneumonic lesions 
in M. hyopneumoniae infections (7). Rarely does any mycoplasma infection progress deeper 
than the epithelial layers. When infections extend beyond the initial area of infection, 
organisms can be detected in almost any body cavity depending upon the species. For 
example, the human pathogen M. pneumoniae has been implicated in the development of 
striatal lesions leading to acute neurologic dysfimction (187). 
Mycoplasmas produce very few toxins, and of those known, none has been shown to 
have a direct effect on pathology. Also, it has been speculated that metabolic byproducts, 
such as hydrogen peroxide production or arginine metabolism, may contribute to pathology. 
Even though disease pathogenesis is similar between mycoplasma infections, the total 
package of virulence factors may result in each species having a distinctive progression of 
cell injury and disease (197). 
In the last few years, three species of mycoplasmas, M.fermentans subsp. incognitas, M. 
pirum and M. penetrans, were discovered that appeared to violate many of the previously 
held dogma regarding mycoplasma pathology. These species were isolated from humans in 
16 
association with the AIDS. There continues to be ongoing debate about whether these species 
are contributors to AIDS, whether they alone are capable of causing AIDS, or if they only 
have a high prevalence in AIDS patients. The discovery of M. fermentans subsp. incognitus 
was unusual in that it was originally thought to be a virus capable of infecting NIH 3T3 cells 
(95). Evidence indicates that these three species can reside intracellularly in the cytoplasm of 
the host cell (206), and that they are invasive. M fermentans subsp. incognitus has been 
linked with renal and central nervous system complications in patients with AIDS (11, 117) 
as well as with acute fatal respiratory disease in otherwise healthy individuals (118). In 
primates infected with M. fermentans subsp. incognitas, there was weight loss, leukocytosis, 
and periodic mycoplasma antigenemia. Mycoplasma infection was apparent in the spleens, 
livers, kidneys and brains of these infected animals. All animals infected died after a long 
term infection of 7-9 months (120). M. penetrans has been isolated from the urine of patients 
infected with HIV (119), and has also been shown to have the capacity to invade cells (116). 
AIDS-associated mycoplasmas have been the subject of several recent reviews which discuss 
their role in development of AIDS and associated pathology (16,17,114). Most mycoplasma 
researchers believe that mycoplasmas are at the least a cofactor in the development of AIDS. 
Treatment and vaccination 
For most mycoplasma infections, antibiotic treatment is recommended, but only partially 
effective. Antibiotics are helpful in reducing the severity of the disease, but usually are 
unable to clear the organism from the site of infection. Because they lack a cell wall, 
mycoplasmas are imafifected by those antibiotics which a^ect cell wall synthesis, such as 
ampicillin. Treatment of diseases caused by M. pneumoniae, the causative agent of atypical 
pneumonia, involve long term use of general antibiotics. However, Niitu reported that M. 
pneumoniae could be recovered for two to three months after clinically effective antibiotic 
treatment (151). In a patient systemically infected with M. fermentans subsp. incognitus, 
recovery was apparent after a six week treatment with deoxycyline (115). Unfortunately, 
antibiotic resistance in Af. pneumoniae and other mycoplasmas has been reported (25), and, 
as with many other bacterial pathogens, is becoming an increasing problem in mycoplasma 
infections. Because of the general inadequacies of antibiotic treatment, development of 
vaccines are a more promising approach to the control of mycoplasma infections in humans 
and animals (52). 
Many different types of vaccines have been tested over the years, including passive 
transfer of antibodies, formalin fixed mycoplasmas, temperature sensitive mycoplasmas, 
attenuated or killed mycoplasmas, etc. To date, the present conclusion is that none of the 
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commercial vaccines are able to prevent colonization of the organism. This situation is no 
better than treatment with antibiotics. Ellison et al has stated the following in relationship to 
development of a vaccine for M. pneumoniae-. 
The current working concept for successful immunization can be stated simply as 
follows: preventing attachment prevents initiation of disease, and preventing tissue 
damage prevents or reduces the severity of disease. Several conditions must be met 
for immunization to be successful: (i) a vaccine must contain a protective 
immunogen(s), (ii) the antigens must be genetically and phenotypically stable, (iii) 
the route and presentation must elicit a protective respiratory mucosal response, and 
(iv) the vaccine must protect without inducing untoward toxic reactions or adverse 
immune abnormalities, including potentiation of disease (52). 
Although there are approved vaccines for animal use, as for partial protection from M 
hyopneumoniae or M. gallisepticum, there is not an approved vaccine for any mycoplasma 
causing human disease. There are several inherent problems in the development of vaccines. 
First, administration of some mycoplasma preparations may potentiate the disease. 
Potentiation has been observed with formalin-inactivated M. pneumoniae vaccines (203), 
inactivated M. gallisepticum (1) and with either M. hyopneumoniae antigens (184) or a 
whole-cell formalin-inactivated vaccine (96). Second, considering the prevalence of variable 
surface antigens found in mycoplasmas, it is unlikely that one strain or one type of protein 
preparation will be protective against other strains of the species. Finally, as with many other 
bacterial pathogens, mycoplasmas rapidly lose virulence upon in vitro passage. To be 
effective, vaccines must contain the virulence determinants produced during infection. Those 
determinants are difficult to characterize in mycoplasmas due to the complex nature of 
growth media, the poor in vitro growth of some species of mycoplasmas, and the length of 
time necessary to grow mycoplasmas in broth or on plates from clinical tissues, generally 
from 1 week to 1 month. Because of the inadequacies of vaccines to date, Bmnner has stated 
that "the availability of a rapid diagnostic method and a mycoplasmacidal antibiotic are more 
pertinent goals than the development of a vaccine" (25). 
Mycoplasma membrane proteins 
While a considerable amount of research has focused on the adherence factors and 
surface antigens, little research has been done on other membrane proteins which may also 
be involved in parasitism. It is surprising that in M. genitalium, which like all mycoplasmas 
has only one membrane, has devoted 140 (30%) of its 482 genes to encode membrane 
proteins (73). Of the 96 genes coding for unknown proteins, most of them are membrane 
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proteins. These observations underscore the importance of membrane proteins to 
mycoplasmas and the general lack of information regarding these proteins. 
Major surface antigens 
Mycoplasmas produce a number of surface proteins which are immunogenic and are 
thought to play a role in evasion of the host immune response process. Many of the surface 
antigens of Mycoplasma hyorhinis. Mycoplasma bovis, M. gallisepticum, and M. hominis are 
grouped into protein families with similar transcriptional and translational controls, and 
similar protein motifs and characteristics. 
The variable lipoprotein family of M. hyorhinis has been characterized in great detail 
(reviewed in (231)). There are six members known in this family, VlpA-VlpF (179,238). It 
is hypothesized that this family, which undergoes both size variation and phase switching, 
generates extreme population diversity in M. hyorhinis (231). These proteins constitute the 
major membrane protein and surface coat of the organism, which is the primary interface 
with the external environment (33). Different strains of M. hyorhinis house different numbers 
of the Vlp genes in their chromosome, i.e. strain GDL-1 has all six of the genes, whereas 
SK76 contains only VlpA-VlpC (179,238,239). Phase switching of these genes is generated 
from a homopolymeric tract of adenine residues between the -35 and -10 regions upstream of 
the transcriptional start site (238). Addition or loss of adenine bases in this region control the 
on/off phenotypic switch of the protein. Each vlp gene can be transcribed alone or in any 
combination with other vlp genes in a non-coordinate maimer (33). 
The Vlp proteins are divided into three distinctive regions; region I is the membrane 
signal domain, region n is a constant domain and region m, the C-terminus, is the surface 
exposed domain. All of the Vlps have a homologous signal sequence of 30 amino acids and a 
prolipoprotein signal peptidase n recognition sequence, A/T ISC (239). Radiolabeling of 
VlpC demonstrated that during signal sequence cleavage, a lipid moiety is attached to the 
cysteine residue adjacent to the cleavage site serving to anchor the protein within the 
membrane (34). The remaining portions of the Vlp proteins are hydrophilic in nature. The 
size variation among the Vlp proteins is due to the direct identical repeated blocks of 36-39 
bp within region m of each Vlp structural gene (33). Each Vlp has its own unique repeat unit 
with all of the repeat units being highly charged. The relative abundance of each Vlp is 
affected by the number of repeating units, i.e. the longer the protein, the less product is 
produced (33). Size variation occurs only in region m. Possible mechanisms of size variation 
leading to the precise deletion or insertion of the repeat sequences include homologous 
recombination and slipped-strand mispairing (231). 
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The variable surface antigens from M. bovis are designated Vsps - variable surface 
proteins. These proteins share the following characteristics with the Vlps: they are 
lipoproteins and are anchored by the N-teiminal domain, they have regions of shared 
epitopes defined by monoclonal antibodies, the C-terminal region is surface exposed and has 
extensive repetitive structure, they undergo high-frequency size variation, they undergo high-
frequency phase variation and combinatorial expression, and the proteins are the most 
abundant amphiphilic protein in these organisms (13). Unlike the Vlps, the Vsps can undergo 
size variation in region II of the protein (13), and the repeat units of region m are multiple 
sets of similar or nonsimilar repeat sequences, which generate nonequal ladder patterns upon 
enzyme digestion (13). To date, the Vsps have not been genetically characterized. 
Using a monoclonal antibody that recognizes a common epitope among the Vsps, Yogev 
et al. discovered a shared epitope on a size-variant protein of M. gallisepticum (237). This 
finding led to the discovery of PvpA. Like the others described, PvpA varies in size and 
undergoes high-frequency phase variation. However, PvpA is not a lipoprotein, but rather has 
a typical prokaryotic signal peptide followed by a second hydrophobic domain (237). PvpA 
is also not a member of a gene family, but exists as a single chromosomal entity. There 
appears to be no genetic relationship between the Pvp proteins and Vsps. Yogev et al. (237) 
and other investigators (66) have also described other phase variant proteins from M. 
gallisepticum, but these have not been characterized or grouped into families. 
Phase variant proteins have also been recently described for M. hominis (240). These 
proteins also undergo phase and size variation, with similar mechanisms to the Vlps. 
Furthermore, analysis of mycoplasmal DNA from synovial fluids indicates that variation 
occurs in vivo, suggesting that variation may be a mechanism for antigenic variation (240). 
Another research group also described antigenic variation involving lipid modified surface 
proteins in M. hominis. Size variation occurs not only within the same strain, but also 
between different strains isolated from human hosts. The authors raise the possibility that 
variation could be occurring in the human host (155,156). The proteins investigated by the 
two research groups may or may not be identical. Other species isolated from hvmians have 
also been investigated for phase and size variation of surface markers, including M. 
fermentans (228). 
The discovery of gene families encoding size- and phase-variant proteins in several 
different species of mycoplasmas indicates that surface antigen variation may be common. In 
Af. pulmonis, a size variant surface exposed lipoprotein, termed the V-1 surface antigen, has 
been described. This antigen is thought to be involved in hemadsorption (200). At the amino 
acid level, the V-1 antigen is similar to the Vlps. Region I contains the membrane 
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prolipoprotein signal, region n appears to be a constant region, and region m consists of 
repeated units (14). The repeated units of most of the V-1 antigens are proline rich, much like 
the adhesin molecules described above (14). Genetically, the mechanism of regulation is 
unique among mycoplasmas. The V-1 antigens are encoded by the vsa gene locus. Phase 
variation is generated by DNA inversion of a 34 bp region of DNA termed the vsa box. For 
each of the various proteins, there is a vsa box at the beginning of region III (14). The area of 
inversion contains the N-terminal sequences. Thus, only one serotype of antigen is expressed 
at any given moment. All of the other genes remain silent imtil an inversion event occurs 
to place the N-terminus in position to allow proper translation (14). DNA inversion in the vsa 
gene locus apparently is coordinated with the DNA inversion shown to be responsible for 
phase switching of the restriction-modification system, termed the hsal locus (14). In M. 
pulmonis KD73S, seven different potential structural genes have been identified in the vsa 
gene locus (14). In M. piUmonis CT, however, a much smaller gene locus was found 
containing only two different structural genes (200). One of the genes found in strain CT, the 
one encoding for the originally described V-1 antigen, was not described for strain KD73S 
(200). Future research must be done to correlate the results between the two research groups 
and to fully determine the genetic structure of the vsa locus. 
One of the common features among the surface antigens is the presence of repeat 
sequences In the Vlps and Vsps, these repeats are involved in size variation, are typically 
only 12-13 amino acids long and are located in the C terminal domain. Another family of 
surface exposed antigens is the Lmp proteins of M. hominis. These proteins have up to ten 
nonidentical repeated units of approximately 160 amino acids (101). The repeat units are not 
necessarily complete repeats as Lmpl has 9 1/2 repeats. In comparison to the Vlps, region 1 
of the Lmp proteins contains a nonlipoprotein hydrophobic signal sequence, region II is a 
central region without any repeated sequences, and region HI contains the repeated domains 
(101). These proteins do not appear to undergo size or phase variation. Recent experiments 
implicate the Lmps in aggregation, a potentially helpful feature for M. hominis in a disease 
situation (84). The Vlp, Vsp, Vsa and Lmp proteins are all hydrophilic except for the 
membrane spanning domain. 
The function of these varying surface antigens is unknown. For the V-1 antigen and the 
Lmp proteins, hemadsorption and aggregation are potential functions, respectively. It has 
been speculated that for the most part these antigens are involved in evasion of the host 
immune response. Structurally, they are all similar. Region 1 has either an attached lipid or a 
single membrane spanning domain, region n is generally constant while region HI has repeat 
domains. Infected animals produce strong antibody responses toward the repeated units. 
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Because all known mycoplasmas are surface parasites, it is expected that many more families 
of surface antigens will be discovered. 
Membrane-associated activities 
Besides the surface antigens, other membrane activities are common to the mycoplasmas, 
one of which is hemolytic activity. Minion and Jarvill-Taylor established that the membranes 
of most mycoplasmas contain an activity which is capable of lysing trypsinized mouse red 
blood cells (138). It was also demonstrated that the hemolysin from M. pulmonis is inhibited 
by cholesterol and selected cholesterol derivatives (83). The activity was affected by heat 
treatment, thiol-reducing agents, thiol-activating agents and oxidizing compounds (83,138), 
thus resembling the gram positive thiol-activated hemolysins (streptolysin, pneumolysin, and 
listeriolysin). The stereo-specificity in sterol recognition, however, was distinctly different 
than the pattern observed with the gram positive thiol-activated hemolysins (83). All but one 
of the gram positive thiol-activated hemolysins are secreted proteins, whereas the 
mycoplasma hemolysins are primarily associated with the membrane (136,139). A 
hypothesis has been proposed that the hemolysin is involved in the acquisition of cholesterol 
based upon the observations that mycoplasmas have an absolute requirement for this 
molecule and that the probable receptor for the hemolysin is cholesterol (83,135). 
Interestingly, M. hominis, and other arginine metabolizing mycoplasmas, M. fermentans 
subsp. incognitus, and M. penetrans were negative for the hemolytic activity as assayed in 
that study (138). 
Both M. fermentans subsp. incognitus and M. penetrans are associated with AIDS and are 
believed to reside intracellularly. Shibata et al. undertook a study aimed at determining if 
these species were similar to the intracellular pathogen Listeria monocytogenes in the 
production of phospholipases (191). In L monocytogenes it is thought that the phospholipase 
aids in releasing the organisms from the iysosome into the cytoplasm where the organism 
replicates (27). This study showed that both M. fermentans subsp. incognitus and M. 
penetrans contained a phospholipase C which was capable of hydrolyzing both 
phosphatidylinositol and phosphatidylcholine (191). Two other mycoplasma species, M. 
hominis and M. arginini, did not have phospholipase C activity (191). 
Salman and Rottem have reported phospholipase Al activity in M. penetrans (ISS). 
Other reports of phospholipases in mycoplasmas indicated that some species may have 
phospholipase A or lysophospholipase A activities (217). Considering that serum, a media 
component for all mycoplasmas, contains phospholipases (138), the presence of 
phospholipases in mycoplasmas needs additional investigation. 
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Another protein which may aid the entrance of M. fermentans subsp. incognitus and M. 
penetrans into the cytoplasm is a tyrosine phosphatase. Tyrosine phosphorylation is 
associated with alterations in receptor activity, cellular proliferation and modulation of the 
cell cycle (236), and is regulated by tyrosine kinases and tyrosine phosphatases (79). Protein 
tyrosine phosphatases have been found to have an important role in bacterial pathogenesis 
(18). Phosphatase activity directed toward tyrosine was found in Mycoplasma faucium and 
M. fermentans subsp. incognitas (192). Low levels of activity were determined for M. 
pneumoniae, M hominis, and M. buccale while M. orale and Af. salivarium were negative 
(192). The authors speculate that the tyrosine phosphorylation-dephosphorylation pathways 
in the host might be disturbed by these phosphatases which may play some important role in 
pathogenesis (192). In Yersinia, it was thought that the phosphatase might disrupt host signal 
transduction processes involved in bacterial killing (18). 
One mycoplasma activity which has been hampering AIDS research is a membrane 
nuclease activity. It has been known for a many years that mycoplasmas contain both DNases 
and RNases, and these activities are believed to be involved in the acquisition of nucleotides 
(160,174). Undegraded RNA and DNA can fulfill the requirement for nucleotide precursors 
for mycoplasmas. Nuclease activity has been found to be present in the particle-free 
supernatant of contaminated cell culture lines (SI) and associated with the membrane (137, 
139). It inhibits HTV reverse transcriptase activity (51),which is a measure of viral particle 
production and the most commonly used indicator for establishing the growth kinetics of 
HIV. Curing the cell lines of mycoplasmas removed the inhibitor, allowing for a more 
accurate assessment of HIV activity (51). 
Nucleases 
Nucleases in bacteria have been shown to function in protection of the organism, repair 
of damaged DNA and in recombination. Endonucleases are those enzymes which cleave 
bonds within a nucleic acid chain and may be specific for either RNA or DNA. Exonucleases 
cleave nucleotides one at a time from either the 5' or 3' termini, depending upon the 
specificity of the enzyme. With RNA substrates, the function of these enzymes is usually the 
degradation of mRNA. Other enzymes have been classified as either endonucleases or 
exonucleases, and some have now been determined to have other activities, such as 
glycosylases and AP (apurinic/apyrimidinic) lyases. This section on nucleases will provide a 
brief review on DNA exo- and endonucleases from bacteria. Nonspecific bacterial nucleases 
or those thought to be involved in disease processes will be the focus of the final section. 
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Specific bacterial nucleases 
Nucleases can be divided into the following types. Restriction endonucleases are those 
enzymes, which along with modification enzymes, are designed to protect resident DNA 
from attack by sequences of foreign DNA. There are both endo- and exonucleases which are 
involved in excising damaged DNA so that other enzymes can synthesize a correct 
replacement of the bases. Also involved in repair are the DNA polymerases, most of which 
contain both 3'-S' and S'-3' exonuclease activities. Finally, nucleases are involved in DNA 
recombination. Bacteria can contain multiple types of each of these groups of nucleases, and 
many of them can be considered to be found in all bacteria. Restriction systems foimd in 
bacteria may be intrinsic or may have been introduced by a plasmid or phage. All species 
with a restriction enzyme also contain a DNA methylase activity with the same sequence 
specificity to provide host chromosomal DNA protection against the restriction enzyme. 
These enzymes are commonly used in biotechnology, many are readily available 
commercially and have been extensively studied. Table 1.3 describes the different types of 
restriction systems known. 
There are several different mechanisms of DNA repair present in bacteria. These include 
photoreactivation (light repair), base excision repair, nucleotide excision repair and mismatch 
repair (to include both long patch and short patch repair). Following severe damage, the 
mistake prone SOS response is induced. Photoreactivation processes do not use nucleases. 
Table 1.3. Restriction Systems' 
Type n Enzyme Type HI Enzyme Type I Enzyme 
Protein Structure 
Recognition site 
Cleavage site 
Restriction and 
methylation 
ATP needed for 
restriction 
separate endonuclease 
and methylase 
short sequence (4-6 bp), 
often palindromic 
same as or close to 
recognition site 
separate reactions 
no 
bifimctional enzyme of 
2 subunits 
asymmetrical sequence 
of 5-7 bp 
24-26 bp downstream of 
recognition site 
simultaneous 
yes 
bifiinctional enzyme of 
3 subunits 
bipartite and asymmetri­
cal (e.g. TGANgTGCT) 
nonspecific >1000 bp 
from recognition site 
mutually exclusive 
yes 
'taken from (110). 
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Most of the known nuclease can be assigned to the base excision repair systems, while a few 
nucleases play prominent roles in the other repair mechanisms. Of the original nine 
endonucleases described for E. colt, three are now known to be DNA glycosylases, two of 
the activities are contained in exonuclease in and one is an AP endonuclease (64,110). The 
gene for endonuclease V has not been identified. Thus, most of the early discovered 
endonucleases fimction in base excision. Likewise, the function of several of the originally 
described exonucleases have been more accurately determined. For example, exonuclease n 
and exonuclease IV activities are found in DNA polymerase I (64). Endo- and exonucleases 
known to aid in base excision are: recE (originally termed exonuclease Vni), a 5'-3' double 
stranded DNA specific endonuclease; recJ (originally exonuclease VII), a single stranded 
specific 5'-3' exonuclease which also has deoxyribophosphodiesterase activity; and 
exonuclease I, a 3'-S' single stranded exonuclease (64,110). Base excision is normally used 
to remove only damaged or incorrect bases, which explains the use of single strand specific 
nucleases. 
The nucleotide excision repair system removes thymidine dimers or other damage 
resulting from ultraviolet light damage (64). UvrA is an ATPase, DNA binding protein which 
recognizes the damage and when combined with the two endonucleases, UvrB and UvrC 
removes a 10-13 base pair section of DNA. UvrD is the helicase which unwinds and releases 
the cut DNA. The gap is filled in by DNA polymerase I. 
Mismatch repair is similar to the base excision repair but only the mismatched base is 
removed. This repair system, termed the dam repair system, uses the MutH, MutY, and 
MicA endonucleases to excise adenines from an adenine-guanine mismatch (110). The 
correct strand of DNA repaired during mismatch repair is determined by dam methylation; 
the newly synthesized, or noimiethylated, strand is the repaired strand. 
As can be seen in the brief review of exo- and endonucleases of E. coli, each of the 
identified nucleases has a specific fimction, most of which relates to correction of duplication 
errors and repair of damaged DNA. Tight regulation of these processes prevent additional 
damage during the repair process. It can be assumed that many of these functions are 
common to both bacterial and eukaryotic systems. 
Nonspecific bacterial nucleases 
Several nonspecific nucleases fi"om various species of bacteria, including mycoplasmas, 
have been discovered that are either membrane-associated or secreted. In most cases, these 
species are pathogenic, and the nuclease is a suspected virulence determinant. However, as in 
mycoplasmas, the actual relationship of the nuclease to the disease process is unknown. The 
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most well studied bacterial nuclease is the staphylococcal nuclease, also referred to as 
micrococcal nuclease, heat-stable nuclease or thennonuclease. This enzyme is a small (149 
amino acid residues) extracellular enzyme produced by many pathogenic strains of 
Staphylococcus aureus (194). It is an extracellular phosphodiesterase which hydrolyzes RNA 
and DNA to 3'-phosphomononucleotides and is one of over 30 known extracellular proteins 
produced by this species (3). Two different forms of the enzyme are secreted. Nuclease A is 
the predominant form of 149 amino acids. Nuclease B has an additional extension of 19 
amino acids at the amino terminus of nuclease A. Because of its small size and simple amino 
acid structure, staphylococcus nuclease has become one of the most extensively studied 
enzymes physiologically and biochemically. The advantages of working with this enzyme are 
that it is a small monomer with no cysteines, highly soluble in both its native and denamred 
forms, displays a simple reversible denaturation reaction plus a very high resistance to 
irreversible inactivation (194). Initially, the protein was used as a simple model system for 
analyzing protein structure and folding. As recombinant DNA techniques became popular, 
the nuclease was cloned and has been expressed in E. coli (193), B. subtilis (94,132), 
Corynebacteriumglutamicum (111), andSaccharomycescerevisiae (159) to investigate 
protein secretion signals, identification of amino acids in the active site, over expression of 
the protein, protein structure and protein biochemistry. Initial studies of expression in E. coli 
indicated that the amount of nuclease activity synthesized in E. coli strains carrying the 
nuclease gene on a multicopy plasmid was much less than the amount produced from the 
genomic gene in 5. aureus (193). The nuclease A form also appeared to be inefficiently 
processed from the nuclease B precursor form (193). The inefficiency of expression in E. coli 
led investigators to pursue secretion in B. subtilis. In this heterologous host, both the native 
promoter and the Bacillus promoter efficiently drove production of the nuclease, which is 
efficiently processed and secreted at high levels (94). It was in the Bacillus studies that the 
nuclease B form was determined to be the precursor of nuclease A with the additional amino 
acids fimctioning as the signal sequence (132). In another gram-positive organism, C. 
glutamicum, expression of the nuclease was not as high as in Bacillus using the native 
promoter. Placing the gene under the transcriptional control of the tac promoter increased 
expression by about 10-fold (111). The authors speculate that the expression is influenced by 
the G+C content of the organism, 5. aureus has a low G+C content whereas C. glutamicum 
has a high G+C content (111). Since the initial studies in E. coli were performed with the 
nuclease gene using its native promoter, low expression may have been due to poor 
recognition by gram negative organisms of gram-positive promoters. Jing et al. expressed 
nuclease R, an analogue of nuclease A, in E. coli under the transcriptional control of the 
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lambda Pr and Pl promoters regulated by temperature sensitive repressors. High levels of 
expression were obtained, and there appeared to be little host dependence in different strains 
(83). The nuclease is translocated across the cytoplasmic membrane in all cases supporting 
the hypothesis concerning the conserved nature of protein transport among all organisms. 
Because the nuclease is easily monitored and well studied, it was an ideal candidate to 
investigate the effects of the amino-tenninal sequences in secretion. Using 5. cerevisiae, 
three different derivatives of the nuclease were expressed, each with different amino terminal 
signals, the OmpA signal sequence from E. coli, a lipoprotein signal sequence, and one with 
no signal sequence (1S9). In previous woik, a hybrid gene encoding the OmpA signal 
sequence fused to the mature portion of the nuclease was efficiently secreted and correctly 
processed in E. coli, whereas a nuclease lacking the amino-terminal signal sequence was not 
secreted from E. coli and was lethal in the presence of high concentrations of Ca* (212). In 
yeast, the nuclease lacking a signal sequence was synthesized at levels tenfold lower than the 
other derivatives. In contrast, the nuclease with the OmpA signal peptide and the nuclease 
with the lipoprotein signal sequence were synthesized at high levels (1-1.5% of the total 
protein) and a significant amount of the product was secreted into the yeast periplasm (1S9). 
High expression of nuclease in the yeast did not appear to be lethal or harmful as active 
nuclease was found in both soluble and membrane fractions of the cells (1S9). These results 
suggested that lower eucaryotes could decipher prokaiyotic secretory information within the 
signal peptides. 
The heat-stable nuclease is not the only nuclease produced by 5. aureus. Vakil et al. 
found a heat-labile cellular nuclease which shares a number of properties with the heat-stable 
nuclease (221). In comparison, the heat-stable nuclease is stable to heating at 100°C for IS 
minutes whereas the heat-labile nuclease is inactivated within 5 minutes of treatment. Both 
enzymes are monomers, prefer heat-denatured DNA as a substrate but can also use RNA as a 
substrate, have a pH optimum of approximately 10, have a temperature optimum in the range 
of 45°C to 50°C, and have an absolute requirement for Ca^* ions which could not be 
substituted by other monovalent or divalent cations (221). Both the heat stable and heat labile 
nucleases are relatively inactive at pH 7.0 and only have moderate activity at 37°C. (221). 
A thermonuclease also is produced by Salmonella and Thermus. In Salmonella this 
activity was discovered during PGR studies with crude cell extracts when reaction mixtiu-es 
were held overnight at 4°C post reaction. Strains tested to be found with the nuclease were 
Salmonella enteritidis, Salmonella typhimurium. Salmonella virchow. Salmonella dublin, 
Salmonella hadar and Salmonella agona (70). Under similar conditions, amplified DNA 
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from Listeria and Locrococcu^ remained intact after storage at 4°C for up to several months. 
This indicated that not all bacteria produce comparable nucleases capable of withstanding the 
temperatures and conditions encountered during PCR cycling (70). The thermostable 
nuclease from Thermus filiformis was found by expressing DNA from T. filiformis in E. coli. 
The preferred substrate of this nuclease is single-stranded DNA, although double-stranded 
DNA can be digested. Nuclease activity increases with increasing temperatures up to 80°C, 
with low activity between 30°C and 40'C, and requires the divalent cations Ca^* or Mg^"^ for 
catalysis (57). This enzyme can convert supercoiled plasmid to nicked circular DNA and to 
linear DNA, indicating that it is primarily a nonspecific endonuclease. It is also able to digest 
lambda DNA to small fragments with S' phosphates indicating the presence of exonuclease 
activity. These properties are similar in some respect to the endo-exonucleases found in 
Neurospora, Aspergillus and Saccharomyces (57). This particular activity was not described 
from Thermus prior to its expression in E. coli, and it is unknown if the protein is membrane-
associated or secreted by Thermus. 
Non-sequence specific endonucleases are produced by many different species of 
Streptomyces. These enzymes are located in the cell-wall cytoplasmic membrane space, have 
similar molecular masses, require Mg for optical activity and are released after protoplast 
production (5). These enzymes differ in their patterns of DNA cleavage. They are believed to 
have a function in the recycling of the nucleic acids components before the formation of 
aerial mycelium (26). 
In Serratia marcescens, a gram-negative enteric pathogen, the extracellular nuclease 
e.xpression is regulated at the transcriptional level. The nuclease appears during the transition 
between exponential to stationary phase (31). This endonuclease demonstrated no strong base 
preference, is equally active against single and double-stranded DNA, has activity against 
both RNA and DNA, and produces short unequal 5' oligonucleotides (133). Two isoforms, 
SMI and SM2, which are kinetically identical are produced by the organism (55). Unlike the 
staphylococcal nuclease, these proteins contain essential disulfide bonds. As these bonds do 
not form in the cytoplasm, the nuclease remains inactive in the cytoplasm (55). These 
nucleases have been expressed in E. coli (157). 
Unlike all of the nucleases described, the nuclease gene from Shigella flexneri is located 
on a plasmid. This plasmid has been studied extensively because it is able to transfer to and 
replicate in a wide range of gram-negative bacteria (222). Derivatives of this plasmid have 
been used as cloning vectors. The most useful phenotype of this plasmid is its ability to 
completely suppress the ability of Agrobacteriwn tumefaciens to incite crown gall tumors on 
plants (121). During efforts to define the suppressing region of the plasmid, an open reading 
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frame was discovered with significant amino acid sequence homology to the staphylococcal 
nuclease. Subsequently, it was determined that an E. coli strain harboring the plasmid 
expressed nuclease activity. The protein has a potential signal peptide and insertions of 
Tr^phoA within the open reading firame resulted in alkaline phosphatase activity, confirming 
the presence of a functional signal sequence (35). Nuclease activity was also found when the 
plasmid was placed into A. tumefaciens. (35). The authors speculate that although the 
nuclease gene is not required for oncogenic suppression, it may play an accessory role 
involving the transfer of the T-DNA of the Ti plasmid from^l. tumefaciens to plants (35). 
In summary, there are different types of nucleases produced by pathogenic bacteria. 
Many of these are released into their surrounding environment. They are active on both RNA 
and DNA, and many of them are extremely stable biochemically. Their potential roles in 
pathogenesis however have not been studied or defined. The nucleases of mycoplasmas may 
potentially share similarities to many of these enzymes. 
Nuclease activities found in mycoplasmas 
Although not a nuclease, the DNA polymerase from several species of mycoplasmas has 
been characterized. Recently, DNA polymerase m was purified from M. pulmonis and the 
gene sequenced (9). It is believed that many mycoplasmas contain only DNA polymerase m 
(99). Early studies failed to identify 3'-5' exonuclease activity contained within the 
polymerase, an activity present in all other known DNA polymerase His. Barnes et al. (9), 
however, showed that the polymerase from M pulmonis did have nuclease activity. The 
authors proposed that mycoplasmas have at least two distinct DNA polymerases, depending 
upon which species is analyzed. One is an exonuclease containing polymerase such as that 
found in M. pulmonis. The other is a polymerase lacking exonuclease activity as those found 
in M. orale, M. hyorhinis oiM. mycoides. Alternatively, those preparations which appear to 
lack exonuclease activity may be preparations of a polymerase which lacked a subunit 
responsible for exonuclease activity (9,99). Exonuclease positive polymerases are 
approximately 165 kDa in size whereas those which are negative are around ICX) kDa. 
Restriction-modification systems have only been identified recently in mycoplasmas. A 
Type I restriction-modification system has been identified in Af. pulmonis, termed the hsdl 
locus (50). An analogue of subunits for restriction, methylation, and sequence specificity was 
found in the predicted amino acid sequences. This locus is located on an invertible element 
much like the V-1 antigen, and the inversion of the element regulated expression. On one 
side of the hsdl locus is the polC gene. 
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A Type II restriction-modification system has been characterized in M. fermentans. (195). 
The endonuclease and the methyl transferse are specific for the sequence CAATTG and are 
encoded by divergent genes. The enzyme has the abbreviation muni and both the genes and 
amino acid sequence share similarity with £coRI and Rsrl. A second enzyme, termed Mfel 
has been discovered in M. fermentans. It is an isoschizomer of Muni (195). It is likely other 
restriction enzymes will be described in mycoplasmas. Many species have methylated DNA 
suggesting that they have restriction systems (46). 
There are only a few studies which have addressed DNA repair systems in mycoplasmas. 
M. buccale possessed dark repair activity, but not light repair (4). However, M. gallisepticum 
apparently does not possess either light or dark repair (69). These studies were performed 
prior to 1980, and no more recent studies have been reported. 
The recA genes from M. pulmonis and M mycoides subsp. mycoides exhibit a high 
degree of homology with other recA genes of gram positive bacteria (87). Homologous 
recombination has been shown to occur in several mycoplasma species, including M. 
pulmonis and M. gallisepticum (29,134). It is unknown if there is a LexA binding domain 
upstream of the recA gene as in E. coli, and lexA has not been discovered in mycoplasmias to 
date. The only known activity for RecA in mycoplasmas is in recombination. 
Few nucleases have been discovered in mycoplasmas, and except for the prelimiiunary 
report by Minion and Goguen of membrane associated nucleases in M. pulmonis(l39), all of 
the nucleolytic activities were associated with "housekeeping" activities. None could be 
considered as potential virulence factors. This work extends the original observations by 
identifying and characterizing membrane associated nuclease activities in different 
mycoplasma species and by cloning and sequencing one nuclease gene from M. pulmonis. A 
uvrB homolog was also discovered as a consequence of these studies as part of a two gene 
operon with mnuA, the cloned membrane nuclease. 
30 
CHAPTER 2. MEMBRANE-ASSOCIATED NUCLEASE ACTIYITIES IN 
MYCOPLASMAS 
A p^r published in the Journal of Bacteriology' 
2 2J F. Chris Minion , Karalee J. Jarvill-Taylor , Diane E. Billings, and Eli Tigges 
Abstract 
Membrane-associated nucleases of various mycoplasmal species were investigated using 
two nuclease assays. A lambda DNA assay was developed to measure nuclease activity 
associated with whole cell suspensions, activity released from intact cells, and activity 
associated with detergent-disrupted cells. In most species, nuclease activities were entirely 
membrane-associated, and disruption by a detergent had a stimulatory effect on these 
activities. All mycoplasmal species contained nuclease activity, but Mycoplasma capricolum 
was unusual because its activity was dependent upon magnesium and was inhibited by 
calcium. We developed a sodium dodecyl sulfate-polyacrylamide gel electrophoresis system 
that produced reproducible nuclease patterns, and this system was used to determine the 
apparent molecular weights of the nuclease proteins. An examination of 20 mycoplasmal 
species failed to identify common bands in their nuclease patterns. An examination of 11 
different Mycoplasma pulmonis strains, however, indicated that nuclease patterns on 
polyacrylamide gels may provide a means for categorizing strains within a species. Our 
results suggest that nucleases are important constituents of mycoplasmal membranes and 
may be involved in the acquisition of host nucleic acids required for growth. 
Introduction 
Mycoplasmas, cell wall-less bacteria of the class Mollicutes, are among the smallest self-
replicating organisms known and have been described as a minimal living unit (141,166). 
They are typically noninvasive animal pathogens that readily colonize mucosal surfaces and 
have immunomodulatory activities (36,210,213,218), but are totally incapable of 
synthesizing the typical eubacterial cell wall components, the major bacterial 
immunomodulatory components. It has been hypothesized that the selective association of 
'Reprinted with permission of Joumal of Bacteriology, 1993,175:7842-7847. 
^Associate Professor and Graduate Student, respectively. 
Wmary Researcher. 
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host cell proteins with mycoplasmas could alter the immunoresponsiveness of a host (227). 
The presence of a small genome and the lack of numerous biosynthetic pathways correlate 
with growth requirements for macromolecular precursors such as phospholipids, cholesterol, 
nucleotides, and amino acids. The exchange of lipophilic probes from host cells to 
mycoplasmas has also been demonstrated (135,229), but the mechaiiism(s) by which the 
mycoplasmas acquire these materials is unknown. Yet this mechanism must function 
efficiently, and it may contribute to immunomodulation and pathogenesis. 
Unlike other eubacteria, mycoplasmas lack the biosynthetic capacity to synthesize de 
novo nucleic acid precursors (166). Nuclease activity in members of the Mollicutes has been 
proposed as the mechanism by which these organisms acquire the precursors required for 
their nucleic acids. Uptake of precursors could occur either as uptake of finee bases or as 
uptake of small oligonucleotides. Therefore, a mechanism(s) must be present to induce 
release, degradation and transport of host nucleic acids to intracellular sites. Transport 
processes have been identified in mycoplasmas (166,171), but DNA and RNA degradation 
processes have not received adequate attention. Pollack and Hoffinan (160) and Roganti and 
Rosenthal (177) demonstrated that members of the genus Acholeplasma produce multiple 
proteins with nuclease activities, as indicated by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE). Minion and Goguen (137) found membrane-
associated nucleases in M. pulmonis. In addition, RNases are known to be present in 
mycoplasmas (123). Together, these activities are sufficient to produce all of the required 
nucleotides from undegraded DNA and RNA, as observed originally by Razin and Knight 
(173). This study was undertaken to expand our knowledge about the occurrence of 
membrane-associated nucleases and the proteins involved in various Mollicutes species. Our 
results suggest that nuclease activities are primarily associated with the membrane and may 
be essential to growth and survival (137,177). This fmding suggests that there is a unique 
mechanism of in vivo nucleotide acquisition. 
Materials and Methods 
Mycoplasma growth and isolation 
The mycoplasma strains and the media used for cultivation are described in Table 2.1. 
Standard mycoplasma broth medium contained 25 g of PPLO broth (Difco Laboratories, 
Detroit, Mich.) per liter, 10% heat-inactivated (56°C, 30 min) GG-free Horse Serum 
(Gibco/BRL, Grand Island, N.Y.), 5% fresh yeast extract (63), 0.5% Dextrose and 2.5 |ig of 
Cefobid (Pfizer, Inc., New York, N.Y.) per ml; the pH was 7.8. Broth A was prepared as 
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described previously (42). Friis medium consisted of 12 g of PPLO broth per liter, 12.6 g 
Brain Heart Infusion (Difco Laboratories) per liter, 20% heat-inactivated Horse Senmi 
(Gibco/BRL), S% firesh yeast extract, 7.2% Hanks Balanced Salts Solution (Gibco/BRL), 
0.5% Dextrose and 2.5 ^g Cefobid per ml, the pH was 7.4. SP4 medium was made as 
described previously (220) and was modified by adding 0.02% arginine. Frey's medium was 
prepared as described previously and was modified by adding 0.01% NADH (63). Cultures 
were obtained from a stock culture maintained at -70°C, inoculated into fresh broth and 
incubated statically at 37°C. Cultures were maintained by serial passage. The total number of 
in vitro passages prior to testing could not be accurately determined. 
Nuclease assay 
Mycoplasma cultures were harvested at the mid to late log phase of growth by 
centrifiigation at 12,(X)0 x g for 4 min, washed once with 0.01 M sodiimi phosphate - 0.14 M 
sodiimi chloride (pH 7.3) (PBS), and resuspended at a concentration of 100 of protein per 
ml in PBS containing 1% dextrose, 2 mM CaClj and 2 mM MgClj (PBS-CM). In some 
studies, optimal bultfer conditions were examined by altering the magnesium and calcium 
concentrations in the assay buffer. Protein concentrations were determined with the Bio-Rad 
dye reagent (Bio-Rad Laboratories, Richmond, Calif.) by using bovine serum albumin as a 
reference standard. To determine external activity, 25 ^ 1 of suspended cells, representing 2.5 
|ig protein, were diluted in twofold increments in a 96-well plate with PBS-CM. An equal 
volume of lambda DNA (10 |Xg/ml in PBS; GIBCO/BRL) was added to each well, and the 
plate was then incubated for 30 min at 37°C. Lambda DNA digestion was stopped by the 
addition of 7 )il of borate sample buffer (122) to each well. Digestion products were analyzed 
by loading a Tris-Borate agarose gel with 8 fil of sample per well, running the gel at 100 V 
for 45 min, and then staining it with ethidium bromide. Activity was expressed as the amount 
of mycoplasma protein that resulted in the complete loss of 250 ng of intact, full size lambda 
DNA in 50 111 of PBS-CM at 37°C during a 30 min incubation period. The endpoint was 
determined by analyzing the reaction mixtures on agarose gels and identifying the dilution at 
which the undigested, full length lambda DNA first disappeared (Fig. 2. IB, lane 2). Each 
species was tested at least three times by using different passages and the mean value for 
nuclease activity was determined. 
In order to determine whether the nuclease activity was released from intact cells or 
located on the external membrane surface, the following experiments were performed. 
Table 2.1. Mycoplasma strains, species, source, loss in viability and nuclease activity 
Nuclease Activity 
Species' Strain Host Media^ Source or reference Loss in 
Viability 
Intact 
Whole 
Cells^ 
Released' Total' 
M. pulmonis UAB6510 rodent P M. K. Davidson NL 1250 ± 20 
UAB5782 rodent A G. H. Cassell NL 1250 ± 20 
UABCT rodent A M. K. Davidson ND 1250 ± 208 
UABT rodent A M.K. Davidson NL 1250 ± 26 
JB rodent A G. H. Cassell ND 1250 - 1250 
19612 rodent P ATCC ND 833 ± 416 
(PG34) 
KD735 rodent A K. Dybvig NL 625 ± 625 
X1048 rodent A M. K. Davidson NL 1250 ± 625 
ISM3050 rodent A F. C. Minion 75 1250 312 156 
Ml rodent P M. K. Davidson NL 156 625 78 
66 rodent P M. K. Davidson NL 78 416 20 
M. arthritidis 19611 rodent PA ATCC ND 104 ± 96 
M. neurolyticum 19988 rodent F ATCC 44 416 1250 156 
M. J swine F R. F. Ross ND 833 - 625 
hyopneumoniae 
232A swine F R.F. Ross ND 833 - 625 
M. hyorhinis GDL swine F R. F. Ross NL 208 833 156 
M. hyosynoviae 25591 swine FA ATCC ND 312 - 312 
M. dispar SDO bovine F R. Rosenbusch 14 26 416 19 
M. bovis 79-27323 bovine F R. Rosenbusch ND 208 833 312 
M. bovoculi C52 bovine F R. Rosenbusch NL 52 416 39 
M. capricolum 27343 caprine F ATCC ND - 6250" -
M. gallisepticum 19610 avian P ATCC 14 416 833 20 
15302 avian P ATCC ND 833 833 52 
A5969 avian P Hofstead ND 208 ± 20 
M. meleagridis 25294 avian FA ATCC ND 833 - 833 
M. gallinacium avian P field isolate ND 104 208 26 
M. fermentans PG18 S S.-C. Lo ND - - 625 
M. fermentans 
incognitus 
M. penetrans 
M. hominis 
M. pneumoniae 
A. laidlawii 
Acholeplasma 
jm 
human P S.-C. Lo ND 416 1250 39 
human S S.-C. Lo ND ± - 416 
1620 human PA L. D. Olson ND 32 208 39 
15531 human P ATCC ND ± - 416 
23206 (PG8) F ATCC NL 104 208 20 
14192 F ATCC ND 208 ± 20 
ISM1499 P This laboratory ND 104 ± 10 
' For every species and strain, except for Acholeplasma spp. ISM 1499 which is a high passage laboratory isolate 
representing at least 150 in vitro passages, the number of in vitro passages in our laboratory was less than twenty. 
Actual passages prior to our receiving the strains are unknown. 
^ P = Standard PPLO broth media; F = Friis media; S = SPA media; FR = Frey's media; PA = PPLO broth with 
arginine; FA = Friis media supplemented with arginine 
^ Loss in viability is the percent loss in viability during a 30 min incubation at 3TC in assay buffer supplemented with 
glucose. (NL) = no detectable loss in colony forming units. (ND) = not determined. 
Whole cell activity was subjectively scored as the nanograms of protein in a whole cell suspension required to digest 
250 ng lambda DNA as described in the Materials and Methods. Data represent the mean of at least three replicates. 
(±) in^cates that a small amount of nuclease activity was present, but an accurate measure was beyond the assay 
sensitivity. (-) indicates a complete lack of activity under £dl experimental conditions. 
^ Released activity is the amount of nuclease activity released during a 30 min incubation at 37°C in assay buffer as 
described in Materials and Methods. Data represent the mean of three observations. 
® 10 mM magnesium only. See Table 2. 
^ Total activity represents the activity associated with detergent-solubilized whole cells. 
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1/Dilution 
1 2 4 8 16 32 
+ Magnesium 
ISM 1250 
+ Calcium 
ISM1250 
ISM1250 
Figure 2.1. Effects of calcium and magnesium on membrane nuclease activity in 
Acholeplasma sp. strain ISM 1499. An overnight culture of strain ISM 1499 was washed and 
prepared for the whole-cell nuclease assay as described in Materials and Methods. The 
beginning concentration of mycoplasma protein was approximately 5% of the normal 
concentration so that we could measure the effects of divalent cation addition. Mycoplasmas 
were added to the first well and serially diluted twofold with PBS. In parallel well, cdcium 
or magnesium was added to the concentration of 5 mM to the diluted cells. An equal volume 
of DNA substrate in PBS was then added to each well, and the plate was incubated for 30 
min at 37°C. The digestion products were analyzed on a Tris-borate agarose gel. 
Mycoplasma suspensions were incubated at 37°C for 30 min in assay buffer, the cells and 
membrane fragments were pelleted by centrifiigation in a microfuge at 12,000 rpm for 15 
min, and 25 |il of the resulting supernatant fraction was diluted in twofold increments with 
PBS-CM and assayed as described above. CFU were measured before and after incubation to 
assess cell viability. Hexokinase activity (170) was measured in the supernatant fractions in 
parallel experiments from which dextrose was omitted to assess cell membrane integrity. 
Mycoplasma membranes were isolated by osmotic shock and were purified on sucrose 
gradients as described previously (167), and the purity of each membrane preparation was 
assessed by measuring its hexokinase activity (170). In other experiments, the total nuclease 
activity of each mycoplasmal species was determined by diluting 25 |i.l of suspended cells in 
PBS-CM containing 0.1% Tween 20 prior to the addition of the lambda DNA. 
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SDS-PAGE nuclease assay 
To examine the variability in nuclease size, a modified SDS-PAGE system was used. The 
mycoplasmas were grown to mid-log phase, pelleted by centrifugation at 12,000 x g for 4 
min, washed with PBS, resuspended in 40% glycerol, and stored at -20°C until they were 
used. Protein samples were prepared by mixing cells or supemate 1; 1 with SDS-PAGE 
sample buffer, and the preparations were incubated at 60°C for IS min and centrifiiged at 
12,000 X ^ for S min prior to loading. For some experiments, samples were boiled for 5 min 
prior to loading. 
The SDS-PAGE was performed by using a modification of the method of Laenmili (102) 
and a Bio-Rad mini-PROTEAN II unit. Sheared salmon sperm DNA (Sigma Chemical Co., 
St. Louis, MO) was incorporated into the 10% resolving layer at a final concentration of 10 
^g/ml. The anode buffer contained (per liter) 3 g of Trizma base, 14.4 g of glycine, and 1 g 
of SDS (pH 8.3). The cathode buffer was 2x Anode buffer supplemented with 0.15% SDS. 
The gels were electrophoresed at a current of no more than 10 mAmp per gel at 4®C until the 
dye front exited the gel. The optimal conditions for nuclease renaturation were as follows. 
The gels were washed by rocking them four times for 15 min in 100 volumes of incubation 
buffer (0.04M Tris [pH 7.5], 0.01% Casein, 0.04% P-mercaptoethanol), kept in incubation 
buffer overnight at room temperature, and then incubated statically for 8 hours at 37°C in 100 
volumes of incubation buffer supplemented with 2 mM CaCl2 and 2 mM MgClj. The gels 
were stained with ethidium bromide (0.5 to 1 mg/ml) for 5 min, destained in water for 20 to 
30 min, and subjected to UV illumination. Nuclease activity was detected as nonfiuorescing 
regions on the gels. After photography, gels were rinsed again with water and fixed in 50% 
ethanol, 12% acetic acid for 1 h. The gels were then stained using a silver staining kit 
(Accurate Scientific Chemical Co., Westbiuy, N.Y.) according to the manufacturer's 
directions. Silver stained gels typically had a dark background because of the presence of 
DNA in the gels, but staining was sufficient to determine the positions of the molecular 
weight standards (GIBCO/BRL). 
Results 
Nuclease activity comparison 
To effectively compare levels of nuclease activities in different mycoplasma species, we 
developed an assay in which lambda DNA was used as a substrate and then the digestion 
products were analyzed on 0.7% agarose gels (Fig. 2.1). Divalent cations had a measurable 
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effect on nuclease activity (Fig. 2.1 and Table 2.2). Addition of calcium resulted in a 32-fold 
increase (5 well difference) in Acholeplasma sp. strain ISM 1499 activity, whereas addition of 
magnesium increased the activity 128-fold (Fig. 2.1). The combination of 2 mM magnesium 
and 2 mM calcium resulted in maximum activity in M. pulmonis and all of the other species 
(data not shown) except for Mycoplasma capricolum. In M. capricolum, nuclease activity 
was detectable only when 10 mM magnesium was added, and the presence of calcium was 
inhibitory (Table 2.2). Interestingly, in two of the three M. pulmonis strains tested, xl048 and 
UAB6510, nuclease activity was observed only when calcium was present. 
The results of the lambda nuclease assay are shown in Table 2.1. Nuclease activity was 
present in all of the strains and species tested, and the level of activity varied in different 
strains and species. To control for nonspecific effects such as the association of media 
components with the mycoplasma membrane surface (22,150,232), broth was screened for 
nuclease activity before it was used. The medium controls were consistently negative. The 
assay sensitivity using DNase I (Sigma) was determined to be 0.(X)08 units (data not shown). 
To determine whether significant proportions of the observed nuclease activities were 
cytoplasmic or membrane-associated, assays were performed to measure (i) the amounts of 
nuclease activity secreted from the cells or released from the surface during incubation in 
assay buffer supplemented with glucose, (ii) the effects of incubation on cell viability, (iii) 
the amounts of nuclease and hexokinase activity associated with purified membranes 
obtained from selected species, and (iv) the total activities of detergent-solubilized cells. 
Several mycoplasmal species secreted or released nuclease activity into the assay buffer 
during incubation (Table 2.1), but incubation in assay buffer had no measurable effect on cell 
viability of most species. The exceptions included M. pulmonis ISM3050, Mycoplasma 
neurolyticum. Mycoplasma dispar and Mycoplasma gallisepticum 19610. Spontaneous lysis 
of cells with concomitant release of intemal nucleases was ruled out as a factor in the 
appearance of soluble nuclease activity because less than 2% (0.18 to 1.68%) of the total cell 
hexokinase activity was released into the assay buffer by M. pulmonis Xl048, M. 
gallisepticum 19610, Mycoplasma bovoculi and M. dispar doling incubation (data not 
shown). There was no difference in the percentage of hexokinase release between strains that 
also released nuclease activity (M. bovoculi, M. dispar and M. gallisepticum) and M. 
pulmonis X1048, which released very low levels of nuclease activity. 
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Table 2.2. Comparison of cation effects on membrane-associated nuclease activity 
Nuclease activity in the presence of*: 
2mM 5mM 10 mM 2mM Mg 5mM Mg 
Organism Mga Mg Mg + + 
2mM Ca 5mM Ca 
M. pulmonis x 1048 0 0 0 1562 1562 
M. pulmonis UAB6510 0 0 + 1562 1562 
M. pulmonis Ml 390 390 390 390 781 
M. capricolum 0 0 6250 0 0 
'The effects of different magnesium and calcium concentrations on the nuclease activities 
associated with whole cells were determined as described in the Materials and Methods. 
Nuclease is expressed as the number of nanograms of protein required to digest 250 ng of 
lamb^ DNA ±, a small amount of nuclease was present, but accurate measurement was 
beyond the sensitivity of the assay. 
Membranes were purified fromM. p u l m o n i s M .  g a l l i s e p t i c u m  19610, andM. 
dispar SDO, strains that represented species that released low, moderate, and high levels of 
nuclease activity into the assay buffer during incubation, respectively. No hexokinase activity 
was detected in the membrane preparations, but the nuclease SDS-PAGE patterns were very 
similar to the patterns obtained with whole cells (Fig. 2.2). 
The activity of detergent-lysed cells was determined by incorporating Tween 20 into the 
buffers of the lambda assay, resulting in the lysis of the cell wall-less mycoplasmas. The 
results of this comparison are shown in Table 2.1. In many of the species, there was a 
dramatic increase in the levels of activity compared with the levels of activity in whole cells 
or cell lysates. 
SDS-PAGE nuclease assay conditions 
The SDS-PAGE nuclease assay was optimized for source of SDS, sample incubation 
temperature, running, renaturation, and storage conditions. Sequanol grade SDS obtained 
from Pierce Chemical Co, Rockford, DL, and SDS obtained from BDH Chemicals Ltd., 
Poole, England, were sufficientiy pure to prevent permanent nuclease inactivation, 
supporting the findings obtained previously (100,130). No effect of sample incubation 
temperature (room temperature for 30 min; 37®C for 15 min; 60°C for 15 min; 100°C for 5 
min) on banding patterns or nuclease activity was observed. The running gel temperatures. 
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however, did have a dramatic effect on banding patterns and reproducibility (data not 
shown). When preparations were separated at a temperature greater than 10°C, nuclease 
activity was permanently inactivated. The most consistent results were obtained when the 
gels were run slowly in a BioRad mini-PROTEAN II apparatus in a cold room with 
precooled buffers. The use of 0.25% SDS in the cathode buffer also increased the resolution 
of the bands, so 0.25% SDS was routinely used in this study. Variation in the renaturation 
temperature (4,22,30, or 37°C) or the addition of Nonidet P-40 (0.001 to 0.1 %) had no 
effect on banding patterns. The presence of 0.2 M NaCl was inhibitory. Additions of protein 
to the renaturation buffer were stimulatory in the following order: 1% Bacto Peptone > 0.01 
to 1% casein > 0.01% bovine serum albumin > 0.01 to 1% gelatin > 1% egg albumin » 1% 
skim milk. Concentrations of bovine serum albumin higher than 0.5% were inhibitory. The 
addition of p-mercaptoethanol (5 X 10"^ - 5 X 10*2 M) or dithiothreitol (5 x 10'^ M) 
significantly increased nuclease activity, as did the inclusion of magnesium and calcium. 
Nuclease activities were stable for several months when preparations were stored in 40% 
glycerol at -20°C. 
Mp Mg Md 
I I I I I I 
WC M WC M WC M 
200-
Figure 2.2. Comparison of nuclease activities in whole cells and purified membranes as 
determined by the SDS-PAGE nuclease assay. Membranes were purified on sucrose 
gradients and the SDS-PAGE nuclease assay was performed as described in Materials and 
Methods. The amount of protein added to each lane was as follows: M. pulmonis X1048 
(Mp), 5.4 ng of whole-cell protein (lane WC) and 1.7 fig of membrane protein (lane M); M. 
gallisepticum 19610 (Mg), 5.6 |i,g of whole-cell protein (lane WC) and 1.4 jig of membrane 
protein (lane M); Af. dispar SDO (Md), 2.5 |i,g of whole-cell protein (lane WC) and 0.7 |ig of 
membrane protein (lane M). The position of size markers (in kilodaltons) are indicated on the 
left. 
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Analysis of mycoplasmal nudeases by SDS-PAGE 
The protein profiles of the nucleases from the M. pulmonis strains are shown in Fig. 
2.3A. The amounts of total protein in the lanes were adjusted in order to facilitate analysis. In 
general, 1-10 jig of protein was loaded into each lane, but the level of nuclease activity in 
strain 66 was significantly higher and less protein was required for analysis. The banding 
patterns of all of the strains tested except for PG34 and JB were very similar. The most 
consistent feature of these patterns was the prominent triplet of nuclease activity in the 35 -
SO kDa range. 
The nuclease patterns obtained from other mycoplasma species were variable. The three 
M. gallisepticwn strains tested produced the same pattem of banding (Fig. 2.3B). The 
nuclease patterns of bovine and porcine species generally appeared to be similar, but there 
were no bands of similar size in the different species. 
In general, the human mycoplasma species exhibited low levels of nuclease activities 
(Table 2.1). To detect nuclease activity in Mycoplasma fermentans PG-18 and Mycoplasma 
penetrans samples, more protein was loaded into each lane (24 and 57 ^g, respectively). M. 
fermentans PG18 and M. fermentans subsp. mcognim^ produced similar patterns which 
differed primarily in the size of the lower-molecular-weight doublet (Fig. 2.3C). Mycoplasma 
pneumoniae exhibited very low activity as shown by the single band (Fig. 2.3C) and by the 
level of total activity observed after detergent solubilization (Table 2.1). Of the human 
species tested. Mycoplasma hominis exhibited the highest level of membrane-associated 
nuclease activity (Table 2.1). 
Discussion 
Our data indicate that membrane-associated nuclease activities are a common feature of 
members of the class Mollicutes. The lambda assay detected nuclease activity in every 
species tested, confirming and expanding on previous reports of this activity in M. pulmonis 
(137) and in A. laidlawii (177). The vast majority of activity in most mycoplasma species 
was cell and membrane associated, and little nuclease activity was released when organisms 
were incubated in assay buffer. This finding was confirmed by monitoring cell viability and 
hexokinase release. M. capricolum was unusual because its low level of nuclease activity was 
inhibited by calcium and required a high magnesium concentrations (10 mM). Some species 
released nuclease activity to the extracellular environment during incubation although it was 
not clear whether this was the result of an active export process or a degradation product of 
membrane-associated activity. This soluble activity could be accounted for by cell lysis in 
only four of the strains tested; it could not be accounted for by cell lysis in the majority of 
Figure 2.3. Nuclease SDS-PAGE band patterns of various mycoplasma species. (A) M. 
pulmonis strains. (B) Various animal mycoplasmal pathogens and Acholeplasma species, (C) 
Human mycoplasma species. Washed mycoplasmas were suspended in 40% glycerol and 
stored at -20°C until they were used. For electrophoresis, cells were mixed 1:1 with SDS-
PAGE sample buffer and incubated at 60°C for IS min, and the proteins were separated on a 
10% polyacrylamide gel containing 10 jig of DNA per ml. After electrophoresis, the gels were 
washed as described in Materials and Methods. To monitor digestion gels were stain^ with 
ethidium bromide, subjected to UV illumination, and photographed with a Polaroid MP-4 
camera and type 57 film. Species names and designations are indicated at the top of each gel. 
The positions of size nuiricers (in kilodaltons) are indicated on the left 
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species, in which no loss of viability occurred during incubation and only a small amount of 
hexokinase release was detected. If nuclease activity is secreted in some species, it may 
provide a convenient model system to study mycoplasmal protein translocation. 
Despite careful adherence to the conditions described in previous studies in which SDS-
PAGE analysis of nuclease-containing preparations was used (130,177, 182), we were 
initially unable to obtain reproducible nuclease patterns in mycoplasma samples. Carefiil 
examination of the system variables revealed that control of the gel ruiming temperature, the 
quality of the SDS, higher SDS concentrations in the cathode buffer, and addition of casein 
and p-mercaptoethanol to the wash buffer were major factors in increasing reproducibility. In 
addition, the stability of nuclease patterns during storage at -20°C enhanced the results 
significantly. 
One unusual observation was the number and variability of the nuclease bands. Since 
mycoplasmas are often considered to be minimal living units, it was surprising that multiple 
nucleases were present The presence in mycoplasma membranes of variable lipoproteins 
which exhibit size and charge variability has received considerable attention recently (21, 
180,181). Although the results of preliminary experiments indicate that the nucleases from 
M. pulmonis are not modified by palmitic acid (data not shown), the membrane-bound 
nucleases may exhibit peptide length variability based upon a mechanism similar to the 
mechanisms observed with the variable lipoproteins. 
It was hoped that the patterns could provide a means to differentiate between 
mycoplasma species, and our studies performed with multiple strains of M. pulmonis and M. 
gallisepticum indicated that most strains of a species could be categorized on the basis of the 
banding profile (Fig. 2.3A). The three Af. capricolum strains tested had similarly low, but 
detectable levels of activity (data not shown). The nimiber of strains tested was limited, 
however, and additional studies would be required to expand these observations. 
In conclusion, mycoplasmas produce multiple membrane-associated nucleases which 
may provide a mechanism for obtaining nucleotide precursors by degrading host 
chromosomal DNA. Whether this activity is actively involved in the pathogenic process is 
not known. Because of the requirement for nucleic acid precursors, this activity may be 
expected to contribute significantly to the survival process of the organism in hosts. 
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CHAPTER 3. CHARACTERIZATION OF A MEMBRANE 
NUCLEASE ENCODING GENE OF MYCOPLASMA PULMONIS 
AND ANALYSIS OF ITS EXPRESSION IN ESCHERICHIA COU 
A p^r to be submitted to Molecular Microbiology 
Karalee J. Jarvill-Taylor, Christina VanDyk and F. Chris Minion 
Abstract 
Membrane nucleases of mycoplasmas have been proposed to play an important role in 
growth and pathogenesis. As a first step in defining the function of this unusual activity at the 
cellular and molecular levels, a membrane nuclease gene of Mycoplasma pulmonis, 
designated mnuA, was cloned in Escherichia coli. To expedite antigen expression and 
functional analysis of cloned sequences, an opal suppressor host was used to overcome 
premature translational termination at UGA codons which code for tryptophan in 
mycoplasmas. Four nuclease positive clones from two different chromosomal DNA regions 
were obtained. This suggested that M. pulmonis contains at least two distinct nuclease-
encoding genes. Insertional mutagenesis was used to locate a nuclease gene subsequently 
designated mnuA within a cloned 12 kilobase chromosomal fragment. DNA sequence 
analysis of the gene and its surrounding region identified an open reading fiame of 1,410 
base pairs with a deduced 470 anaino acid polypeptide of 53,739 daltons. A prolipoprotein 
signal peptidase n recognition sequence was detected, and an extensive hydrophobic region 
in the amino terminal region suggests that the protein spans the membrane. Analysis of the 
gene products produced in E. coli showed two classes of products, full length and partial 
products that resulted from aberrant transcription and translation initiation. Some of these 
latter products were initially inactive, but became active (nuclease positive) after DNA-
sodium dodecyl sulfate polyacrylamide gel electrophoresis. The mnuA gene products from E. 
coli showed no apparent DNA substrate specificity. However, one membrane nuclease in M. 
pulmonis failed to digest eucaryotic chromosomal DNA. This observation might provide 
additional approaches to the identification and analysis of other membrane nuclease genes 
from M. pulmonis and other mycoplasma species. 
Introduction 
The nutritional requirements of the mollicutes indicate that they lack most capacities for 
de novo synthesis of nucleotides. To compensate, mycoplasmas must encode enzyme 
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activities and transport functions to facilitate the uptake of nucleic acid precursors either as 
free bases or as oligonucleotides (56). Potent external membrane-associated nucleases have 
been identified in all mycoplasma species tested with most species appearing to produce 
multiple nucleolytic proteins (139). The membrane location of this activity could satisfy the 
need for purines and pyrimidines by the degradation of DNA or RNA in mucosal secretions. 
Nucleic acids could also be obtained &om dead and dying cells of the respiratory tract to 
which the organism is attached. It has been shown that mycoplasmas can utilize external 
radiolabeled RNA and incorporate the labeled nucleotides into either DNA or RNA (154). 
The divalent cation requirement of the nucleases varied. In Acholeplasma oculi, calcium 
was not as effective as magnesium in stimulating activity. The membrane nucleases of 
Mycoplasma capricolum were inhibited by calcium and were only active in the presence of a 
high concentration (10 mM) of magnesium. In M. pulmonis, strain differences in the cation 
requirements were observed; the membrane nucleases of strain UAB6510 and its rat 
passaged derivative xl048 were active only in the presence of calcium whereas magnesium 
was required for strain MI membrane nuclease activity (139). Thus, it is clear that although 
all mycoplasma species appear to contain these surface nuclease activities, there is variability 
in their cation requirements suggesting that they may not be encoded by related genes. 
The membrane-nuclease activity in the mollicutes was initially reported in M pulmonis, a 
rodent respiratory and genital tract pathogen (137,197). Further analysis of this activity 
revealed that different strains of M. pulmonis produced remarkably similar nuclease banding 
patterns in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) nuclease 
gels (139). This species also expressed a higher amount of nuclease activity than the other 
mycoplasmal species tested (139). 
The approach used to identify the structural gene for one of the membrane nucleases of 
M. pulmonis involved the production and use of anti-membrane nuclease antisera to screen a 
genomic library. The antisera was raised against semi-purified nuclease preparations 
obtained by preparative SDS-PAGE nuclease gels. Immunoreactive recombinant X phage 
were then scored phenotypically for the expression of nuclease activity in an Escherichia coli 
opal suppressor host. The chromosomal DNA firagments were subcloned and restriction 
mapped. TnlOOO mutagenesis was then used to identify a region within one chromosomal 
fragment producing nucleolytic activity. The gene thus identified has been sequenced and has 
been designated mnuA for membrane nuclease, the first such gene identified in the 
mycoplasmas. Our results indicate that M. pulmonis contains at least two membrane nuclease 
genes. The DNA sequence, putative open reading frame and protein profile analysis are 
described for nrnuA. 
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Materials and Methods 
Organisms and media 
M. pulmonis CT, M. pulmonis X1048, Mycoplasma gallisepticum R, Mycoplasma 
hyorhinis GDL, Mycoplasma hyopneumoniae 232, Mycoplasma capricolum 27343, 
Mycoplasma fermentans PG-18, Mycoplasma fermentans subsp. incognitus. Mycoplasma 
penetrans. Mycoplasma hominis 1620, Mycoplasma pneumoniae ATCC15531 and 
Acholeplasma oculi ISM1499 were grown as previously described (139). Cultures were 
obtained from a stock culture maintained at -70°C, inoculated into fiesh broth medium and 
incubated statically at 37°C. E. coli strains (Table 3.1) were started from stock cultures and 
maintained in IX or 2X Luria-Bertani broth, in superbroth (32 g tryptone, 20 g yeast extract, 
5 g NaCl, per liter, pH 7.2) or on Luria broth agar media. Phage plates for screening genomic 
libraries on E. coli strain ISM612 consisted of superbroth base with superbroth soft agar 
overlays. 
Isolation of M. pulmonis chromosomal DNA 
Mycoplasma chromosomal DNA was isolated from 1 liter of mid log phase culture. The 
cells were centrifuged at 10,000 x g for 20 min and washed once in 0.01 M sodium 
phosphate - 0.15 M sodium chloride, (pH 7.4) (PBS). The pellet was resuspended in 7 ml of 
NET buffer (0.15 M NaCl - 0.08 M EDTA - 0.10 M Tris, pH 7.5) containing 1 mg of 
proteinase K (Sigma Chemical Co., St. Louis, Mo.) per ml. The cell suspension was 
incubated at 45°C for 30 min, one fifth volume lysis buffer (1%NP40-1% Triton X-100 -
1% deoxycholate) was added, and the suspension was incubated overnight at 45°C. The 
mixture was then extracted 4 times with an equal volume of phenol/chloroform (1:1) 
(Amresco, Inc., Solon, Ohio) and once with chloroform/isoamyl alcohol (24:1) (Fisher 
Scientific Co., Pittsburgh, Pa.). DNA was dialyzed overnight at 4°C against TE buffer (10 
mM Tris - 1 mM ethylene diamine tetraacetic acid, pH 8.0). 
Antisera 
Antigen preparations containing semi-purified nucleolytic proteins were prepared from a 
SDS-PAGE nuclease gel using preparative spacers with the Bio-Rad Protean n 
electrophoresis unit (Bio-Rad Laboratories, Richmond, Calif.). The running and renaturation 
conditions were adapted from standard conditions (139) in order to obtain the maximal 
nuclease activity in preparative gels. The nuclease gels were electrophoresed at constant 
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Table 3.1. Bacterial strains and plasmid descriptions 
E. coli strains Description ReT 
F- hsdR514 (rk", mk") lacYl supE44 supF58 galKl 
galT22 trpR55 metBl 
(fe«(UGA) lacZ659CUGA) trpA9605(\JAG) his29(UAG) 
ilv thyA metB argH rpoB rpsLprfBS) pISM300I 
LE392 [F- hsdR514 (rie" mk") lacYl supE44 supF58 
galK2 galT22 trpR55 metBl] pISM3001 
XLl-Blue [recAl lac endAl gyrA46 thi hsdR17 supE44 
relAl {FproAB* lacM lacZmiSTnlO)] pISM3001 
F+ mating donor 
F" mating recipient, Kan" 
LE392 
ISM612 
ISM614 
ISM647 
DPWC 
BW26 
Plasmids 
pISM3001 
pISM4030 
pISM4060 
pISM4061 
pISM4070 
pISM4170 
pISM4172 
pISM4175 
pISM4176 
pMOB 
trpT gene cloned behind a lac promoter in the vector 
pACYC184, Cm" 
12.2 kb Sad fragment from phage 9.2C cloned into pKS 
4.7 kb 5acl fragment from phage 13.SC cloned into pKS 
8.1 kb Sad fragment from phage 13.5C cloned into pKS 
3.7 kb and 7.5 kb Sad fragments from phage 14.1 IF 
cloned into pKS 
6.6 kb Sad fragment from phage 13-2B cloned onto 
pMOB, Ap"" 
7.0 kb Sad fragment from phage 13-2B cloned onto 
pMOB, Ap'' 
2.2 kb Clal fragment from pISM4172 cloned into pMOB, 
Ap'^ 
2.6 kb Clal fragment from pISM4172 cloned into pMOB, 
Ap*^ 
Cloning vector for TnlOOO mutagenesis, Ap*^ 
(202) 
This study 
This study 
Gold 
Biotechnologies 
Gold 
Biotechnologies 
(202) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Gold 
Biotechnologies 
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current (no greater than 10 mA per gel) at 4°C. Followmg electrophoresis, the gels were 
washed four times in 100 volumes of incubation buffer (40 mM Tris - 0.01% Casein - 0.04% 
merc^toethanol, pH 7.5) for 1 h each, and then incubated overnight in the same buffer at 
room temperature. Nucleolytic activities were identified by incubating the gel in renaturation 
buffer supplemented with 2 mM CaCl2 and 2 mM MgCl2 for 24 h, staining the gel with 
ethidium bromide, and then observing it under UV illumination. Areas displaying digestion 
of the DNA (nonfluorescing regions of the gel) were excised and minced using a 22 gauge 
needle. For each isolated band, two New Zealand White rabbits were immunized by 
injecting the acrylamide/protein slurry subcutaneously. Rabbits were boosted 2 weeks post 
immunization with the same antigen, and the antisera collected at 4 weeks was tested for 
reactivity by ELISA using M. pulmonis lysed whole cell antigen (30) and by inununoblot as 
described previously (216). 
Genomic library 
Chromosomal DNA from M. pulmonis was partially digested with SauSA, and 9-15 
kilobase fragments were isolated using sucrose gradients (122). The fragments were partially 
filled in and ligated into X/ioI-digested XGEM 12 arms according to the manufacturer's 
directions (Promega Corp., Madison, Wis.). The recombinant phage were packaged and 
plated onto lawns of E. coli strain LE392. Single plaques were picked using a sterile pasteur 
pipette and dispensed into 200 [il of buffer 100 mM sodium chloride -10 mM magnesium 
sulfate - 50 mM Tris - 0.01% gelatin, (pH 7.5) (SM) in one well of a 96-well plate. To elute 
the phage, the plates were maintained at 4°C overnight on a shaking platform. The phage-
containing supematants were then plated in 10 (il volumes onto mini-lawns of E. coli LE392 
in microtiter plates. After overnight incubation at 37°C, the mini-lawns were overlaid with 
100 jil of SM buffer per well, the plates were incubated for 4 to 6 h at 4°C to allow for phage 
elution, the plates were centrifiiged at 300 x g for 10 min, and the supernatant was removed 
and placed in sterile 96-well plates with an equal volume of SM buffer. Each microtiter plate 
was sealed with tape, and stored at 4°C. 
Library screening 
Screening of the genomic library was accomplished by inoculating lawns of E. coli 
ISM612 prepared in 85 mom petri dishes with the phage from the microtiter plates using a 48 
pin replicator and growing the phage overnight at 37°C. Isopropyl-B-D-thiogalactopyranoside 
(Gold Biotechnologies, Inc., St. Louis, Mo.) - saturated nitrocellulose filters were placed on 
the plates, and the plates were incubated for an additional 5 to 6 h at 37°C. Nitrocellulose 
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lifts were screened for antigen positive plaques by incubating the filters in blocking solution 
(5% nonfat dry milk-O.lO M Tris-0.15 M NaCl-0.05% Tween 20, pH 7.5) for 2 h, and then 
with rabbit anti-nuclease serum diluted 1:100 in TS-Tween (0.10 M Tris-0.15 M NaCl-0.05% 
Tween 20, pH7 .5). The lifts were washed three times with TS-Tween, incubated with goat 
anti-rabbit inununoglobulin, alkaline phosphatase conjugate (Organon-Teknika, Durham, 
N.C.) diluted 1:1000 in TS-Tween for 2 h and then washed three times with TS-Tween prior 
to development with Naphthol AS-MX Phosphate and Fast Red (Sigma). 
Recombinaiit DNA 
Plasmid DNA was isolated by alkaline lysis (15). DNA electrophoresis was performed in 
Tris-acetate gels as described (122). Restriction mapping of the genomic fragments was 
performed initially using isolated X DNA and then confirmed using the plasmid 
constructions. X DNA was isolated from recombinant phage as described (122), digested with 
Sad (New England Biolabs, Inc., Barely, Ma.) and ligated into 5acl-digested pMOB DNA 
(Gold Biotechnologies). Plasmids pISM4175 and pISM4176 were constructed by digesting 
plasmid pISM4172 with Clal and ligating to C/al-digested, dephosphorylated pMOB. All 
plasmid constructions were confirmed by restriction analysis. 
Nuclease detection assays 
For nuclease detection, mycoplasma suspensions were produced as previously described 
(139). To determine the expression of nuclease activity by the recombinant X phage, the opal 
suppressor E. coli ISM612 was infected with the phage at a multiplicity of infection of 10:1 
and the cells shaken at 37°C. IPTG was added (40 mM final concentration) at 2 h, the cells 
were harvested by centrifiigation after a 7 h incubation at 37°C, resuspended in PBS and 
sonicated prior to use. Nuclease activities associated with recombinant plasmids were 
monitored in the E. coli ISM647 background (Table 1). Transformed colonies were picked, 
grown overnight, harvested, resuspended in PBS and sonicated prior to use. Soiucation was 
performed using a Branson Ultrasonicator at the maximvim setting for the micro tip, 50% 
duration pulse for 20 pulses. The nuclease digestion of \ nuclease and the SDS-PAGE 
nuclease gel assays have been described (139). In some SDS-PAGE nuclease gels, X, DNA 
(Bethesda Research Laboratories, Inc., Gaithersburg, Md.) was substituted for salmon sperm 
DNA. 
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TnlOOO mutagenesis 
Plasmids pISM4172 and pISM4175 were transformed into E. coli DPWC and mated with 
BW26 according to method described by Strathmann (209). Recipient cells were selected on 
LB containing 50 fig per ml kanamycin and 100 ^g per ml ampicillin. Colonies were picked, 
grown in 2X Luria broth, and the plasmids were isolated by alkaline lysis (15). InlOOO 
insertions were mapped, oriented by restriction digests, and the plasmids analyzed for the 
loss of nuclease activity. This was accomplished by transforming the plasmids containing 
TtlIOOO inserts into E. coli ISM647, preparing cell lysates and analyzing those lysates for 
nuclease activity as described above. TnlOOO inserts were also used as primer sites for DNA 
sequence analysis. 
Hybridization studies 
Chromosomal DNA was isolated as described above. Approximately 2 to 5 ^ g of DNA 
from each species was digested to completion with EcoRl and the fragments were separated 
on a 0.7% agarose gel. DNA fragments were transferred by the method of Southern to nylon 
membrane (Pall Biosupports) as previously described (122). Blots were treated with UV light 
for 3 min, baked at 80°C for 2 hours and hybridized with DNA probes using Rapid-hyb 
buffer (Amersham, Arlington Heights, 111) as previously described (122). Hybridization was 
performed at 46°C. Blots were washed 3 times for 15 minutes in 2X SSC-0.1% SDS at room 
temperature and 2 times for 30 minutes in IX SSC-0.1% SDS at 46°C. DNA probes were 
labeled using alpha labeled ^^P-CTP using the Rediprime random labeling system 
(Amersham) and uncorporated nucleotides were removed by spinning the labelled probe 
through microspin S-300 HR columns from Pharmacia-Biotech (Piscaway, NJ). 
DNA sequence analysis 
Plasmids for DNA sequencing were prepared using the midi plasmid isolation kit from 
Qiagen (Qiagen, Inc., Chatsworth, Calif.). All sequencing was performed by the Nucleic 
Acid Instrumentation facility at Iowa State University using cycle sequencing protocols. The 
sequencing primers were oligonucleotides complementary to the transposon sequences 
adjacent to the inverted repeat ends of TnlOOO. Primer 187 (5'-CAACGAATTATCTCCTT-
3') (Gold Biotechnology) binds to base pairs 39-63 of the transposon and provides sequence 
information outward from the end closest to the 5acl site in the transposon (21). Priiner 486 
(5'-TCAATAAGTTATACCAT-3') binds to base pairs 5924-5947 of the transposon and 
provides sequence information outward from the opposite end. Three other primers were 
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constructed from sequencing data and used to sequence selected regions, primer 2590 (5'-
GCGACACTGAGCCTAGAG-3'), primer 1145 (5'-GGTGTAGCTACTAATAAAC-3 ), and 
primer 890 (5'-GACCTTAGCCAAATGA AAC-3'). Sequence analysis was performed using 
Mac Vector software (Eastman Kodak Company, New Haven, Conn.)- The hydrophilicity of 
the translated product was determined by the method of Kyte and Doolittle (98) and the 
secondary structure predictions by the methods of Chou and Fasman (32) and Robson and 
Gamier (67). The translated product was also analyzed for signal sequences and 
transmembrane domains with PSORT (available on the World Wide Web at URL 
http://psort.nibb.ac.jp). PSORT uses the methods of McGeoch (129) and von Heijne (223) for 
signal sequence determination and the method of Klein et al. (88) for determining 
transmembrane domains. 
Nucleotide sequence accession number 
The nucleotide sequence of the mnuA gene of M. pulmonis has been assigned GenBank 
accession number U38841. 
Results 
Characterization of the anti-nuclease antisera 
Antisera produced against SDS-PAGE purified membrane nucleases from M. pulmonis 
were used in immunoblot analysis of whole cells of M. pulmonis % 1048 separated by a 10% 
SDS-PAGE nuclease gel. Two different immunoreactive profiles were seen using the antisera 
(data not shown). These crude antisera did not react specifically with a particular region of 
the blot, and none of the antisera were able to inhibit nuclease activities in M. pulmonis 
whole cells. 
Identification and characterization of immunoreactive X phage 
The genomic library of M. pulmonis representing 1920 independent, recombinant X with 
an average insert size of 10-12 kilobases (kb) was plated on E. coli ISM612 and screened as 
described above. In addition to the laci controlled trpT opal suppressor on plasmid 
pISMSOOl (202), a release factor 2 mutation, prfBl, is located on the chromosome in this 
strain. This combination is more efficient in expressing mycoplasma genes containing 
multiple internal UGA codons than strains containing only the trpT allele (202). Nineteen 
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Table 3.2. Antisera reactivity and nuclease activities of recombinant phage. 
Rabbit Antisera No. 
Phage Number 89938 89786 Nuclease Act.' 
1.6G + - -
3.6H + - -
6.2B + - -
6.3E + - -
8.12F + + -
9.2A + - -
9.2B + + -
9.2C - + +++ 
9.3B + - -
9.6G + + -
9.10G + + -
9.12E + + -
11.2D + - -
11.6E + - -
13.2B - + +++ 
13.5C + + + 
14.3D + - -
14.7C + + -
14.11F - + + 
"The nuclease activity was determined by screening X lysates using the X DNA nuclease 
assay as described in the Materials and Methods. Results were recorded as positive if any 
nuclease activity was observed in the cell lysates. (+) refers to a slight amount of detectable 
nuclease activity expressed by E. coli infected with the recombinant phage. (+++) refers to 
high nuclease activity expression. 
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C Mp 9.2C 13.2B E.coli C 
Figure 3.1. Analysis of recombinant phage 9.2C and 13.2B by % assay. Phage lysates 
were prepared and examined for nuclease activity as described in the text. Undigested X 
DNA is shown in the outer lanes (C). M. pulmonis antigen (Mp) was used as the positive 
control and E. coli ISM612 as the negative control. The thr^ lane groupings represent 
increasing two-fold protein concentrations from left to right. The gel was digitized using a 
Cohu model 4900 high performance CCD camera (Cohu, Inc., San Diego, Calif.) and a 
Macintosh lici equipped with a Scion Corporation (Frederick, Md.) video board. The 
resulting TIFF file was cropped with assembled in Adobe photoship and labeled in Aldus 
Freehand. 
immunopositive phage were identified in the library by the antiserum (Table 3.2). Four of the 
19 immunoreactive phage expressed nuclease activity by the k assay. The two demonstrating 
the highest level of activity are shown in Fig. 3.1. The inserts cloned within these positive 
phage were restriction mapped (Fig. 3.2). The chromosomal DNA from 9.2C, 13.5C and 
14.1 IF were subcloned into pKS whereas the chromosomal DNA from 13.23 was subcloned 
into pMOB. 
Cloning and functional analysis of the chromosonial fragment from phage 13.2B 
In order to further analyze the plasmids, they were transformed into the opal suppressor 
strain ISM612 which had no endogenous nuclease activity in our assays (data not shown). 
When the plasmids containing chromosomal inserts from phage 9.2C and 13.5C (Fig. 3.2) 
were analyzed for expression of nuclease activity, the activity was present in less than 10% 
of the isolated colonies. This was not the result of loss of the plasmid. It was assumed that the 
nuclease genes were undergoing a high rate of mutation and these plasmids were not studied 
further. When pISM4170 was placed into strain ISM612, the same phenotype was obtained. 
All attempts to transform plasmid pISM4172 into strain ISM612 failed. This was 
interpreted to be the result of plasmid instability in the trpT-prfBl background. To test this 
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Figiire 3.2. The physical maps of the chromosomal inserts in recombinant phage 13.2B, 
13.5C, 14.1 IF, and 9.2C. The subcloned regions and the plasmid designations are also given. 
The sizes are given in kilobases. Symbols: A, Apal; B, BanHl; Bs, C, Clal; E, 
EcoRI; Ev, EcoRV; K, Kpnl; H, Hindni; P, Pstl, S, Sad; Sm, Smid. 
possibility, two E. coli strains lacking the prfB2 mutant allele, LE392 and XL 1-Blue, were 
transformed with pISM3001. The resulting strains, ISM614 and ISM647, were screened for 
endogenous nuclease activity which might interfere with mapping the nuclease structural 
gene by transposon mutagenesis and examined for stable maintenance of pISM4172. Both E. 
coli strains lacking the prfB3 mutation supported replication of plasmid pISM4172, but only 
ISM647 lacked the type of nuclease activity identified in our X assay (data not shown). 
To locate the membrane nuclease structural gene within the 7.0 kb insert of pISM4172, 
the plasmid was subjected to TnlOOO mutagenesis as described (209). The resulting 
insertions were restriction mapped, and selected plasmids representing insertions across the 
entire cloned fragment were screened for the loss of nuclease activity following 
transformation into ISM647. Insertions of TniOOO within a 1.0 kb region of pISM4172 
knocked out nuclease activity (Fig. 3.3, Panel A, black bar). Plasmid pISM4176 containing 
the 2.6 kilobase Sacl-Clal fragment of pISM4172 was nuclease positive in the ISM647 
background while the adjacent Clal internal fragment in pISM4175 encoded no nuclease 
activity (Fig. 3.3) 
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Figure 3.3. TtilOOO analysis of pISM4172. The plasmid pISM4172 was subjected to TnlOOO 
mutagenesis and analyzed as described in the text. (A) Shown are locations of selected 
TnlOOO inserts in pISM4172 are designated by inverted, filled triangles. Below the map are 
the results of the X, DNA assay. Inserts that knocked out nuclease activity in the X assay are 
designated (-) and those that had no effect on nuclease activity are designated (+). The bar 
indicates the minimal coding region encoding mnuA as defined by TnlOOO mutagenesis. The 
arrow indicates ORFl {rnnuA) as determined by DNA sequence analysis and the direction of 
transcription. (B) Analysis of TnlOOO inserts by SDS-PAGE nuclease gel assay was 
performed as described in the text. The apparent molecular weight of the nucleolytic bands is 
shown on the left. (*) indicates nucleolytic bands arising from E. coli with specificity for 
salmon sperm DNA. All lanes contained 5 ^g E. coli protein from strain ISM647 harboring 
the indicated plasmid except for the lane labeled Mp which contained 116 ng (upper gel) or 
175 ng (lower gel) of M. pulmonis protein. The upper gel contained salmon sperm DNA and 
the lower gel contained X, DNA. Symbols: Mp, M. pulmonis antigen; 72, pISM4172; 
76, pISM4176; 75, pISM4175; C, ISM647 (pMOB); the remaining lanes (1-7) contain 
protein from the strains harboring the correspondingly labeled TnlOOO insertions shown in 
panel A. 
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DNA sequencing and computer analysis 
Approximately 5.0 kb of DNA sequence information was obtained from the region 
encoding the nuclease activity as shown in Fig. 3.4. An open reading frame (ORF) of 1410 
bp was identified within this region encoding a 470 amino acid (aa) polypeptide of 53.7 kDa 
(Fig. 3.4). TnlOOO insertions upstream and downstream of ORFl failed to eliminate nuclease 
activity (Fig. 3.3). No Shine-Dalgamo-like sequence was found upstream of the mnuA ORF. 
There was also no apparent promoter region, but the region was AT rich with several 
potential TATA boxes. Analysis of the predicted translated product of the mnuA DNA 
sequence shows an amino terminal region rich in lysine residues followed by a 42 amino acid 
hydrophobic region and another lysine rich region which could serve as a membrane 
spanning region to anchor the protein (Fig. 3.4). There was no typical cleavable signal 
sequence, but the charged - hydrophobic - charged domains in the amino terminal region 
resembled principle features of bacterial signal peptides (163). The single cysteine residue 
was associated with a T-I-S-C motif near the amino terminus previously reported to be a 
procaryotic prolipoprotein signal peptidase n recognition sequence (24,239). The remaining 
portion of the molecule was extensively hydrophilic with substantial alpha helical character 
(Fig. 3.4). The estimated pi of the translated product was 9.04, and it had a calculated 
molecular mass of 53,738 daltons. Homology searches with the translated product revealed 
short stretches of homology (10-15 amino acids) with the CpG methylase of Spiroplasma 
citri, but no other homology with known DNA or protein sequences was observed. Several 
regions of the translated product of mnuA showed homologies to proteins with DNA binding 
characteristics. Among these was the DNA topoisomerase I of yeast, mouse and human, and 
the lU^A polymerase beta of maize. No typical transcriptional terminator was identified. 
Analysis of mnuA products produced in E. coU 
E. coli containing pISM4172 expressed four distinct products of 66,53,45 and 39 
kilodaltons (kDa) from the chromosomal fragment containing mnuA (Fig. 3.3). The band at 
45 kDa, however, was weak and was sometimes missing (lower panel, lanes 72,1 and 2). 
The 45 and 66 kDa bands appeared to be related since the Tn/000 insertion at position 175 of 
the mntdA gene sequence (insertion 2) knocked out expression of both bands. The 53 and 39 
kDa nucleolytic products produced with an insertion at position 2 (lane 2) may be derived 
from internal transcriptional initiation within the structural gene at a site downstream of this 
insertion. The 45 and 39 kDa products may result from premature truncation at the last UGA 
codon. TnlOOO insertions located further downstream of insertion 2 (locations 3 and 4), 
knocked out all nucleolytic bands in the SDS-PAGE nuclease gels. 
Figure 3.4. Nucleotide and deduced amino acid sequence of the M. pulmonis rmuA gene. 
Nucleotide coordinates are counted from the begimiing of the sequence. The mnuA ORF 
begins at nucleotide 97 and extends through nucleotide 1486. An inverted repeat is underlined 
at Sie 3' end of the sequence, (i) indicates a TnlOOO insertion site. 
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* * * * * * *  
ATAGAAATTGGCATAGAATTGGATAAATAATTGTTAAAACGCCTTTTAACGCTTTGAAAAAGGCGTTTTTT 7 0 
M K N K M K S L K V S L L V A  
AATTAAGCAATAATAAAATTATTGATATGAAAAATAAGATGAAATCGTTAAAAGTTAGTTTATTAGTAGCT 140 
T P I I T L P L F T I S C I P N N E S K S Y Q D  
ACACCAATAATTACACTCCCATTATTTACAATTAGTTGCATTCCAAATAATGAATCTAAATCTTATCAAGA 210 
L N A K A N Q A A I L L K Q K Q I N S N i K L E E  
TTTAAATGCCAAGGCTAATCAAGCGGCCATTTTGCTTAAACAAAAACAAATTAATAGCAATAAATTAGAAG 280 
L I D S I L P E G T E L E I L D L W V D R E N  
AGCTAATTGACAGCATTCTACCCGAAGGAACTGAGTTAGAAATTTTAGATCTTTGAGTGGATCGTGAAAAT 350 
K E I N V K F R L R Y K D R R Y P Y S S D V K I  
AAAGAAATTAATGTTAAATTCCGTCTTAGATATAAAGACAGAAGATATCCTTATAGTTCGGATGTCAAAAT 420 
I K L K Y E S I L E N L K P Q E K P K E K P G R  
AATTAAGTTAAAGTATGAGTCTATCTTGGAAAACTTCAAACCGCAAGAAAAACCAAAGGAAAAACCCGGAC 490 
K S K E K N P K T Q N D E K S K D G L N K K S  
GTAAGTCTAAAGAAAAGAACCCAAAAACCCAAAATGATGAAAAGTCTAAAGATGGCCTTAATAAAAAGTCA 560 
N G K Q K M K W G H W N V L K L S D K N D K K I  
AATGGAAAACAAAAAATGAAATGAGGACATTGGAATGTTCTTAAATTAAGCGACAAAAATGATAAAAAAAT 630 
A A I A A L I K K I D Y D V V G L T E V F S E E  
TGCTGCCATTGCCGCTTTAATTAAAAAAATTGACTATGATGTCGTTGGCCTAACGGAAGTATTTAGCGAAG 700 
A V K i E V V A Q L N K L A G S G T Y S Y V A S  
AAGCCGTTAAAGAAGTCGTTGCTCAATTGAATAAACTAGCCGGCAGTGGCACATATTCTTATGTTGCATCA 770 
K K L K G S Y A G N L Q A E H V G V I Y N S Q K  
AAAAAACTTAAAGGCTCATATGCTGGCAATTTGCAAGCTGAACATGTCGGAGTAATTTATAATAGCCAAAA 840 
I K T I P F E K T K N N K K E I G Y S Y I E K F  
AATTAAAACTATTCCATTTGAAAAGACTAAGAATAATAAAAAAGAAATAGGCTATAGTTATATAGAAAAAT 910 
N S E F I K K H N K A E Y V R P P Y G V K F Q  
TCAATTCAGAATTTATTAAAAAACATAACAAAGCCGAGTATGTACGACCACCATATGGTGTTAAATTCCAA 980 
W L K G K K E D F T F V F D H F D S P G G S K G  
TGATTAAAAGGGAAAAAAGAAGATTTTACATTTGTTTTCGACCATTTTGATAGCCCTGGCGGAAGCAAAGG 1050 
E G T T S G V G N Q E L A E A R Q L A N V L D H  
TGAAGGAACAACTAGTGGAGTCGGCAATCAAGAGCTAGCAGAAGCTAGACAACTTGCAAATGTACTTGATC 1120 
F D E I D G E N E D I F F S G D T N I K A G K  
ATTTTGACGAAATTGATGGCGAAAACGAAGATATCTTCTTTAGCGGAGACACCAACATCAAAGCGGGCAAA 1190 
E K F A F G E X E I i F K K Y Q S A F K D N L E F A  
GAAAAATTTGCTTTTGGTGAAGAATTATTCAAAAAATATCAATCCGCTTTTAAAGATAACCTTGAGTTTGC 1260 
T S L G I K A G N Y S Q P Y D K M F T K T K F K  
AACATCATTAGGAATAAAGGCCGGCAACTACTCACAACCATATGATAAAATGTTCACAAAAACCAAATTTA 1330 
T S N H G I Y K L W D L S K D D E F T N L F K  
AGACTTCAAATCATGGCATCTATAAACTATGAGACTTGAGTAAAGATGATGAATTTACAAATCTTTTCAAA 1400 
E L H N G K I E T S E I R K L V S D H A P I Y S  
GAATTACATAATGGAAAAATTGAAACTAGTGAAATAAGAAAACTAGTATCTGATCACGCGCCTATATATAG 1470 
E V E F E 
TGAAGTTGAATTTGAATAATTAAAAAAATATAAAAAAATCGATGCCTAACTTTnGTATCGATTTTAArTTT 1532 
60 
Hydrophilidty Window Size = 7 Scale = Kyte-DoolitUe 
4.00 
1 2.00 
g- 0.00 
 ^-2.00 
 ^0.90 
I 0-70 
I ® 
•g 0.30 3 
CO I 
g 0.40 ID 
 ^ 0.00 
1-0.40 
< -0.80 
I* £ CfRg Hlx 
•g -g CfRg Sht 
8 B CfRgTm 
Figure 3.5. Predicted properties of the translated sequence of mnuA. All analyses were 
performed using MacVector software. The scale at the bottom of the figure indicates the 
amino acid residue number. The type of analyses are indicated on the left. Positive numbers 
indicate high probability for hydrophilic regions, surface exposure and antigenicity. Shown 
in the bottom panel are the regions of secondary structure that agree using ^e Chou-Fasman 
(Cf)(4) and Robson-Gamier (Rg)(9) methods. Hlx, a-helix; Sht, P-sheet; Tm, turn. 
Correlation of the X assay results with the SDS-PAGE nuclease gel results shown in Fig. 
3.3 shows that mnuA translation products which probably lack the amino terminus are 
inactive in whole cell lysates. Some nuclease activity could be regained in these truncated 
products, however, in the SDS-PAGE nuclease assay (Fig. 3.3, lower panel, lane 2). 
Presence of mnuA. like sequences in other mycoplasma species 
The internal EcoRV fragment of mnuA was used to determine if this gene was shared 
among mycoplasma species. As is shown in Figure 3.6, there was cross-hybridization 
between the mnuA probe and chromosomal fragments from M hyopneumoniae and M. 
pneumoniae. There was only one copy of mnuA in the M. pulmonis chromosome and that the 
gene is located in a similar location in both Af. pulmonis CT and M. pulmonis XI048, the 
latter being the strain iirom which mnuA was isolated. 
61 
Figure 3.6. Hybridization of analysis of mycoplasma species with a mnuA probe from M. 
pulmonis. The probe used for analysis was a £coRV fragment from pISM4l76. 
Hybridization conditions are described in the Materials and Methods. Lanes: CT, M. 
pulmonis strain CT; Xl048, M. pulmonis gallisepticum, M. gallisepticum R; 
hyopneumoniae, M. hyopneumoniae 232; hyorhinis, M. hyorhinis GDL; capricolum, M. 
capricolum ATCC 27343; fermentans, M. fermentans PG-18; incognitus, M.fermentans 
supsp. incognitus; penetrans, M. penetrans-, hominis, M. hominis 1620; pneumoniae, M. 
penumoniae ATCC 15531, oculi, A. oculi ISM1499. 
Discussion 
This work represents the first cloning and analysis of a membrane-associated nuclease 
gene, mnuA, from a mycoplasma. Identification and functional analysis of mnuA was 
possible because of the suppression of UGA codons by trpT176 resulting in expression of 
nucleolytic activity from cloned and mutated fragments. A highly efficient suppressor strain, 
ISM612, was unable to stably maintain any fragment containing membrane nuclease activity. 
This suggests that the higher levels of nuclease due to increased suppression efficiency of 
this strain as compared to strain ISM647 resulted directly in strain instability. The lower 
efficiency of UGA suppression in ISM647, however, would result in prematurely truncated 
protein products, some of which may contain nucleolytic activity (Fig. 3.3). 
62 
These studies clearly show that level of active nuclease expression from the cloned 
fragments was low in E. coli (Fig. 3.3). Also, expression was independent of vector-directed 
promoter activity. Neither A,GEM 12 nor pMOB contain promoters to regulate expression of 
cloned genes. Therefore, the promoter activity that directed the expression of mnuA was 
associated with the mycoplasmal sequences. This is common in mycoplasmas (89) and is 
presumably due to the AT richness of the chromosomal DNA. Low level expression of the 
nonspecific nuclease activity might be essential for "K viability since high level expression 
could result in damaged "K concatameric DNA and an unsuitable packaging substrate. Thus, 
cloning strategies that would raise the nuclease product levels within the cell, i.e. cloning into 
a high copy number cloning vector such as pKS or using a strong external promoter, would 
increase the likelihood for instability. 
E. coli has previously been a host for the expression of several nonspecific nucleases, 
such as those from S. aureus (26), Thermus filiformis (57) and Shigella flexneri (35). The 
staphylococcal nuclease has been extensively studied (194) and is expressed at low levels 
from its native promoter in E. coli (193). The product is secreted either from its own signal 
peptide or with a lipoprotein signal sequence attached (159). Higher levels of activity can be 
obtained when expressed from a X promoter (85), but in the absence of a fimctional signal 
sequence, expression of the nuclease was lethal (212). All of these nucleases have been 
expressed in E. coli, indicating that expression of heterologous nucleases in E. coli is 
possible and a convenient way to study these proteins. 
Mapping of the nuclease gene within the cloned fragment in pISM4172 involved random 
mutagenesis with TnlOOO. Over 30 different insertions were analyzed, but only a portion are 
shown in Fig. 3.3 for clarity. Correlation of the insertion location with loss of nuclease 
activity identified a minimal coding region for the mnuA structural gene, minimized the 
amoimt of DNA sequencing needed for identification of the coding region, and confirmed the 
location of the ORF determined by computer analysis (Figs. 3.3 and 3.4). 
Interestingly, both E. coli and M. pulmonis mcleiisc banding patterns differed in their 
SDS-PAGE nuclease gel profiles as a function of the DNA substrate (Fig. 3.3). E. coli strain 
ISM647 contained nuclease bands of 64 and 32 kDa that digested salmon sperm DNA (Fig. 
3.3, upper panel, lane C), but not X DNA (lower panel, lane C). This correlated with our 
results with this E. coli strain in the X, DNA assay (see above). A M. pulmonis derived 
nucleolytic band of about 28 kDa was also absent in the gel containing X DNA (Fig. 3.3, 
panel B, lower gel, lane Mp). The lane was loaded with a third more protein (175 ng) and 
showed much stronger bands in the 43 kDa region of the gel, but there was clearly no 
nucleolytic activity present in the 28 kDa region when X, DNA was used as a substrate. It is 
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not known what distinquishes the substrate specificity of these enzymes. Two possible 
explanations would be methylation pattern differences between eucaryotic and 
procaryoticDNA or single vs. double strandedness of the template (the salmon sperm DNA 
was sheared and boiled prior to inclusion in the SDS-PAGE lesolvmg gel). The mnuA gene 
products in E. coli, however, were unaffected by the DNA substrate differences. 
These data suggest, but do not prove, that MnuA is the S1 kDa protein in the M. pulmonis 
banding pattern (Fig.3.3). Considering the possibility that the single cysteine residue serves 
as a signal peptidase cleavage and acylation site (163,239), the processed polypeptide would 
be 50,769 daltons in size (not including the fatty acid side chain). All nuclease activities in 
M. pulmonis partition into the detergent phase during Triton X-114 fractionation suggesting 
that each nuclease has large regions of hydrophobicity or are lipoproteins (data not shown). 
While this possibility seems plausible, there is no direct e\idence supporting this hypothesis. 
For instance, it is not known what effects, if any, acylation might have on protein mobility in 
SDS-PAGE gels. Additionally, mobility of nucleases might be altered during SDS-PAGE in 
DNA-containing resolving gels as well. 
It seenas reasonable that mnuA does code for a membrane nuclease because all M. 
pulmonis nuclease activities observed in the SDS-PAGE nuclease gels are membrane 
associated (139). Also, the activity expressed in E. coli survived the sample preparation and 
SDS-PAGE analysis just like the membrane-associated nucleases reported earlier (137,139) 
and had the same substrate specificity (Fig. 3.3). There may still be a possibility, however, 
that the cloned nuclease activity is unrelated to the membrane nuclease activity observed in 
M. pulmonis membranes. We have not been able to conclusively correlate the mnuA gene 
product in E. coli with one of the membrane nucleases in M. pulmonis due to our inability to 
construct site-directed mutations in this mycoplasma species. 
Interestingly, TnlOOO insertion 2 (Fig. 3.3) knocked out nuclease activity in cell lysates, 
but not in the SDS-PAGE nuclease assay. The nuclease banding pattern lost two of the four 
bands seen with the nonmutated plasmid. The presence of the two bands confirms the 
hypothesis of internal transcriptional initiation because this insert is located behind the signal 
sequence of mnuh. The resulting protein products were probably folded incorrectly in the 
cell lysate, but regained a functional conformation during the denaturation and renaturation 
conditions of the assay. 
To confirm the identity of the structural gene from M. pulmonis with a product produced 
by E. coli, further studies will be needed. Several different products are being produced, 
which may result from internal initiation and/or premature truncation. To confirm this 
suggestion, amino acid sequencmg would need to be performed. However, purifying these 
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proteins may prove difficult as previous attempts to purify membrane nucleolytic activity 
from M. pulmonis have failed. This has been due to difficulties in purifying membrane 
proteins while maintaining functional activity. It is also likely that these nucleases are 
produced in low amounts, compounding the purification difficulties. A specific knockout 
mutation in mnuA in M. pulmonis would correlate the mnuA gene sequence with a specific 
gene product simply by comparing mutant and wildtype SDS-PAGE nuclease gel patterns. 
Two factors might hinder this approach, however; genetic tools in M. pulmonis are limited 
(47,48), and mnuA may be essential to growth preventing the construction of a single 
knockout mutation. 
It is evident that two different chromosomal regions of M. pulmonis express nuclease 
activities in £. coli.. The restriction maps of the cloned fragments of are distinctly different 
(Fig. 3.2). These genes also show little homology at the nucleotide level since the mnuA gene 
sequence failed to hybridize to 9.2C phage DNA (data not shown) and to plasmids derived 
from 13.SC. The relative positions of the two regions on the chromosome could not be 
determined smce a physical map of M. pulmonis was not available. It is clear, however, that 
the multiple bands observed in the nuclease banding pattern in M. pulmonis (139) is due at 
least in part to the expression of separate, unrelated genes in the chromosome. 
Using an internal fragment fix>m mnuA, there appears to be related genes to mnuA in other 
mycoplasma species. Analysis of 11 different species of mycoplasma indicated that 
homologous gene sequences are present in M. hyopneumoniae and M. pneumonia. One copy 
of the gene was present in M. pulmonis. These three species of mycoplasmas are not closely 
related phylogenetically, but they are all respiratory pathogens. 
It is not yet clear what role, if any, the MnuA nuclease plays in growth and virulence in 
M. pulmonis. These nucleases are fully capable of digesting mycoplasmal chromosomal 
DNA (data not shown) inferring that cotranslational translocation of the mnuA gene product 
may be occurring (163). Further study of this unique activity could reveal basic mechanisms 
of gene expression and protein translocation in mycoplasmas. 
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CHAPTER 4. MOLECULAR ANALYSIS OF THE uvrB HOMOLOG IN 
MYCOPLASMA PULMONIS 
A paper prepared to be submitted to Joumal of Bacteriology 
Karalee J. Jarvill-Taylor and F. Chris Minion 
Abstract 
Previous studies have described the cloning and analysis of a membrane nuclease gene in 
Mycoplasma pulmonis, mnuA. DNA sequence analysis upstream of the mnuA gene revealed a 
second open reading frame with a homology with uvrB, a component of the short patch repair 
excinuclease. The uvrB gene had 51% identity and 70% homology with the uvrB gene from 
Haemophilus influenzae, and contained a Walker type A nucleotide binding motif. An 
internal fragment from the M. pulmonis uvrB gene was used to probe chromosomal 
fragments of 11 mycoplasma species. The results indicated that many, but not all 
mycoplasma species have sequence homology to the uvrB gene of M. pulmonis. This also 
suggests that mycoplasmas have the capacity to repair DNA damage by the nucleotide 
excision repair system. 
Introduction 
The nucleotide excision repair system, sometimes referred to as dark repair or short patch 
repair, has been extensively characterized in several bacteria, most notably Escherichia coli 
(64). The critical enzyme for this process is the multi-component excinuclease composed of 
UvrA, UvrB, and UvrC subunits. UvrD helicase n and DNA polymerase I also participate in 
the process. The primary function of short patch repair is to recognize and remove thymidine 
dimers in UV damaged DNA, and damage resulting from exposure to various chemical 
agents or mutagens. The presence of the short patch repair is assumed in most bacterial 
species, and its absence restilts in an increased mutation rate and an inability to survive UV 
exposure. 
Mycoplasmas are among the smallest free living organisms known and are responsible 
for a number of respiratory and genital tract diseases in humans and animals (166,169). As 
parasitic organisms, they are lacking a number of biosynthetic pathways (169). Early studies 
reported a dark repair system in Mycoplasma buccale (4), but not in Mycoplasma 
gallisepticwn (69). This work was based upon survival after exposure to ultraviolet light. 
Further studies to identify and characterize a short patch repair system in mycoplasmas has 
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not been reported. Only recently have the genes of various proteins involved in DNA 
replication and repair, such as RecA and topoisomerase, been identified and characterized in 
mycoplasmas (49,59,87). 
Mycoplasma pulmonis, & rodent pathogen, has been the subject of several genetic studies. 
The genes for RecA (87), DNA polymerase EI (9), and a restriction-modification system (50) 
have been identified in this species. It was the first mycoplasma to be transformed using a 
clearly defined genetic element, Tn975 (48). Transformation studies using plasmids which 
integrate into the chromosome by homologous recombination indicated that M. pulmonis has 
an active recombination system that could be exploited for the introduction of specific 
mutations or genetic markers (134). Even with the genetic progress made over the last 10 
years, there is still no chromosomal map available for this species and no transposon besides 
TnP/5 has been found capable of transforming M. pulmonis. 
Recently, a gene for a membrane nuclease gene from M. pulmonis was identifred and 
characterized (82). During the course of those smdies, it was determined that this gene, 
designated mnuA for niembrane nuclease, was located in a two gene operon. The upstream 
open reading frame was found to be 70% homologous to the UvrB proteins of E. coli and 
Haemophilus influenzae. The results of the analysis of M. pulmonis uvrB is described here. 
Materials and Methods 
Bacterial strains and plasmids 
M. pulmonis CT, M. pulmonis Mycoplasma gallisepticum ATCC 19610, 
Mycoplasma hyorhinis GDL, Mycoplasma hyopneumoniae 232, Mycoplasma capricolum 
ATCC 27343, Mycoplasma fermentans PG-18, Mycoplasma fermentans subsp. incognitus. 
Mycoplasma penetrans. Mycoplasma hominis 1620, Mycoplasma pneumoniae ATCC 15531 
and Acholeplasma oculi ISM1499 were grown as previously described (139). Cultures were 
obtained from a stock culture maintained at -70°C, inoculated into fresh broth medium and 
incubated statically at 37°C. E. coli strain LE392 [P hsdR514 (rk", mk") lacYI supE44 
supF58 galK2 galT22 trpR55 metBl] was started from a stock culture and maintained in 
Luria-Bertani broth. 
Plasmids pISM4170 and pISM4172 have been described elsewhere (see Chapter 3) (82). 
Plasmid pISM4170 contains a 6.6 kb Sacl fragment from phage 13.2B cloned into pMOB 
(Fig. 3.2). Plasmid was constructed by cloning a 7.0 kb Sacl fragment from phage 13.2B 
cloned into pMOB (Fig.3.2). 
67 
Isolation and manipulation of DNA 
Plasmid DNA was isolated from E. coli by alkaline lysis (IS). DNA £ragments used for 
cloning and as probes were isolated from ethidium bromide stained agarose gels using 
GenElute Agarose Spin Columns (Supelco, Bellefonte, Pa.). The uvrB probe for the DNA 
hybridizations was isolated as a Sacl-HinSBl fragment from plasmid pISM4172. The 
fragment was labeled with the Rediprime random labeling kit (Amersham, Arlington 
Heights, ni.) using alpha labeled "P-CTP (Amersham). 
Plasmids pISM4170 and pISM4172 were transformed into E. coli DPWC and mated with 
BW26 according to the method described by Strathmann (209). Recipient cells were selected 
on LB containing 50 ^ g per ml kanamycin and 100 fig per ml ampicillin. Colonies were 
picked, grown in 2X Luria broth, and the plasmids were isolated by alkaline lysis (IS). 
TnlOOO insertions were mapped, either by restriction digest or by polymerase chain 
reaction. Polymerase chain reactions were done in a SO (jJ volume containing Ix buffer 
(GEBCO, BRL), approximately 1 ng of plasmid DNA from alkaline lysis, T7 primer and 
either primer 187 or primer 486 (S pmole) (see below), 4 mM MgCl, 20 mM dNTPs and 1 
unit of Taq Polymerase. Cycling was performed as follows: one cycle of S min at 92°C, and 
30 cycles of I min at 92°C, 1 min at 5S°C and 2 min at 72°C. InlOOO inserts were also used 
as primer sites for DNA sequence analysis. 
Hybridization studies 
Chromosomal DNA was isolated from the mycoplasmal species described above. 
Approximately 2 to S ^g of DNA of each species was digested with EcoRI to completion, 
and fragments were separated on a 0.7% agarose gel. DNA fragments were transferred by the 
method of Southern to nylon membranes as previously described (122). Blots were exposed 
to a transilluminator for 3 min, baked at 80°C for 2 h and hybridized with DNA probes using 
Rapid-hyb buffer (Amersham, Arlington Heights, El). Hybridization was performed at 42°C. 
Blots were washed in 2X SSC-0.1% SDS three times for IS minutes at room temperature and 
in IX Ssc-0.1% SDS twice for 30 minutes at 42°C. 
DNA sequence analysis 
Plasmids for DNA sequencing were prepared using Qiagen columns (Qiagen, Inc., 
Chatsworth, Calif.). All sequencing was performed by the Nucleic Acid Instrumentation 
facility at Iowa State University using cycle sequencing protocols. The sequencing primers 
were oligonucleotides complementary to the transposon sequences adjacent to the inverted 
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repeat ends. Primer 187 (5'-CAACGAATTATCTCCTT-3')(Gold Biotechnology) binds to 
base pairs 39-63 of the transposon and provides sequence information outward from the end 
closest to the Sacl site in the transposon (209). Primer 486 (5'-TCAATAAGTTATACCAT-
3') binds to base pairs 5924-5947 of the transposon and provides sequence information 
outward from the opposite end. The T7 primer (5'-AATACGACTCACTATAG-3') was 
produced by the Nucleic Acid Instrumentation facility at Iowa State University. Sequence 
analysis was performed using MacVector software (Eastman Kodak Company, New Haven, 
Conn.). 
Nucleotide sequence accession number 
The nucleotide sequence of the uvrB gene of M. pulmonis has been assigned GenBank 
accession number U59874. 
Results 
Sequencing of uvrB 
During studies to identify genes coding for membrane nucleases in M. pulmonis, a 
lambda clone was identified with nuclease activity and its fragment subcloned into plasmid 
pISM4172 (See Chapter 3). TnlOOO mutagenesis was performed, and the mutants were 
screened for loss of nuclease activity in E. coli (82). DNA sequence analysis revealed an 
open reading firame coding for the membrane nuclease which was subsequently designated as 
mnuA. A potential upstream open reading frame was also identified with homology to uvrB 
genes in other bacteria. Since little is known concerning DNA repair systems in 
mycoplasmas, it was of interest to compete the sequence of this uvrB homolog and the rest of 
the mnuA operon. In order to complete the DNA sequence of the uvrB homolog, plasmid 
pISM4170, which contained the chromosomal region upstream of mnuA, was subjected to 
TnlOOO mutagenesis and inserts were localized by PCR. Those inserts located near the T7 
promoter of pISM4170 were used for completion of the uvrB homolog sequence and the 
mnuA operon. 
DNA sequence analysis 
The complete sequence, with the corresponding amino acids, of thewvrB homolog is 
shown in Figure 4.1. The deduced amino acid sequence is also given. The gene codes for a 
protein of 75,878 daltons. There were no open reading frames of greater than 50 amino acids 
Figure 4.1. Nucleotide and deduced amino acid sequence of uvrB from M. pulmonis. The 
coding region begins at nucleotide 201 and ends at nucleotide 2172. The underline indicates 
potential ribosoi]^ binding sites. 
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TCTTGAAATTTGCTTAATAACTTATAAAGATCATCGTCCGAAGACACACTTAAAAATGGCTCAAG 6 5 
ATCAAAATTATTTATTTTATTTGTGCTCATTTAACGAAACTCCATCAGACTTTTTTTTAGTAAAT 130 
TTTAAAGAATATTAAATCGCTAATAACTTTTTGAATAACTAAGTTGATTAATAGTAAAATTAAGG 195 
M E E K F V L H S P F A P S G D Q P E A  
AAGTTATGGAAGAAAAATTTGTATTACATAGTCCATTTGCTCCTTCGGGCGATCAACCAGAAGCA 260 
I K A L V D G I D E K K E H Q V L L G V T G  
ATCAAAGCACTAGTAGATGGCATTGATGAAAAAAAAGAACATCAAGTCCTTTTGGGAGTAACCGG 325 
S G K T F T I A N V I A Q L N R P S L I I S  
TTCGGGTAAAACATTTACTATTGCTAATGTTATTGCACAACTAAATCGTCCTTCTTTAATCATTA 390 
H N K T L A S Q L Y S E L K A L F P D N R  
GCCACAACAAAACTTTGGCAAGTCAACTATATAGTGAGCTAAAAGCGCTATTTCCAGATAACCGT 455 
V E Y F V S Y F D F Y K P E A Y I P K S D r .  
GTTGAATACTTTGTTTCGTATTTTGATTTTTATAAACCTGAAGCCTACATTCCTAAGAGCGATCT 520 
Y I  E K T S K N N K E L E A M R M S A I N A  
TTATATTGAAAAAACTAGTAAAAACAATAAGGAATTAGAAGCGATGCGAATGTCAGCTATCAATG 585 
L S I R K D T I V V A S V A A I Y G E S N  
CCTTAAGTATTAGAAAAGACACTATTGTTGTTGCCTCAGTTGCAGCTATTTATGGTGAAAGCAAT 650 
P K H Y R Q N F F P I E V G M Q I D R K S L  
CCTAAGCACTATCGCCAAAACTTTTTTCCCATTGAAGTGGGTATGCAAATCGATCGAAAGAGTTT 715 
L L K L S Q I G Y E R N R M E L N K G Q F D  
GCTACTAAAACTTTCGCAAATTGGATACGAAAGAAACCGCATGGAACTAAATAAAGGACAATTTG 780 
V K G D S I E I C P G Y V S D T N I R I D  
ATGTTAAAGGTGACAGCATTGAAATTTGTCCCGGATATGTTAGTGATACTAATATTCGAATTGAT 845 
M F G N E I E A I T L I D P L S K N V E G S  
ATGTTTGGTAATGAAATTGAAGCTATTACTTTAATTGATCCTCTTTCGAAAAATGTTGAAGGGTC 910 
R K N M T I i F P A T T Y T V H E N T I Q N T  
AAGAAAAAATATGACGCTTTTCCCGGCCACTACTTATACCGTGCATGAGAATACCATTCAAAATA 975 
V D L I K Q E L S E R I E Y F K S H D K L  
CTGTAGATCTAATTAAACAAGAGCTTTCTGAGCGGATTGAATACTTTAAATCGCACGATAAGCTT 1040 
L E A Q R I K D R T L N D L D S L L E F G Y  
CTTGAAGCGCAAAGAATTAAGGATCGTACTTTGAACGATCTTGATTCACTACTAGAGTTTGGTTA 1105 
T S G I  E N Y S R Y L D G R A P G Q R P Y T  
CACTTCGGGAATTGAAAACTACTCTAGATATCTAGATGGCAGAGCTCCAGGACAACGCCCTTATA 1170 
L F D Y L P D D S V I F I D E S H L M I P  
CTTTGTTTGACTACTTACCAGATGATAGTGTTATTTTTATTGATGAAAGTCACTTAATGATTCCC 1235 
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Q L H G M H N G D R A R K L S L V E Y G F R  
CAATTGCATGGTATGCATAATGGTGATCGTGCCAGAAAACTTAGTTTAGTTGAATATGGTTTTAG 1300 
L P S A L D N R P L R F E E F A E F K F P K  
ACTACCATCTGCCCTTGATAATCGTCCATTACGTTTTGAAGAGTTTGCCGAATTCAAATTTCCTA 1365 
l Y l S A T P G D Y E L D L T H G E I V T  
T^TCTACATTTCCGCCACTCCTGGCGACTATGAACTTGATTTAACCCATGGCGAGATTGTTACT 1430 
Q Y I R P T G L L D P I  l E I H S R D N Q I  
CAGTATATTCGGCCAACTGGTTTGCTAGATCCTATTATTGAAATCCACAGTCGCGACAATCAAAT 1495 
E D I Y D H L K E Q I A K K E R T L I L T T  
TGAAGATATTTATGACCATCTTAAAGAGCAAATAGCAAAAAAAGAACGAACCTTGATTCTAACTA 1560 
T K K N A E E L S L F L Q E K K I K S A Y  
CTACCAAGAAAAATGCTGAAGAGCTGTCTTTATTCTTGCAAGAAAAGAAAATCAAAAGTGCTTAT 1625 
I H D R F K I F E R N E I L K G L R M G K F  
ATTCACGATCGTTTTAAGATTTTTGAACGTAACGAAATTCTAAAAGGGCTTAGAATGGGCAAGTT 1690 
D V V V G I N L L K E G I D L P E V S L I C  
CGATGTCGTTGTTGGAATTAATTTGCTTAAAGAAGGAATTGACTTACCAGAAGTTAGTTTGATTT 1755 
V L N A D S T G L M R D T R S L I Q I V G  
GCGTTTTAAACGCCGATAGCACTGGACTAATGCGTGACACTAGAAGCTTAATCCAAATTGTTGGT 1820 
R A A R N D H G K V I F Y A N E I T S S M R  
AGAGCGGCGCGAAATGACCATGGTAAAGTTATTTTTTATGCCAATGAAATAACAAGTAGCATGCG 1885 
E C I E D N L F K R K I Q S E Y N E K H N I  
TGAATGCATTGAAGATAATTTATTTAAAAGGAAAATTCAAAGCGAATATAACGAAAAACATAATA 1950 
I P K T I V K P I A P P I Q N G I L S E D  
TCATTCCAAAAACAATTGTAAAACCGATTGCTCCGCCAATTCAAAATGGCATTCTTAGTGAAGAT 2015 
H S K Y Y G E K D L S Q M K H N K K F I D Q  
CATTCAAAATACTATGGTGAAAAAGACCTTAGCCAAATGAAACATAATAAAAAATTCATTGATCA 2080 
M V R K M T Q L A K A N K F E E A I E I R D  
AATGGTTCGCAAGATGACTCAATTAGCTAAAGCCAACAAATTTGAAGAAGCAATTGAGATTCGTG 2145 
Y L I E I G I E L D K  
ATTATCTAATAGAAATTGGCATAGAATTGGATAAATAATTGTTAAAACGC 2194 
Figure 4.1 (Continued) 
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upstream of theuvrfi homolog. Two potential ribosomal binding sites were identified 
upstream of the start codon (Figure 4.1). Termination of the operon most likely occurs after 
mnuA where an inverted repeat is located (data not shown). No UGA codons were found 
within the sequence of the homolog as diere were no tryptophan coding codons present. This 
is also true of the E. coli uvrB sequence. BLASTN and FASTA homology searches were 
performed on the DNA sequence. Homology searches revealed that the reading frame was 
51% identical and 70% homologous to the uvrB gene sequence of H. influenzae and 49% 
identical and 70% homologous with the uvrB gene sequence of E. coli. Numerous other 
uvrB genes were also found. Figure 4.2 shows the genetic and restriction map of the mnuA 
operon including the genes coding for uvrB and mnuA and their direction of transcription. 
Comparison of the M. pulmonis uvrB protein to other species 
The UvrB protein is a component of the ABC excinuclease, an endonuclease responsible 
for cleaving short patches of damaged DNA during short patch repair. One of the most 
notable features of this protein is the presence of a Walker type A nucleotide binding motif 
(64,224). Figure 4.3 compares the amino acid sequence of the nucleotide binding sites of the 
M. pulmonis UvrB homolog with those amino acids determined from the uvrB genes in E. 
coli, H. influenzae. Micrococcus, luteas, M. genitalium and Neisseria gonorrhoeae. The 
nucleotide binding domain from M. pulmonis is identical to that of H. influent and£. coli. 
Surprisingly, the amino acid sequence of the uvrB gene from M. genitalium shows 
considerably more heterogeneity. Sequence analysis indicated that the M. pulmonis UvrB 
homolog is more closely related to H. influenzae and to E. coli than to M. genitalium. The 
uvrB homolog of M. capricolum has been partially sequenced, but the region needed for this 
comparison, the 5' two hundred amino acids, was not available. 
Identification of uvrB sequences in other mycoplasma species 
Previous reports have indicated that mycoplasmas may not contain short patch DNA 
repair systems. With the discovery of uvrB homolog gene sequences in M. pulmonis, it was 
of interest to screen other mycoplasma species for the presence of uvrB -like sequences 
particularly Af. gallisepticum where previous studies have indicated that M. gallisepticum 
lacked dark repair (69). Using an internal fragment of uvrB as a probe (Fig. 4.2), 
chromosomal DNA from 11 different species of mycoplasmas were analyzed to determine 
the presence of uvrB like sequences. As is shown in Figure 4.4, uvrB like sequences were 
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mnuA 
Figure 4.2. Genetic and physical map of the mnuA operon in M. pulmonis. The arrows 
indicate the coding regions for the uvrB and mnuA genes. Shown below the arrows is the 
region used for probing for uvrB homology in other mycoplasma species. The scale is in 
kilobases. Symbols: C, Clal; E, Ec6Bl\ Ev, EcoRV; H, //indlll; S, SacV, Sp, Spel. 
Species 
Concensus Binding Motif 
Binding Domain 
M. pulmonis H Q V L L 
H. influenzae H Q T L L 
E. coli H Q T L L 
N. gonorrhoeae Y Q T L L 
M. genitalium Q Q V L L 
M. luteus D V V L M 
A Q L N R P 
A Q L N R P 
A D L Q R P 
A Q S G R P 
Q N S Q L P 
E R L Q R P 
Figure 4.3. Comparison of Walker type A nucleotide binding sites. The binding domains 
from the uvrB genes of various bacteria species were obtained from GenBank and are shown 
along with the concensus motif determined by Walker et al. (224). The light shaded region is 
the Walker type A concensus binding sequence. The darker shaded areas are regions of 
identity of other bacterial species wiUi the M. pulmonis amino acid sequence within the 
binding motif. 
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observed in the two M. pulmonis strains tested, CT and X1048, and also in M. gallisepticum, 
M. hyopneumoniae, M. hyorhinis, M. capricolum, M. fermentans, and M. hominis. The 
probe failed to hybridize with M. pneumoniae and A. oculi 1499 DNA (Fig. 4.4). 
The nucleotide excision repair system repairs DNA that has been damaged by ultraviolet 
light or chemical exposure. Repair begins by recognition of the damaged DNA, mismatched 
bases, or modified bases by the multi-component excinuclease. The recognition of thymidine 
dimers or AP (apurinic or apyridimic) DNA is initiated by ATP and two molecules of the 
UvrA subunit protein. The subunits UvrB and UvrC are then added to the complex which 
introduces two nicks in the DNA strand. These nicks are located 8 base pairs upstream of the 
DNA lesion and downstream four or five base pairs. The UvrD helicase II then 
Figure 4.4. Hybridization of analysis of mycoplasma species with a uvrB probe from M. 
pulmonis. The probe used for analysis was a Sad - Hindin fragment from pISM4172. 
Hybridization conditions are described in the Materials and Methods. Lanes: CT, M. 
pulmonis strain CT; xl048, M. pulmonis x^04S\ gallisepticum, M. gallisepticum R; 
hyopneumoniae, M. hyopneumoniae 232; hyorhinis, M. hyorhinis GDL; capricolum, M. 
capricolum ATCC 27343; fermentans, M. fermentans PG-18; incognitus, M. fermentans 
supsp. incognitus', penetrans, M. penetrans; hominis, M. hominis 1620; pneumoniae, M. 
pneumoniae ATCC 15531, oculi, A. oculi 1499. 
Discussion 
 ^ -v >" -v - w > -v' x "v  ^
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unwinds the damaged DNA region and the gap is filled in by DNA polymerase I (64). The 
nucleotide excision repair system is assumed to be present in most organisms because of the 
need to repair damage done by exposure to UV light. With the small genome of 
mycoplasmas, the presence of any repair or biosynthetic pathway cannot be assumed, 
however. It was not determined if the uvrB product was fimctional in M. pulmonis. Previous 
studies by King et al. show that both M. pulmonis and M. mycoides possess recA gene 
sequences (87), but the products of those genes have also not been fimctionally characterized. 
It is interesting that the uvrB homologous fragment in M. gaUisepticum is less than a kilobase 
in size (Fig. 4.4) suggesting that uvrB has been truncated. This correlates with the previous 
study by Ghosh et al. showing a lack of dark repair activity in this species (69). Although it is 
not known if any of the mycoplasma species showing uvrB homology have a functional 
nucleotide base excision system, uvrA ,uvrC and uvrD homologs have been found in the 
mycoplasma sequencing projects in M. genitalium and M. capricolum. 
Mycoplasmas are believed to have evolved from other procaryotes by degenerative 
evolution. Therefore, for mycoplasmas to have maintained a functional nucleotide excision 
repair system, selective pressure must have been exerted. The lack of cell walls and small 
genomes that are very AT rich should make mycoplasmas highly susceptible to DNA 
damage by UV radiation and thymidine dimer formation. In the absence of repair processes, 
thymidine dimers inhibit DNA replication resulting in cell death. Along with the photolyase, 
the Uvr excinuclease complex is a critical component in the thymidine repair process and 
long term survival in the environment. 
The Uvr proteins are constituitively expressed at low levels in E. coli and are upregulated 
during the SOS response. This response is coordinated by the LexA protein. Upstream of the 
uvrB gene in E. coli is a LexA binding domain. There does not appear to be a LexA-like 
binding motif upstream of theuvrB homolog in M. pulmonis, however. Another protein which 
is upregulated by the LexA protein in E. coli is DNA polymerase I, which is required to fill 
in the gaps created by the removal of the thymidine dimers. Mycoplasmas are thought to use 
DNA polymerase HI as their sole polymerase, and this protein and its promoter have been 
characterized for M. pulmonis (9). As is the case for uvrB, there does not appear to be a 
LexA binding motif upstream of the DNA polymerase EI (9). It is also possible that a LexA 
homolog might be present in M. pulmonis with a different binding motif A LexA homolog 
has not been found in M. genitalium for which the complete sequence is known or in M. 
capricolum for which about one half of the sequence has been reported. A SOS response in 
mycoplasmas has not been completely ruled out, but it appears unlikely. Further research will 
need to be done to directly answer this question. 
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In most cases, uvrB is monocistronic. In M. pulmonis, however, uvrB is the first gene of a 
two gene operon. This operon also codes for a membrane-associated nuclease gene, mnuA 
(82). Although it may seem feasible for a nuclease to be used to recycle the nucleotides in the 
short oligonucleotide released upon thymidine dimer repair, this particular nuclease appears 
to be localized in the membrane. Another possible explanation for the inclusion of mnuA in 
the two gene operon with uvrB is that the amount of UvrB is coordinately regulated with this 
membrane nuclease to ensure that an adequate supply of nucleotides is available for repair 
purposes. It is likely that the membrane nucleases function in acquiring nucleotides from the 
surrounding environment. In the absence of adequate levels of membrane nucleases and 
consequently purines and pyrimidines, gaps would remain in the DNA which would be lethal 
to the cell. 
In summary, M. pulmonis contains a uvrB homolog which probably produces a functional 
protein, although this must be tested directly. These results suggest that many mycoplasma 
species contain uvrB homologs and possibly nucleotide excision repair systems. The deduced 
UvrB amino acid sequence is highly homologous to the H. influenzae and E. coli 
counterparts, indicating the conserved nature of these DNA repair proteins. 
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CHAPTER 5. GENERAL CONCLUSIONS 
General Discussion 
Nonspecific nucleases are produced by many bacteria species, many of which are 
pathogenic. In these studies, nuclease activity was demonstrated to be present in all 
mycoplasma species tested (Table 2.1). Because of their inability to synthesize their own 
nucleotides, these nucleases are postulated to function in the acquisition of purines and 
pyrimidines rather than as a restriction barrier. The nucleolytic activity present in whole cell 
lysates is able to cause relaxation in supercoiled plasmid DNA (137), nick open circular 
forms to produce linear DNA, and digest linear plasmid and phage DNA into small 
fragments (137) possibly to single bases if the reaction is allowed to go to completion. The 
nucleases from mycoplasma appear to have endonuclease and/or exonuclease activities. The 
nuclease activity is also able to digest its own chromosomal DNA as well (134). Since many 
mycoplasmas contain methylases (46), it is probable that the nucleases are not inhibited by 
DNA methylation. Whether these activities are located within one protein or are the result of 
the interaction between multiple proteins is unknown. There are endo-exonucleases found in 
Neisseria, Aspergillus and Saccharomyces species (57). The staphylococcal nuclease and the 
nuclease identified from Thermus also show both endo and exonuclease properties (57, 194). 
It is reasonable to assume that the mycoplasmal nucleases may also contain both properties 
as both features would be beneficial to the acquisition of nucleotides. 
Not only do all mycoplasmas produce nonspecific nucleases, the results indicate that 
these organisms localize the nuclease activity to their membrane. Most species appear to 
contain more than one nucleolytic protein (Figures 2.2-2.5). Although not specifically 
addressed by this study, it is likely that these nucleases are compartmentalized; they are 
located solely in the membrane and are either not present, not in the proper conformational 
state, or there is an inhibitor present to prevent their activity in the cytoplasm. In the case of 
the staphylococcal nuclease, the nuclease is released directly from the cell. In fact, most of 
the nonspecific nucleases discovered in bacteria have membrane signal sequences and are 
released directly from the organism. The presence of a nuclease on the membrane surface 
appears to be unique to the mycoplasmas, although the ones in Streptococcus are localized in 
the periplasmic space (5). 
The presence of apparently more than one nucleolytic protein on the surface of 
mycoplasmas was unexpected, but there are several possible explanations. First, 
mycoplasmas may produce nucleases from multiple genes. This postulate is reasonable 
considering that mycoplasmas have assigned a considerable amount of their DNA to code for 
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adherence genes (62,172). Recently, it has been suggested that recombination may occur 
between multiple copies of adhesin gene sequences (158). This recombination would likely 
result in adhesin antigenic variation and ensure that the adhesins are always produced. To 
address why there may be multiple genes and if recombination also occurs between the 
various genes it will be necessary to determine the fimction, relative position of each 
nucleolytic protein, and sequence each gene. 
Second, in some mycoplasmas there may be only one gene responsible for the nuclease 
activity. (This was shown not to be true for M. pulmonis during this study). Mycoplasmas 
contain variable lipoproteins (Vlps) on the membrane surface that contribute significantly to 
the antigenic variability of the organism. Part of tliis variability is due to repeat units within 
the gene sequence. During DNA replication, slipped strand mispairing occurs within the 
coding regions for the repeated units which causes the insertion or deletion of the units and 
results in a situation where daughter cells produce a variety of different sized proteins (231). 
Alternatively, post-translational modification may be occurring prior to and concomitant with 
membrane translocation. One potential modification would be acylation. Posttranslational 
modification of proteins by proteolytic cleavage has not been reported in mycoplasmas. 
The final alternative is a combination of the first two. There may be more than one 
nuclease gene with each gene producing more than one product. This occurs with the Vlps in 
a population of cells. The individual genes are altered between daughter cells, but there are 
also multiple genes (231). Considering the small genomes of mycoplasmas, altering both the 
protein products and having multiple copies of a gene type within the population is 
advantageous. The Vlps are thought to be involved in evasion of the immune response (231), 
but this has not been established experimentally. 
Further smdies in Af. pulmonis were initiated to specifically address the mechanism for 
multiple membrane nucleases. Antisera was raised against nuclease containing bands from a 
preparative SDS-PAGE gel and used to screen a genomic library. 19 positive XGEM 12 
recombinant phage were obtained (Table 3.2). Because this antisera was produced against 
proteins in a gel slice as opposed to purified protein, it was necessary to more accurately 
identify the nuclease containing phage. This was accomplished by infecting E. coli strain 
ISM612 with the 19 recombinant phage and monitoring the lysates for nuclease activity. The 
ability of strain ISM612 to suppress opal stop codons in mycoplasma genes by inserting 
tryptophan residues has been well documented (140,202). The strain was consistently 
negative for nuclease activity in our assay. Four of the nineteen phage generated nuclease 
activity. When single plaques from one of these purified phage were examined for nuclease 
activity, approximately 85% of the plaques produced nuclease activity indicating that the 
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nuclease activity was relatively stable when produced in a phage host. The chromosomal 
inserts from the four nuclease positive phage were subcloned and restriction mapped. Three 
of the chromosomal fragments were subcloned in two different plasmids due to an internal 
5acl sites. The insert in phage 13.2B was unstable in pKS but could be subcloned into 
pMOB. This may reflect a difference in plasmid number between pKS and pMOB. pKS is a 
high copy number plasmid with unregulated plasmid replication. pMOB is a derivative of 
pBR322 and probably produces 20-30 copies per cell. 
Restriction mapping revealed that three of the four phage were from the same general 
chromosomal region. Phage 14.1 IF was a smaller version of 13.5C. The 3' end of 13.5C and 
the 5' end of 13.2B overlap (Figure 3.2). Phage 9.2C shared no homology with the others. 
Thus, there were at least two different regions of the M. pulmonis chromosome encoding for 
nuclease activity. 
Expression of nuclease activity from cloned fragments from phage 13.SC and 9.2C was 
erratic. Occasionally, nuclease positive colonies were identified, but the expression was 
unstable and was lost upon subculture. Approximately 10% of isolated colonies at any given 
time expressed nuclease activity in these subclones, which was not true for the 13.2B 
subclones. Our explanation was that expression of nuclease activities in these subclones was 
high enough to select for spontaneous mutants at a high fi^uency. This may have resulted in 
a cell population of mostly mutants unable to express activity, without the loss of the plasmid 
in the strains. To try to rectify this problem, we reasoned that inadvertent nuclease expression 
might be the selective pressure that resulted in a high level of spontaneous mutants in our cell 
populations. This could have resulted from a leaky promoter in an efficient suppressor host. 
Thus, two approaches were apparent, reduce suppressor efficiency or tighten promoter 
regulation. The use of the alternative reduced suppressor efficiency hosts, ISM614 (LE392 
with pISM3001) and ISM647 (XL-1 BLUE with pISM3001) were tested. Also tested was a 
protease negative strain, SOLR. Since both ISM614 and SOLR strains contained enough 
endogenous nuclease activity to interfere with our assay, they were not useful. ISM647 did 
not express nuclease activity, but the percentage of nuclease expressing colonies did not 
increase using this strain. The cloned nuclease genes, however, may not contain UGA codons 
and thus moving the plasmids into a less efficient suppressor background may not have been 
helpful. Next, reduction of promoter leakiness was attempted by the addition of glucose to 
the medium to induce catabolite repression. These fragments were cloned into pKS, which 
contains an IPTG inducible promoter for inducing gene expression. Addition of glucose also 
had no effect on the stability of nuclease expression. 
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It is likely that the nuclease genes are transcribed in E. coli from promoter-like sequences 
within the mycoplasma chromosomal DNA (89). It may not be possible to regulate 
expression of these genes until they have been completely sequenced. The observation that 
mnuA was stable when cloned into pMOB and that it does not contain its own promoter 
supports the view that mnuA may be expressed at lower levels than those associated with 
phage 9.2C or 13.SC and that lower levels of expression may result in more stable activity. 
The higher plasmid copy number of pKS may have led to strain instability with the other 
cloned fragments, presumably because of the higher gene copy number. Whether the level of 
nuclease expression from mnuA is low compared to the levels of nucleases in phage 13.SC 
and 9.2B cannot be determined because of the high rate of mutation. 
The portion of the fragment from 13.2B cloned into pISM4172 contained the region 
responsible for active nuclease activity and was only expressed in a low suppressor 
efficiency host. At no time was pISM4172 capable of transforming ISM612, but the plasmid 
was stable in LE392 and the nuclease activity was expressed stably in ISM647. Thus, this 
plasmid and host were chosen for further study. 
These results indicate that there are at least four membrane nuclease genes present in M. 
pulmonis. First, mnuA is present in pISM4172. A second gene must be present in the cloned 
fragment in phage 9.2C. The third gene must be located in the region where pISM4170 and 
phage 13.5C overlap as both of these demonstrate some nuclease activity in their plasmid 
form and 13.SC phage are positive. The final nuclease is substrate specific and is observed as 
a low molecular weight band in SDS-PAGE DNA gels using salmon sperm DNA as the 
substrate (Fig. 3.3). This latter nuclease would not have been discovered in our screening 
method because it does not recognize X DNA. Additionally, this was the first time that a 
difference had been observed between the X assay and the SDS-PAGE nuclease assay. It had 
been assumed previously that the two assays measured similar activities. 
An important aspect of these studies is the use of TnlOOO to identify the coding sequence 
of mnuA within pISM4172 as well as to functionally analyze the gene product. The TnlOOO 
inserts were used to facilitate restriction mapping and DNA sequencing as well. Expression 
of nuclease activity by one of the plasmids mutated by TnlOOO clearly shows that the 
nuclease is coded by the cloned fragment and is not an E. coli product that has been 
upregulated by the presence of the plasmid. Absolute proof will depend upon the availability 
of mnuA insertional mutants in M. pulmonis. Our current ability to mutate M. pulmonis is 
limited to the use of Tn9i5 (48) and homologous recombination (134), although 
recombination has not been smdied extensively. It may be technically difficult to transform 
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this species, and any transfoimation may be lethal if this paiticular nuclease gene is an 
essential gene. 
There is other evidence, albeit circumstantial, that mnuA actually encodes a nuclease. 
First, there is the observation that one of the TnlOOO inseitions in mnuA located near the N-
terminus results in a product that can digest DNA. Colonies of this mutant were nuclease 
negative when analyzed using the lambda DNA digestion assay. Upon denaturation and 
renaturation during the SDS-PAGE nuclease assay, this mutant regained nuclease activity. 
Thus, the insertion is clearly in the structural gene for the nuclease. The products 
demonstrated in the SDS-PAGE nuclease assay presumably result from internal translational 
initiation. There would be no possibility of this protein upregulating a gene product after 
SDS- PAGE sample treatment. Second, the nucleases are membrane proteins and mnuA 
codes for a membrane protein according to the DNA sequence. As the TnlOOO insert near the 
N-teiminus would not contain the membrane spanning domain and activity is observed only 
after denaturation and renaturation, proper conformation and membrane localization may 
also play an important part in nuclease activity. 
A search of other species, using a fragment from mnuA as a probe revealed that there is 
only one copy of mnuA in M. pulmonis and there are similar sequences in other mycoplasma 
species. It should be pointed out that it is not unconmion for gene probes to fail to react with 
other mycoplasma species because of rapid changes in the DNA sequence due to a high 
mutation rate. Thus, the majority of the species did not react even under low stringency 
conditions. Because all mycoplasma species must acquire nucleotides and all species have 
nuclease activity (Table 2.1), it was not surprising to find a few with noticeable homology to 
mnuA. There is often similarity between proteins of similar fimction in mycoplasmas. For 
instance, proteins similar to the PI adhesin of M. pneumoniae have been foimd in four other 
species of mycoplasmas (38,45,81,215). 
In all other bacterial species in which uvrB has been identified, it is monocistronic. The 
finding that uvrB was not monocistronic in M. pulmonis was surprising. There may be 
several advantages to having mnuA located downstream of this gene. The uvrB gene is 
constituitively expressed in other bacteria, and this would ensure that mnuA is also made 
constitutively. Also, uvrB is most likely an essential gene in M. pulmonis and there may be 
selective pressure to preserve this operon. Finally, the placement of these genes together may 
indicate they work cooperatively. As UvrB functions to repair the thymidine dimers, MnuA 
may ensure that there are enough nucleotides to repair the resulting gap in the DNA. 
Hybridization studies using an internal fragment of uvrB also indicated that this gene is 
present in most other mycoplasma species. Notably, uvrB is present in M. gallisepticum. 
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which had previously been repoited as lacking dark repair (69), but the fragment recognized 
is small and may represent a deletion in the chromosomal region where UvrB is located. The 
high homology of the M. pulmonis, M. genitaliwn and M. capricolum uvrB genes to E. coli 
indicated that they are most likely functional since all are approximately 70% homologous. 
The uvrB probe did not react with M. pneumoniae or A. oculi chromosomal DNA. 
Considering the similarity between the chromosomes of M. genitalium and M. pneumoniae, 
this was surprising. Both probes recognized the same restriction fragments for the 
chromosome of two M. pulmonis strains, xl048 and CT. 
In summary, this work has shown that nucleases are conmion membrane components in 
mycoplasmas. In M. pulmonis, there may be multiple genes coding for membrane nucleases. 
One of these genes, mnuA, has been sequenced and analyzed. It encoded for a lipoprotein, 
which is capable of digesting different substrates, and is located in an operon downstream of 
uvrB. 
Comparison of MnuA to Other Bacterial Proteins 
MnuA is the first reported cloned nuclease from mycoplasmas. It has been known for 
over thirty years that these proteins exist, but none of the DNases or RNases have been 
studied at the molecular level. As one of the few membrane proteins studied, it is useful to 
compare this particular protein to the other membrane proteins characterized in 
mycoplasmas. 
It is not tmusual to find both adhesins and variable lipoproteins in mycoplasmas encoded 
by multiple gene copies. Membrane nucleases fail into this category. The variable 
lipoproteins and the MnuA protein share other features as well. Not only are there multiple 
genes located in the chromosome, they are both lipoproteins. In fact, the lipoprotein signal 
sequence present in the vlp genes of M. hyorhinis is identical to that found in mnuA (34). 
Both types of proteins are extracted into the detergent phase upon Triton X-114 phase 
partitioning (21). They also have only one cysteine per protein, the cysteine located at the 
acylation site (34). 
Even with their similarities, there are also notable differences between MnuA of M. 
pulmonis and Vlps of M. hyorhinis. It does not appear that mnuA tuidergoes any form of 
slipped strand mispairing during DNA replication to disrupt transcription or gene expression 
as there are no repeated domains present in the DNA sequence. Another difference is the 
number of tryptophan residues present in these proteins. There are four UGA-encoded 
tryptophan residues in MnuA whereas there are no UGA codons located in the Vlps (238). 
Expression of Vlps in E. coli has been used as a model system for several years, but these 
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proteins do not need to overcome the codon usage difference between mycoplasmas and 
other bacteria. Using an opal suppressor host, translation of the mnuA mRNA proceeded 
through three of the UGA codons, with some product terminating at the fourth UGA codon. 
It is interesting that the truncated product was also expressed nuclease activity. This indicates 
that the active site is upstream of this UGA codon. 
MnuA shares similarity with other gram-positive nucleases. Although this similarity does 
not translate into similarity at the nucleotide or amino acid level, MnuA is a nonspecific 
nuclease. All of these nucleases appear to have both endo- and exonuclease activity, and are 
capable of recognizing different types of DNA. The nucleases were discovered, for the most 
part, in pathogenic bacteria, and are considered to be virulence determinants. The actual role 
of MnuA in virulence is also unknown. Unlike the nucleases of gram positive bacteria, 
MnuA is located in the membrane and is thought to have a role in acquisition of nucleotides, 
which are required macromolecules for mycoplasmas. Because it is easily monitored, it may 
be a good model protein to study membrane localization and protein processing in 
mycoplasmas. 
Recommendations for Future Research 
There are many areas in this project which could be addressed with further research. 
Three different nuclease genes were cloned, but only one of them has been sequenced and 
characterized. Research on the other two may be difficult as the genes and/or the nuclease 
activity are instable in E. coli when they are located on the plasmids constructed during this 
study. This may not be true if the genes are cloned into a low copy number vector. 
Alternatively, it may be possible to subclone smaller fragments containing nuclease activity 
through the elimination of unrelated regions producing instability. This might include 
promoter sequences if they are efficient in E. coli (89). One promoter containing sequence 
from A. oculi was a very strong promoter in E. coli (89). The pitfall of this approach is that it 
is completely unknown which intemal fragments within the cloned sequences contain the 
activity and even slightly deleting a small region of the gene may prove to knock out the 
activity. Alternatively, mutagenesis could be performed on the phage clones. In their current 
form, the chromosomal fragments contained in the phage vector are very large and 
mutagenesis has proven difficult. However, if the fragments were used to screen a different 
phage library, say in XZAP, smaller chromosomal fragments may be identified which express 
nuclease activity and are more adaptable to mutagenesis strategies. This approach would 
probably be the wisest course of action as a M. pulmonis XZAPII library has already been 
constructed. Obtaining the correct fragments and screening the phage could occur relatively 
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quickly. There is always a chance, as with any genomic library, that the fragments are too 
small to contain the entire gene or that the gene was cleaved into two fragments. A potential 
third approach is to sequence the entire fragments. The obstacles with that approach is that it 
is not cost effective, the nuclease may not share homology with any other proteins and the 
proper reading frame may not be identified. 
The expression of the staphylococcal nuclease in E. coli has defined many different types 
of experiments which could be performed with MnuA. Processing and signaling of 
mycoplasma proteins in exogenous hosts has been addressed with a few of the Vlp proteins 
of M. kyorhinis. However, alternative signal sequences and the results of having no signal 
sequence have not been studied. Based upon the observation that very low expression of the 
nuclease activity occurs in E. coli, experiments could be performed with other promoters to 
increase the level of expression as was also done with the staphylococcal nuclease. It may 
also be possible to change the signal sequence to produce a secreted protein. Additionally, 
specific mutations could be introduced to determine the functional domains of the nuclease. 
As E. coli may be an unsuitable host to produce large quantities of this protein, expression 
must be studied, stabilized and tightly controlled before any attempts at purification. Once 
the protein is purified, however, many other types of biochemical studies could be 
performed. These studies include determination of biochemical stability, nucleotide 
specificity, 3-dimensional conformation, etc. 
Purification of nucleases from mycoplasmas has proven to be difficult. The growth of 
mycoplasmas is much more laborious than E. coli because they are grown in a very rich 
media, take days to grow and grow to a low density. The purification of membrane proteins 
has been achieved for very few mycoplasma proteins. There are the complications of media 
protein absorption to the mycoplasma membrane, extraction of the protein from the 
membrane and subsequent removal of detergents. Because MnuA is a lipoprotein, it is higly 
hydrophobic, complicating the purification process. 
MnuA is thought to be involved in the acquisition process for nucleotides. It is unknown 
which nucleotides are recognized by MnuA. It is also unknown if this protein is essential to 
the survival of M. pulmonis both in vitro and in vivo. In order to determine these features, it 
will be necessary to mutate the gene in a virulent strain of M. pulmonis and then test for 
growth in the laboratory and for colonization and virulence in mice. The media used to grow 
mycoplasmas may need to be adapted as standard mycoplasma media contains sources of 
DNA and nucleotides. The amount of nucleotides provided in the media may need to be more 
accurately defined and appropriately adjusted to adequately address the role of this protein in 
the growth of mycoplasmas. This may prove impossible as a defined media for M. pulmonis 
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has not been described. If the nuclease activity is required for survival, mnuA mutants will 
not be viable. Genetic approaches which allow for the controlled transcription of the gene 
may be the only way to determine if the gene is indeed essential. 
The discovery of mv/b in M. pulmonis also leads to other potential areas of research. The 
other components of the nucleotide excision repair system have been sequenced in both M. 
genitalium and M. capricolum. However, they have not been identified in M. pulmonis nor 
have any functional studies been performed on any of these proteins from mycoplasmas. It 
would be interesting to determine if short patch repair actually functions in mycoplasmas as 
has been defined in other bacterial species. 
There are also other potential areas of research which will become apparent when the 
above areas of research are addressed. Acquisition and membrane localization processes in 
mycoplasmas are completely undescribed. The potential role of this protein in nucleotide 
acquisition and possibly in virulence makes MnuA an ideal candidate for further smdy. 
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APPENDIX A. PREPARATIVE ISOELECTRIC FOCUSING OF THE MEMBRANE-
BOUND NUCLEASES OF ACHOLEPLASMA USING THE ROTOFOR 
Karalee J. Jarvill-Taylor and F. Chris Minion 
Abstract 
Acholeplasmas are atypical piocaiyotes which contain no cell wall having only a single 
limiting plasma membrane composed of up to 20% cholesterol as a limiting barrier. This 
increases the ratio of membrane lipid to total protein greater than that found in other 
procaiyotes, and increases the difficulty of purifying membrane proteins. These studies 
establish the experimental protocols for partial purification of the membrane-bound nucleases 
of Acholeplasma ISM1499 using the Bio-Rad Rotofor, a preparative isoelectric focusing unit. 
The parameters examined include concentration and type of detergent used for solubilzation, 
total protein concentration, and the concentration and pH range of ampholyte. Also, Triton 
X-114 partitioning and membrane preparations were investigated as sources for nuclease-
enriched samples. Partial purification was obtained by maintaining the protein concentrations 
within a 10-20 mg range, incorporation of S% ampholytes, and the use of the dialyzable 
detergent CHAPS. 
Introductioii 
Preparative isoelectric focusing (PrIEF)' is rapidly gaining acceptance as a powerful 
separation system for protein isolation. In many cases, it is superior to colunrn 
chromatography because of the establishment of an isoelectric point equilibrium producing a 
superior separation of protein mixtures. In addition, proteins can be isolated in their native, 
enzymatically-active state unlike some separation techniques such as sodium dodecyl sulfate 
polyaciylamide gel electrophoresis (SDS-PAGE) which employ denaturing conditions. The 
enzymatically-active firactions are easily identified using assays, or alternatively, the protein 
of interest can be identified through a variety of other techniques such as western blotting or 
enzyme-linked inmiunoassays using monoclonal antibodies. Preparative isoelectric focusing 
lends itself to a variety of post-focusing separation techniques for further purification if 
necessary. 
' Abbreviations: SDS-PAGE, sodium dodecyl sulfate polyaciylamide gel electrophoresis; 
CHAPS, 3-[(cholamidopropyl)dimethylammonio]-l-propanesulfonate; PrIEF, preparative 
isoelectric focusing. 
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When applied to membrane proteins, the experimental parameters required for separation 
during PrIEF becomes more difficult to determine. In addition to the normal parameters such 
as protein concentration, pH range and concentration of carrier ampholyte, etc., the effects of 
the detergents on the separation and sample processing must also be considered. Protein 
solubilization is essential to purification of membrane proteins, and a wide variety of 
detergents can be used, each having its own specific advantages and disadvantages (148). 
Extraction of integral membrane proteins can often be an important first step in the overall 
purification scheme, but the experimental conditions needed to do this selectively while 
maintaining the native confirmation of the protein and its enzymatic activity, can only be 
determined empirically, a difficult and time consuming exercise. Once separated by lEF, 
there is the additional complication that the detergent chosen may need to be removed prior 
to enzymatic assays and further purification. Detergent removal may also result in the loss of 
enzymatic activity or in protein precipitation. 
Our studies focused on the purification of the membrane-bound nucleases from 
Acholeplasma using the commercially available Rotofor PrIEF unit from Bio-Rad 
Laboratories. The Rotofor is a refrigerated, cylindrical, constantly-rotating PrEEF unit. 
Proteins are separated into twenty discrete fhu:tions along the pH gradient in free solution 
rather than in an insoluble matrix or density gradient. Microgram quantities of partially 
purified proteins can be isolated from crude extracts in four hours or less. 
Acholeplasmas belong to a class of bacteria, the Mollicutes, that are grouped by their lack 
of a cell wall. Their single limiting membrane serves as the sole enviroimiental barrier. This 
class of bacteria is pleomorphic in shape and is approximately 0.2 - 0.4 ^ in diameter. The 
ratio of membrane lipid to total protein in mycoplasmas is greater than in other prokaryotes 
or in eucaryotes. During early attempts to purify the membrane nucleases of Acholeplasma, it 
was observed that the cell preparations contained a high amount of negatively-charged 
phospholipids that caused large insoluble aggregates to form during PrIEF. The nucleases 
were found in association with these aggregates because of their hydrophobic nature, 
preventing their purification. 
In order to determine conditions necessary to purify these proteins, the amount of protein, 
the detergent type and concentration and the ampholite range and concentration were varied. 
Triton X-114 phase partitioning and membrane isolation enrichment procedures were also 
performed as a preliminary step to purification. Efficient separation was obtained by 
preventing precipitate formation through careful control of the protein concentration and 
solubilization, increase in the amount of ampholyte and the use of a mixture of two 
ampholyte pH ranges. 
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Materials and Methods 
Materials and chemicals 
Ampholytes (Ampholine in the pH ranges 3.5 - 5.0,4.0 - 6.5,5.0 7.0,3.5 - 9.5), CHAPS, 
Triton X-100, Triton X-114, salmon sperm DNA, phenol red, ethidium bromide, Trizma, 
glycine, and 2-mercaptoethanol were from Sigma (St. Louis, MO). Lambda DNA, GG-firee 
Horse Senmi, and glycerol were from GIBCO/BRL/Life Technologies (Grand Island, NY). 
PPLO broth base without crystal violet was from Difco Laboratories (Detroit, MI), and 
casein, methanol, ethanol, acetic acid, phosphoric acid, NaOH, NaHPO^, Na^PO^, and NaCl 
were from Fisher Scientific Co. Fleishmanns Bakers yeast was the source of fiesh yeast 
extract prepared as previously described (63). Cefobid was from Pfizer, Inc. (New York, 
NY). Ultra Pure Agarose was from Bio-Rad Laboratories (Richmond, CA). Chemicals for 
the preparation of the SDS-PAGE gels were purchased from Bio-Rad (Richmond, CA; 
acrylamide, N,N-methylene-bis-aciylamide) and Sigma (St. Louis, MO; N,N,N',N',-
tetramethylethylene-diamine). Silver staining of SDS-PAGE gels was performed with a kit 
obtained from Accurate Chemical and Scientific Corp. (Westbury, NY). 
Protein samples 
Acholeplasma ISM1499 was grown to mid log phase in mycoplasma media (PPLO base 
without CV containing 10% GG-free horse serum, 5% fresh yeast extract, 1% dextrose, 25 
(ig/ml Cefobid), centrifuged at 10,(XK) x g for 15 min, resuspended in PBS (0.14 M NaCI -
0.01 M sodium phosphate, pH 7.3), and then centrifuged again. For whole cell preparations, 
the pellets were resuspended in water containing either 0.1 to 0.5% Triton XIOO or 0.3 to 5% 
CHAPS. Cell debris was pelleted at 100,000 x g for 30 min and the supemate was used for 
PrIEF. Nuclease activity was also extracted by Triton X-114 partitioning (230). In specific 
experiments, additional detergents were added to the Triton X-114 phase afrer partitioning 
(0.25 - 0.3% CHAPS or 0.1% Triton X-100). 
For membrane preparations, cells were washed in 0.25 M NaCl, resuspended in 1/10 
volume of 2 M glycerol and incubated for 15-30 min at room temperature. Cells were then 
rapidly injected into four volumes of warm (37°C) water using a syringe fitted with a 26 
gauge needle, allowed to incubate at room temperature for 10 min, and then chilled rapidly 
on ice. Intact cells were pelleted at 7,500 x g for 15 min, and membranes were removed by • 
pelleting at 30,000 x g for 30 min. Membrane proteins were solubilized by incubation in 4% 
CHAPS for 15 min and then diluted to 0.4% CHAPS with water prior to loading on the 
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preparative BEF cell. In some instances, the insoluble debris was pelleted after the initial 
incubation, although the presence of this material from membrane preparations did not seem 
to interfere with the separation. 
Preparative lEF 
The Bio-Rad Rotofor PrIEF cell was assembled and used according to manufacturer's 
directions. All separations were performed in a total volume of SO mis with ampholyte 
concentrations ranging between 2-8% depending on the experiment In most experiments, a 
mixture of ampholytes (pH 3.5 - 5.0 and pH 4.0 - 6.5) was used. Electrolyte solutions 
consisted of 0.1 M HjPO^ (anode) and 0.1 M NaOH (cathode). Separations were performed at 
10-12 constant watts at 4''C for 2 - 3 hrs. Temperature was tightly regulated due to heat 
sensitivity of the nucleases. After separation, 20 fractions were collected by aspiration, and 
200 ^1 of each fraction was dialyzed against 1 M NaCl for 1 to 2 hrs and then against water 
overnight prior to assaying for the nuclease activity. 
Detection and analysis of nuclease activity 
Nuclease activity was determined by testing each fraction in a lambda assay. Following 
dialysis of each fraction, 25 jil was diluted in 2-fold increments in a 96-well plate with PBS 
containing 2 mM CaCl^ and 2 mM MgCl^. An equal volume of lambda DNA (10 jig/ml in 
PBS) was added to each well and the plate was then incubated for 30 min at 37°C. Lambda 
DNA digestion was stopped by the addition of 7 jil of borate sample buffer (122) to each 
well. Nuclease activity was assessed by running the samples (8 ^1 of sample per well) on a 
0.7% agarose gel in TBE buffer (122) at 100 V for 45 min and staining the gel with ethidium 
bromide. 
Positive fractions were run on a SDS-PAGE nuclease gel to monitor active components 
in the fractions. A Bio-Rad mini-PROTEAN n apparatus was used with a 3% stacking gel 
and a 10% resolving gel (102). Salmon sperm DNA (10 p,g/ml) was added to the resolving 
gel prior to polymerization. Anode buffer consisted of 3 g Trizma - 14.5 g glycine -1 g SDS 
per liter. The cathode buffer was 2X anode buffer with the addition of 0.15% SDS. Gels were 
electrophoresed at a constant current of no greater than 7 mAmp per gel at 4°C until the dye 
front exited the gel. The gels were washed four times for 15 min each in 100 volumes of 
incubation buffer (0.04 M Tris pH 7.5,0.01% Casein, 0.04% P-mercaptoethanol) with 
rocking. To allow for renaturation of the enzymatic activity, gels were maintained in 
incubation buffer overnight at room temperature. To assay activity, gels were placed in 100 
90 
volumes of incubation bu^er with the addition of 2 mM CaCl^ and 2 mM MgCl^ and 
incubated statically for 18 hours at 37°C. Gels were stained with ethidium bromide (O.S to 1 
mg/ml) for 5 min, destained in water for 20-30 min, and subjected to UV illumination. 
Nuclease activity was detected as non-fluorescing regions in the gel. After photography, gels 
were rinsed again with water and fixed in 50% ethanol, 12% acetic acid for 1 hour. The gels 
wete then silver stained to assess total proteins in each fraction and to determine apparent 
molecular weights. 
Fractions were also analyzed for total proteins by standard SDS-PAGE. Dialyzed sample 
were precipitated by adding 10 volumes of acetone, placing at -20°C for several hours and 
pelleting by centrifiigation at 100,000 x g for 10 min. Following centrifiigation, protein 
pellets were resuspended in water and precipitated twice more by the addition of 10 volumes 
of absolute ethanol. For some applications, samples were precipitated three times with 
ethanol. The final pellets were placed in SDS-PAGE sample buffer and boiled for 5 minutes 
prior to analysis on a 10% SDS-PAGE resolving gel and silver staining. All gels were 
photographed using Kodak type 57 film. Photographs from these gels were scanned using a 
Hewlett-Packard Scan Jet lie scanner and printed at 2400 dpi resolution. 
Results 
Determination of protein concentration resolvable in the Rotofor 
The manufacturer recommends a protein concentration of 2 to 4 mg protein per 
component for separation in the Rotofor, and more than 2 g of total protein has been 
successfully focused. In initial experiments, focusing was performed with a total 
Acholeplasma whole cell protein concentration of approximately 25 to 50 mg, well within the 
manufacturer's guidelines. These preparations contained detergent solubilized proteins with 
the insoluble cell debris and membranes removed by ultracentrifugation. A large amount of 
gelatinous precipitate developed either upon the addition of the ampholites (2 to 4%) or after 
focusing was begun. During focusing, the precipitate focused near the anode electrode with 
some overflow in the adjacent fractions. Precipitates also tended to clog up the inner core of 
the unit which separated the various fractions, interfering with collection of the fractions. 
Most of the nuclease activity was associated with this precipitate. Upon analysis by SDS-
PAGE, the precipitous material contained most of the protein from the preparation (data not 
shown). 
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Two different approaches were taken to avoid precipitation problems: lowering the 
protein concentration and increasing the ampholite concentration. When the protein 
concentration was reduced to 10 to IS mg total protein and the ampholite concentration 
raised to 5%, most of the focusing experiments were completed with little or no development 
of a precipitate. In some cases, a granular precipitate developed, and nuclease activity was 
often found in these fractions, but it was not associated with the precipitated material. 
Experiments with protein concentrations below 5 mg were difficult to interpret because the 
nuclease activity was barely detectable. Ampholite concentrations greater than 6% increased 
the amount of heat generated which in turn inactivated the nuclease activity. All subsequent 
experiments were performed at a 5% ampholite concentration. 
Solubilization of membrane proteins 
Several parameters were considered when choosing the appropriate detergent to 
solubilize Acholeplasma whole cell preparations for preparative lEF. Included were the 
charge of the detergent, the ability of the detergent to extract the protein of interest, the 
retention of nuclease activity in the detergent-solubilized fraction, the ease with which the 
detergent could be removed, and the effect the removal of the detergent had on the enzymatic 
activity. Preliminary experiments were performed with Tween 20, Triton X-100, CHAPS, P-
octyl glucoside, and Triton X-114 to examine the nuclease solubility and retention of activity 
in the detergent. The nucleases remained active in all of the listed detergents, but there were 
varying degrees of solubilization of each nuclease species as determined by the SDS-PAGE 
nuclease assay (data not shown). Both 0.1% Triton X-100 and 5% CHAPS were used to 
solubilize the nuclease activity in subsequent studies. 
When cells from the same culture were compared in PrDEF, the detergent type used to 
solubilize whole cell preparations had little effect on the nuclease focusing (Figure A.1). The 
pH gradient was reproducible, and the nucleases focused in a single major peak with some 
residual activity present throughout other fractions in the gradient. Separations with Triton 
X-1(X) were not as reproducible as with CHAPS, however. Figure 2 compares two identical 
experiments with Triton X-100 extracted whole cells harvested on two separate days. 
Nuclease activity resolved into single peaks, but at two different isoelectric points (4.1 versus 
5.5). Whole cells solubilized with CHAPS gave reproducible results with two peaks of 
activity (Figure A.2, lower panel). CHAPS-solubilized membrane preparations gave identical 
results to that in Figure A.2 (data not shown). Figure A.3 is a silver stained SDS-PAGE gel 
of the focused proteins from the CHAPS separation in Figure A.2. 
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Figure A.l. Comparison of the effect of Triton X-100 or CHAPS solubilization on 
membrane nuclease Rotofor profiles. Whole cells isolated from the same culture were 
solubilized with either 1% Triton X-100 or 5% CHAPS. Prior to lEF, insoluble material was 
removed by ultracentrifugation. Nuclease activity was determined using the Lambda DNA 
assay and the lEF performed as described in the Materials and Methods. Ampholyte 
concentration was 3% 3.5 - 5.0 and 2% 4.0 - 6.5. Fractions 2-5 and 15-20 from the Triton X-
100 separation were analyzed by the SDS-PAGE Nuclease assay and the results are shown 
below the graph. 
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Figure A.2. Reproducibility of Rotofor separations of membrane nuclease activity. Whole 
cell preparations from two different cultures (separate days) were solubilized with 1% Triton 
XlOO (Upper) or 5% CHAPS (Lower) and prepared for ffiF identically. Nuclease activity 
was determined by the Lambda DNA assay. Shown is the nuclease and pH profiles of two 
runs of each detergent. 
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Figure A.3. SDS-PAGE analysis of fractions 1-18 of the CHAPS separation number 1 
shown in Figure A.2. Fractions were precipitated with acetone and ethanol prior to separation 
on a 10% SDS-PAGE gel and silver staining. Beneath the gel is a graph of the pH value of 
each fraction. 
Finally, the ease of removal is a major consideration when choosing detergents. The 0.2 
mM critical miscelle concentration for Triton X-100 prevented the use of dialysis for its 
removal. When SM-2 Biobeads were used in hydrophobic adsorption chromatography, all 
nuclease activity was bound to the beads (data not shown). When proteins in the Triton X-
100 containing fractions were analyzed by SDS-PAGE, the detergent interfered with the 
proper separation and resolution normally expected with this technique. The bands were 
smeared and were difficult to visualize with protein stains (data not shown). To remove 
Triton X-1(X), the proteins were precipitated with acetone or ethanol which resulted in a loss 
of all nuclease 'activity. In contrast, CHAPS could be removed using an Amicon Centricon 
concentrator or by dialysis overnight in water. Proteins remained active in detergent-free 
solution and were easily visualized by SDS-PAGE. 
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Choice of ampholine pH range 
The concentration and pH range of ampholytes affect the amount of protein that can be 
focused and the retention of the nuclease activity. In preliminary experiments using a pH 
range of 3.5 - 9.5, nuclease activity focused at approximately 4.2 (data not shown). When 
these fractions were refocused without the addition of additional ampholytes, the nuclease 
activity was found throughout the narrow pH gradient preventing further purification by lEF. 
Similar results were seen when a pH range of 4.0 - 6.5 or 5.0 - 7.0 was used (data not 
shown). The best focusing results were obtained with a mixture of ampholyte pH ranges; 3% 
3.5 - 5 plus 2% 4 - 6.5 (data not shown). 
Separation of Triton X-114 extracted proteins 
Triton X-114 phase fractionation separates hydrophobic proteins from other less 
hydrophobic and hydrophilic proteins. The separation is based upon an unusually low cloud 
pomt temperature of Triton X-114. In preliminary experiments, the nuclease activity was 
found to partition exclusively into die detergent phase. Attempts to separate proteins from the 
undiluted detergent phase were unsuccessful. Triton X-114 concentrations greater than 2% in 
the Rotofor cell inhibited focusing and nuclease activity was found throughout the gradient 
(data not shown). By strictly regulating the temperature at 4°C, it was possible to focus 
samples with less than 2% Triton X-114 detergent, but individual fractions became biphasic 
upon collection and were difficult to manipulate experimentally. The addition of 0.3% 
CHAPS or 0.1% Triton X-100 to the Rotofor prior to focusing prevented phase fractionation 
of Triton X-114 and allowed normal focusing and handling. 
Separation of detergent-solubilized membrane preparations 
As a first step toward purification of membrane nucleases, the use of membrane 
preparations was also studied. Membranes were prepared by osmotic lysis as previously 
described, treated with 4% CHAPS, diluted to 0.4% CHAPS and focused in the Rotofor. 
Acholeplasma ISM1499 membranes failed to completely solubilize in 4% CHAPS, but the 
insoluble material had no effect on lEF results and contained no nuclease activity (data not 
shown). The nuclease profile of the fractions was similar to that observed with whole cell 
preparations (Figure A.2). 
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Figure A.4. Rotofor separation and the corresponding SDS-PAGE analysis using Triton 
X-114 extracted proteins. Whole cells were fractionated using Triton X-114 phase 
partitioning. Prior to separation, the detergent phase was diluted to 1% Triton X-114 with 
water and 0.3% CHAPS and 5% ampholytes were added. The upper panel shows the pH 
values and nuclease activity. Nuclease activity was determined by the Lambda DNA assay. A 
scanned image of silver-stained SDS-PAGE gels of fractions 1-20 is shown below. Fractions 
were precipitated with ethanol three times prior to separation. 
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Discussion 
The results described in this study are the first reported attempts to partially purify any 
protein from a mycoplasma using the Bio-Rad Rotofor BEF cell. Problems were encountered 
during these studies because of the uniqueness of the organism involved. Acholeplasmas are 
much smaller than other replicating cells, and as such, have a higher membrane lipid to total 
cell protein ratio. Consequently, only lower protein concentrations could be focused without 
encountering large phospholipid aggregates which "trapped" nuclease activities and 
prevented their purification. The total protein concentration that could be loaded on the 
Rotofor from detergent-solubilized mycoplasmal preparations was 10 to IS mg, much lower 
than that recommended for normal soluble proteins. 
The purification of membrane proteins often is difficult and time consuming, but the 
Rotofor provides a simple, reproducible system for their isolation. The choice of detergent 
influenced many of the subsequent steps in the purification process. Since additional 
manipulation of the fractions was straightforward with the Rotofor, a detergent was chosen 
for solubilization of the membrane-bound nucleases that was uncharged, that could be 
removed easily without loss of activity, and did not interfere with subsequent analysis. The 
Triton series of detergents did not allow for ease of removal without the loss of activity, but 
CHAPS gave reproducible results and could be removed by dialysis. Other detergents such as 
|3-octyl glucoside might also function well, but were not studied. 
Ampholjrte pH ranges and concentrations were chosen after empirical analysis. Excess 
heat generated at higher ampholyte concentrations inactivated nuclease activities, and 
therefore, concentrations above 5% could not be used to focus higher protein concentrations. 
Also, a mixture of ampholyte ranges gave the best results rather than a single range 
encompassing the pi of the protein of interest. This indicates that preparative lEF requires 
investigation of multiple parameters for each particular application. 
Partial purification of the nuclease activities by Triton X-114 phase partitioning and 
membrane purification was also investigated. The nuclease activities associated exclusively 
with the Triton X-114 detergent phase and with purified membranes. The total number of 
proteins present in these preparations was lower than in whole cell preparations, which 
allowed a greater concentration of nuclease activity to be separated. The addition of a second 
detergent to Triton X-114 preparations greatly enhanced subsequent analysis of the Rotofor 
fractions. Since removal of the detergent was important in these experiments, CHAPS 
solubilized purified membranes is being used in purification of the membrane nucleases from 
Mycoplasma pulmonis (data not shown). 
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During these and related studies, additional information regarding the nucleases was 
obtained. The nucleases are hydrophobic, membrane-bound proteins which bind tightly to 
octyl sepharose, phenyl sepharose and many ion exchange resins (data not shown). Because 
of these properties and the observation that the nucleases focus together during preparative 
lEF, it is thought that they may form a membrane complex, possible with phospholipids. 
Unlike many other proteins, the nucleases also fail to stain after SDS-PAGE with either 
silver stains or Coomassie blue R. These proteins are present in all mycoplasmas tested, and 
protein profiles between different species demonstrate great diversity (data not showm). 
In sununary, the Rotofor is rapidly becoming an important tool in the generation of 
partially-purified, enzymatically-active protein preparations. In these studies, partially pure 
fractions of the Acholeplasma membrane bound nucleases were obtained. Optimal conditions 
consisted of protein concentrations of 10-15 mg per separation, use of CHAPS detergent to 
solubilize the proteins, a mixture of 3% 3.5-5.0 and 2% 4.0-6.5 ampholytes, and strict 
temperature regulation at 4°C. 
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APPENDIX B. BIOCHEMICAL METHODS AND ANALYSIS OF MYCOPLASMAL 
MEMBRANE NUCLEASES 
Introduction 
This appendix will discuss the biochemical studies perfoimed on the nucleases. Most of 
these studies were performed with Acholeplasma oculi 1499, with a relative few being 
applied to M. pulmonis. These experiments were not brought to completion and were not 
published. The purpose of their inclusion in this dissertation is to provide an overview of the 
biochemical nature of the nucleases. In general, mycoplasma membrane proteins are veiy 
difficult to purify and in these experiments, only partial purification of the nucleases was 
obtained. At no time were individual nucleolytic proteins separated into distinct fractions. 
Materials and Methods 
Heat and detergent treatment of mycoplasmas 
Mycoplasmas were collected, pelleted at 10,000 x g for 15 min, washed in PBS, 
repelleted and finally resuspended in PBS. The ability of the nucleases to withstand heat 
treatment or detergent treatment was analyzed by the addition of differing amounts of SDS to 
the resuspended cells in combination with or without boiling of the sample for 5 minutes. 
Nuclease activity was monitored prior to treatment, immediately after boiling and 30 min 
after boiling. Activity was scored as follows: m i n (greater than 1/32 dilution was seen to 
digest full length lambda DNA), +++ (1/16 dilution was capable of digesting lambda DNA), 
++ (l/4th dilution was capable of digesting lambda DNA), + (negligible, but measurable 
activity present). 
Several different detergents were also used to determine if they destroyed nuclease 
activity. These include SDS (varying concentration of 0.05 - 5%) octyl-p-glycoside (3-5%), 
Triton X-114 (1%), Triton X-100 (0.1%), CHAPS (4-5%). Detergents were added to the cell 
suspensions in PBS and nuclease activity was determined directly afterwards. 
Membrane isolation 
Mycoplasmas were grown ovemight to an early mid log phase. Membranes are difficult 
to isolate from mycoplasmas obtained from mid to late log cultures. Organisms grown in 200 
mis were harvested by centifugation, washed twice with 0.25 M NaCl and resuspended in 
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1/lOth volume of 2 M glycerol. Cells were incubated for 10 min at 37°C, minced several 
times through a 26 gauge needle and injected into 4 volumes of water at 37°C. The mixture 
was incubated at 37°C for IS min and then cooled rapidly in an ice/water bath. Unlysed cells 
were removed by pelleting at 6,700 x g for IS min. Membranes were harvested by pelleting 
at 31,000 X g for 30 min. Buffer was removed by aspiration, and the pellet was gently 
resuspended by swurling residual buffer in the centrifuge bottle. Membranes went into 
solution fairly easily, whereas any remaining pellet was most likely unlysed cells. The 
membrane suspension was loaded on top of a sucrose gradient (30/60%) and spun at 274,000 
x g for two h under slow acceleration and slow deacceleration. The membrane band was 
removed, and washed once in PBS (10-lS mis) and twice in 1 ml of PBS. To maintain 
nuclease activity, membranes were resuspended in 40% glycerol and stored frozen. Large 
scale membrane preparations were also performed by increasing the above given volumes 
accordingly. 
Trypsin treatment of whole cells prior to membrane isolation was achieved by 
resuspending the cells to approximately 1 mg protein per ml in PBS and treating with SOO 
p,g/ml trypsin (T-1005, Sigma) for 1 h at 37®C. Cells were pelleted and washed in 0.2S M 
NaCI, and membranes were isolated as described above. Trypsin treatment was also done on 
isolated membranes by resuspending the membranes to approximately 1 mg protein per ml in 
PBS and treating with SOO }ig/ml trypsin. Membranes were washed twice with PBS prior to 
use. 
Triton X-114 phase fractionatioii 
Mycoplasmas were pelleted from 2S0 ml of culture, washed once with PBS and 
resuspended in 1% Triton X-114 in TS buffer (0.01 M Tris - 0.15 M NaCl, pH 7.S) at room 
temperature. The suspension was incubated for 30 min at 4°C for equilibration of the 
detergent (mixed well to ensure complete distribution of the detergent), and then for 5 min at 
37°C to induce partitioning. Phases were separated by centrifugation at 6,000 x g for 10 min 
at 20°C or higher temperature (rotor must be warm). If phases did not separate, equilibration 
and the 37°C incubation was repeated prior to centrifugation. The upper aqueous phase was 
removed and stored for later use. The lower detergent phase was diluted with an equal 
volume of distilled water, equilibrated for 30 min at 4°C and phase separation was induced 
by incubation at 37°C for 5 min. Phases were separated as before, the lower detergent phase 
was collected, and subjected to an additional phase partitioning. In specific instances, the 
upper phase was also partitioned by the addition of an equal volume of 1% Triton X-114, 
equilibration and induction of phase partitioning. 
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For specific applications, Triton was removed from the proteins by diluting the sample in 
10 volumes of cold acetone, holding at 20°C for at least several hours to ovemight, and 
pelleting the resulting precipitate at 31,000 x g for 20 min or in a microfiige for IS min. An 
ethanol precipitation may also be performed instead, but ethanol is not as effective as acetone 
in removal of the detergent To precipitate with ethanol, 10 volumes of ethanol were added to 
the protein mixture, held at 20°C for at least several hours and pelleting the resulting 
precipitate. 
Column chromatography 
Hydrophobic chromatography 
Samples were prepared by disrupting washed whole cells in 5% CHAPS, diluting to 
0.25% CHAPS and particulate matter was pelleted prior to use of the supemate. (0.25% is 
below the CHAPS critical micelle concentration of 0.39%). An octyl sepharose column was 
equilibrated with 0.1 M (NH^)SO^ - 0.05% CHAPS and the sample was loaded. The void 
volume of the column was approximately 1 ml. One ml fractions were collected with the 
following elution profile: 5 mis of O.OIM (NH^)SO^ - 0.05 CHAPS, 5 mis of 0.001 M 
(NHpSO^ - 0.005% CHAPS, 5 mis of 0.01 M (NH^)SO^ with no detergent, 2 mis of 0.1% 
CHAPS, 2 mis of 0.25% CHAPS, and 1 ml of 5% CHAPS. Fractions were analyzed by the 
lambda assay to determine elution of the nucleases. In specific instances, beads of octyl 
sepharose were resuspended in 1% SDS and boiled to remove activity. The nucleolytic 
profile of the positive fi^ictions were analyzed by the SDS-PAGE nuclease assay. Phenyl 
sepharose media was used as described for octyl sepharose. 
Size fractionation 
Mycoplasmas were harvested, washed, disrupted in 5% CHAPS and diluted to 0.25% 
CHAPS prior to use. The proteins were applied to a column with an approximately 16 ml 
void volume. PBS was used to elute the proteins and 4 ml fractions were collected. Fractions 
were analyzed for activity using the lambda assay. 
Affinity chromatography 
A group of dye based columns were obtained from Sigma. Samples for these columns 
were prepared by disrupting whole cells in 5% Triton X-100 and centrifuging at 100,000 x g 
for 30 min. The supemate was loaded onto the column and the columns were washed with 5 
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volumes of 0.10 M Tris - 0.15M NaCl - 5% Triton X-100. The column was eluted with the 
buffer plus 1 mg/ml DNA - 25 mM pyrimidines - 25 mM purines. Two ml fractions were 
collected and analyzed for activity by the lambda assay and the SDS-PAGE nuclease assay. 
Antisera production 
Rabbit hyperimmune antisera were produced against various M. pulmonis x 1048 
preparations. Rabbits were immunized i.v. with whole cells and membranes or subcutaneous 
with Triton X-114 detergent fraction or nuclease bands from SDS-PAGE gels. For i.v. 
inmiunizations the antigen was diluted to Img protein per ml in PBS. Rabbits were injected 
on day 1 with 1 ml, day 2 with 2 ml, day 3 with 3 ml, day 4 with 4 ml, and day 7 with 4 ml. 
The antisera was tested on day 11 and the animals were bled on day 18 and following days. 
For subcutaneous immunizations, rabbits were injected with pulverized gel slices (1.5 ml per 
rabbit total in S to 6 injection sites along the back). For Triton X-114 detergent fnictions, 2.5 
ml of 1:1 mixture with Freund's incompete adjuvant also in 5 to 6 injection sites along back. 
These rabbits were boosted at 3 weeks with an identical amount of antigen. A test blee d was 
taken after 3 weeks and examined for anti-M. pulmonis activity by ELISA and immunoblot. 
The rabbits injected with the lower nuclease band were boosted a second time because of low 
activity. The antigen and corresponding rabbit number are given in Table B. 1. 
Results 
Antisera analysis 
Antisera produced against various mycoplasma preparations was analyzed by 
immunoblot against whole cell M. pulmonis lysate. The different antisera are listed in Table 
B.l and the inununological response in each animal is demonstrated in Figure B.l. 
Effects of heat and detergent treatments on nuclease activity 
Treatment of whole cell mycoplasmas with increasing concentrations of SDS inhibited 
nuclease activity as the concentration increased (Table B.2). When the samples were boiled, 
there was no activity immediately after the heat treatment. However, after a 30 min 
incubation, a small amount of activity was seen in the lambda assay (Table B.3). These 
results indicate that the nucleases are relatively resistant to detergent treatment and can also 
renature after denaturation within a short period of time. Using the SDS-PAGE nuclease 
assay, there is no measurable difference between samples which are treated with SDS at 
room temperature for 30 min, 65°C for 15 min or those samples which are boiled for 5 min 
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Table B.l. Description of rabbit hyperimmune antisera 
Rabbit Number Antigen Description 
90021 whole cells 
90108 whole cells 
90132 purified membranes 
90117 purified membranes 
90175 Triton X-114 extract, detergent phase 
90174 Triton X-114 extract, detergent phase 
89786 SDS-PAGE nuclease band, upper 
90171 SDS-PAGE nuclease band, upper 
90039 SDS-PAGE nuclease band, middle 
89938 SDS-PAGE nuclease band, middle 
89961 SDS-PAGE nuclease band, lower 
89971 SDS-PAGE nuclease band, lower 
(data not shown). The location of these proteins in the membrane may provide a means of 
protection from harsh detergent and heat treatments. 
Treatment of mycoplasmas with different detergents at various concentrations also had 
no apparent effect on nuclease activity and stability. These detergents included Triton X-100, 
CHAPS, octyl p-glucoside and Triton X-114. Subsequent experiments were performed with 
CHAPS because of ease of removal. The effects of various storage conditions and 
precipitation methods is shown in Table B.3. 
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Figure B.l. Immunoblot analysis of M. pulmonis whole cell and subcellular fractions using 
different rabbit antisera. Anitgen is M. pulmonis x\OA% whole cells. Rabbit hyperimmune 
antisera was raised against various preparations. The antisera number is given for each lane. 
Lane 1,90021; lane 2,90117; lane 3,89786; lane 4,90191; lane 5,90039; lane 6,89938; 
lane 7,89971; lane 8,89961; lane 9,90174; lane 10,90175. 
Table B.2. Sensitivity of nuclease activity to heat and SDS treatments 
Buffer Before boiling After boiling After 30 minute 
incubation 
PBS t 1 t >•+ - + 
PBS - 0.05% SDS 1 1 1 M - + 
PBS - 0.5% SDS +++ - + 
PBS - 1% SDS ++ - + 
PBS - 5% SDS + - + 
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Table B.3. Effects of purification of nuclease activity analyzed by Lambda and SDS-PAGE 
nuclease assay. 
Treatment Lambda Assay SDS-PAGE 
Triton X-114 
aqueous phase - not determined 
detergent phase + + 
Acetone precipitation - + 
Etlianol precipitation not determined + 
Boiling - + 
1% SDS + + 
0.25% CHAPS + + 
4% CHAPS + + 
Long-term storage 4°C - + 
Long-term storage -20°C + + 
Storage -70°C - not determined 
Cibron Blue 3GA + 
Octyl Sepharose (1% SDS) + + 
Phenyl Sepharose (1% SDS) + + 
Sephadex S-200 + + 
Localization of nuclease activity 
When mycoplasmas were subjected to Triton X-114 phase partitioning, nuclease activity 
was only detected in the detergent phase (Table B.3) indicating significant hydrophobicity 
and a probable membrane location. Analysis of the nucleolytic banding patterns after Triton 
X-114 partitioning was done using an SDS-PAGE nuclease gel after acetone precipitation. 
All of the nucleolytic proteins were present in the detergent phase (data not shown). 
To further determine the location of the nuclease, trypsin treatment before and after 
membrane isolation was performed. Purification of membranes was verified by SDS-PAGE 
gels (Figure B.2). When membranes were isolated and analyzed by SDS-PAGE nuclease 
assay, all of the nucleolytic bands were present in the membranes (data not shown). 
Treatment with trypsin pre or post membrane isolation had no apparent effect on the 
nucleolytic banding patterns indicating that the nucleases are relatively resistant to trypsin 
treatment. This supports the suggestion that the nucleases are protected inside the membrane 
of mycoplasmas. 
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Column chromatography 
Affinity chromatography was attempted using several different dye resins, octyl 
sepharose, and phenyl sepharose media. Nuclease activity bound to Cibron Blue 3GA, octyl 
sepharose and the phenyl sepharose media (Table B.3). The other dye resins did not absorb 
the nuclease activity. Activity, as measured by the lambda assay, was eluted from the Cibron 
Blue 3GA column using a buffer containing DNA and nucleotides. Unfortunately, these 
fractions displayed no activity when analyzed by SDS-PAGE nuclease assay. This may 
indicate that a cofactor was purified along with them in the fractions, which was lost during 
separation. 
Attempts to purify the nucleases off of octyl sepharose or phenyl sepharose columns were 
unsuccessful. Nuclease activity bound tightly to both of these colunm materials and could 
only be eluted when the concentration of CHAPS was raised above the critical micelle 
concentration. Occasionally, a small amount of activity was observed in the void volume. 
Complete elution was achieved by treating the beads with 1% SDS for several hours or 
boiling. Fractions remained nuclease positive in the detergents. Analysis of the released 
material by SDS-PAGE nuclease assay and silver staining after SDS treatment indicated that 
the entire spectrum of nucleolytic proteins, as well as many other proteins, were tightly 
bound to the octyl sepharose resin (Figure B.2). 
1 2  1  2  3  
Figure B.2. SDS-PAGE analysis of membrane fractions and octyl sepharose adhering 
fractions. Left panel (Coomassie Blue stained): lane 1, M. pulmonis whole cells, lane 2, M. 
pulmonis purified membranes; Right panel (silver stained); lane 1, M. pulmonis whole cells, 
lanes 2 and 3, adherent fractions of M.pulmonis to Ocytl Sepharose after standard elution. 
The fractions were eluted by SDS treament of the beads. 
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Size fractionation of the nuclease activity was attempted using Sephadex S-200. All 
activity was eluted in the void volume. This was repeated several times with the various 
detergents at concentrations above and below the critical micelle concentration. These 
changes had no effect on the elution of the nuclease activity in the void volume. 
Discussion 
The experiments described here indicate that the nucleases are hydrophobic membrane 
proteins. The nucleolytic proteins partition exclusively into the detergent phase of Triton X-
114 and are exclusively associated with membrane fractions. Proteins which are integral 
membrane proteins or lipoproteins are known to partition to the detergent phase, whereas 
many of the peripheral membrane proteins partition into the aqueous phase in the extraction. 
The discovery that MnuA has a membrane spanning domain and a prolipoprotein signal 
sequence correlates with these observations. The lipoproteins in mycoplasmas such as the 
Vlps are attached to the membrane by a fatty acid tail, with the remainder of the molecule 
usually bemg hydrophilic. This was also true of MnuA. Although these proteins may be 
hydrophilic in the C-terminus, they are relatively resistant to trypsin treatment. This indicates 
that they may either be in tight association with the membrane, buried in the membrane 
bilayer, or may not have an accessible trypsin cleavage site. 
In the detergent treatments and in the column chromatography studies, it is possible that 
the nucleases were never completely separated firom membrane components. This may 
explain why individual proteins were never resolved and why the proteins appeared to be in a 
complex when size fractionation studies were performed. Even when isoelectric focusing was 
performed, the proteins migrated together. Nonionic detergents may be unable to dissociate 
the strong hydrophobic forces attracting the nucleases and membrane components. In many 
respects, the results of these experiments would also be seen in attempts to purify a lipid 
molecule. Future attempts to purify the nucleases will need to consider the acylation of these 
proteins and possibly treat them as a lipid. It should be pointed out that none of the 
mycoplasma lipoproteins have been purified. 
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APPENDIX C. PLASMID CONSTRUCTIONS 
Plasmid 
Designation 
Parent 
Phage Description of Construction 
pISM400S 6.2B 4.8 kb Sacl fragment cloned into pKS 
pISM4010 6.3E 6.4 kb & 12.2 kb Sacl fragments cloned into pKS 
pISM4011 6.3E 12.2 kb Sacl fragment cloned into pKS 
pISM4012 6.3E small Sacl fragment cloned into pKS 
pISM4013 6.3E small Sacl fragment cloned into pKS 
pISM4020 9.3B 10.4 kb Sacl fragment cloned into pKS 
pISM4021 9.3B 10.4 kb Sacl fragment cloned into pKS 
pISM4022 9.3B 10.4 kb Sacl fragment cloned into pKS 
pISM4030 9.2C 12.2 kb Sacl fragment cloned into pKS 
pISM4040 9. ICG 6.7 kb Sacl fragment cloned into pKS 
pISM4041 9.10G 8.2 kb Sacl fragment cloned into pKS 
pISM4042 9.10G small 5acl fragment cloned into pKS 
pISM4050 11.6E small Sacl fragment cloned into pKS 
pISM4051 1L6E 3.7 kb Sacl fragment cloned into pKS 
pISM4052 11.6E 5.5 kb Sacl fragment cloned into pKS 
pISM4060 13.5C 4.7 kb Sacl fragment cloned into pKS 
pISM4061 13.5C 8.1 kb Sacl fragment cloned into pKS 
pISM4062 13.5C 4.7 kb and 8.1 kb Sacl fragments cloned into pKS 
pISM4070 14.1 IF 3.7 kb and 7.5 kb Sacl fragments cloned into pKS 
pISM4071 14.1 IF 7.5 kb and 1.7 kb Sacl fragments cloned into pKS 
pISM4072 14.1 IF 3.7 kb and 7.5 kb Sacl fragments cloned into pKS 
pISM4073 14.1 IF 1.7 kb Sacl fragment cloned into pKS 
pISM4080 14.3D 3.7 kb Sacl fragment cloned into pKS 
pISM4081 14.3D 4.4 kb and 5.3 kb Sacl fragments cloned into pKS 
pISM4090 16.D2 2.2 kb and 3.1 kb Sacl fragments cloned into pKS 
pISM4091 16.D2 3.5 kb Sacl fragment cloned into pKS 
pISM4100 8.12F 3.5,7 and 8 kb Sacl fragments cloned into pKS 
pISM4101 8.12F 8 kb and 12 kb Sacl fragments cloned into pKS 
pISM4102 8.12F 2.0 kb 5acl fragments cloned into pKS 
pISM4110 9.2A 2.2 kb and small Sacl fragments cloned into pKS 
pISM4111 9.2A 8,10.4 and 12 kb Sacl fragments cloned into pKS 
pISM4112 9.2A 2.2 kb Sacl fragment cloned into pKS 
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pISM4113 9.2A 
pISM4114 9.2A 
pISM4120 9.2B 
pISM4121 9.2B 
pISM4130 9.6G 
pISM4131 9.6G 
pISM4132 9.6G 
pISM4140 9.12E 
pISM4150 11.2D 
pISM4160 14.7C 
pISM4161 14.7C 
pISM4162 14.7C 
pISM4170 13.2B 
pISM4171 13.2B 
pISM4172 13.2B 
pISM4173 13.2B 
pISM4174 13.2B 
pISM4175 13.2B 
PISM4176 13.2B 
pISM4177 13.2B 
pISM4180 13.2B 
pISM4181 13.2B 
pISM4182 13.2B 
pISM4201 13.2B 
pISM4202 13.2B 
10.4 kb Sacl fragment cloned into pKS 
2.7, 3.2 and 8 kb Sacl fragments cloned into pKS 
3.2 and 7.S kb Sacl fragments cloned into pKS 
2.5 kb 5acl fragment cloned into pKS 
8 kb Sacl fragment cloned into pKS 
4.5 kb Sacl fragment cloned into pKS 
6.8, and 10 kb Sacl fragments cloned into pKS 
1.4 kb Sacl fragment cloned into pKS 
1.8 kb Sacl fragment cloned into pKS 
2.0 kb Sacl fragment cloned into pKS 
1.7,2.8 and 4 kb Sacl fragments cloned into pKS 
1.3,7 and 11 kb Sacl fragments cloned into pKS 
6.8 kb Sacl fragment cloned into pMOB 
6.8 kb Sacl fragment cloned into pMOB 
6.6 kb Sacl fragment cloned into pMOB 
2.2 Clal fragments from pISM4172 cloned into 
pMOB 
2.2 Clal fragments from pISM4172 cloned into 
pMOB 
2.2 Clal fragments from pISM4172 cloned into 
pMOB 
2.6 Sacl-Clal fragment from pISM4172 cloned 
into pMOB 
2.6 Sacl-Clal fragment from pISM4172 cloned 
into pMOB 
pISM4176 with small £coRV fragment deleted at 
end of the fragment (pISM4176A10) 
pISM4176 with large EcoRW fragment deleted at 
end of the fragment (pISM4176A8) 
pISM4181 with tetM HincU fragment from 
pISM1002 cloned into HincU. site of MCS 
Sacl • Clal fragment from pISM4176 cloned into 
pG7ZCW (Wise) 
pISM4201 with Sacl - HindUl fragment deleted 
using T4 DNA polymerase and blunt end ligation 
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